JP2010503674A - 血管形成治療用化合物 - Google Patents
血管形成治療用化合物 Download PDFInfo
- Publication number
- JP2010503674A JP2010503674A JP2009528287A JP2009528287A JP2010503674A JP 2010503674 A JP2010503674 A JP 2010503674A JP 2009528287 A JP2009528287 A JP 2009528287A JP 2009528287 A JP2009528287 A JP 2009528287A JP 2010503674 A JP2010503674 A JP 2010503674A
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- phenyl
- isoxazole
- methoxy
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 title claims description 425
- 230000002491 angiogenic effect Effects 0.000 title 1
- -1 triazole compounds Chemical class 0.000 claims abstract description 621
- 230000033115 angiogenesis Effects 0.000 claims abstract description 15
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 6
- 125000001072 heteroaryl group Chemical group 0.000 claims description 208
- 125000000623 heterocyclic group Chemical group 0.000 claims description 175
- 125000000217 alkyl group Chemical group 0.000 claims description 171
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 162
- 125000001188 haloalkyl group Chemical group 0.000 claims description 161
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 156
- 125000003107 substituted aryl group Chemical group 0.000 claims description 156
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 150
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 149
- 125000004475 heteroaralkyl group Chemical group 0.000 claims description 147
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 141
- 125000004426 substituted alkynyl group Chemical group 0.000 claims description 138
- 125000005017 substituted alkenyl group Chemical group 0.000 claims description 137
- 125000003545 alkoxy group Chemical group 0.000 claims description 136
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 134
- 150000003839 salts Chemical class 0.000 claims description 129
- 229940002612 prodrug Drugs 0.000 claims description 123
- 239000000651 prodrug Substances 0.000 claims description 123
- 239000012453 solvate Substances 0.000 claims description 123
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 121
- 125000003282 alkyl amino group Chemical group 0.000 claims description 106
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 102
- 125000004404 heteroalkyl group Chemical group 0.000 claims description 89
- 125000003342 alkenyl group Chemical group 0.000 claims description 85
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 73
- 125000004076 pyridyl group Chemical group 0.000 claims description 73
- 125000000304 alkynyl group Chemical group 0.000 claims description 70
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 66
- 125000005907 alkyl ester group Chemical group 0.000 claims description 61
- 229910052757 nitrogen Inorganic materials 0.000 claims description 56
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 52
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 45
- 125000001041 indolyl group Chemical group 0.000 claims description 44
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 43
- 125000002971 oxazolyl group Chemical group 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 24
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 23
- 125000000539 amino acid group Chemical group 0.000 claims description 20
- 229910052760 oxygen Inorganic materials 0.000 claims description 19
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 18
- 125000002947 alkylene group Chemical group 0.000 claims description 17
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims description 17
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 16
- 125000002098 pyridazinyl group Chemical group 0.000 claims description 16
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 16
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims description 15
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 15
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 15
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 14
- 125000001544 thienyl group Chemical group 0.000 claims description 14
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims description 13
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims description 13
- 125000002883 imidazolyl group Chemical group 0.000 claims description 13
- 125000001786 isothiazolyl group Chemical group 0.000 claims description 13
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 13
- 125000002541 furyl group Chemical group 0.000 claims description 12
- 125000001715 oxadiazolyl group Chemical group 0.000 claims description 12
- 125000001113 thiadiazolyl group Chemical group 0.000 claims description 12
- 125000000335 thiazolyl group Chemical group 0.000 claims description 12
- 125000005955 1H-indazolyl group Chemical group 0.000 claims description 11
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 11
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 claims description 11
- 125000003384 isochromanyl group Chemical group C1(OCCC2=CC=CC=C12)* 0.000 claims description 11
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 11
- 238000011282 treatment Methods 0.000 claims description 11
- 229920003169 water-soluble polymer Polymers 0.000 claims description 9
- 239000004305 biphenyl Substances 0.000 claims description 8
- 235000010290 biphenyl Nutrition 0.000 claims description 8
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 claims description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 5
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 5
- 125000001475 halogen functional group Chemical group 0.000 claims 11
- 230000014399 negative regulation of angiogenesis Effects 0.000 claims 4
- 150000003854 isothiazoles Chemical class 0.000 abstract description 2
- 150000002545 isoxazoles Chemical class 0.000 abstract description 2
- 125000001424 substituent group Chemical group 0.000 description 178
- 125000005843 halogen group Chemical group 0.000 description 169
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 110
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 48
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 45
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 34
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 31
- 125000003118 aryl group Chemical group 0.000 description 31
- 125000004414 alkyl thio group Chemical group 0.000 description 30
- 159000000000 sodium salts Chemical class 0.000 description 30
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 21
- SVSARCCKBMZNMR-UHFFFAOYSA-N [1-[2-[methyl-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethyl]amino]ethyl]pyridin-4-ylidene]methyl-oxoazanium;dichloride Chemical compound [Cl-].[Cl-].C1=CC(=C[NH+]=O)C=CN1CCN(C)CCN1C=CC(=C[NH+]=O)C=C1 SVSARCCKBMZNMR-UHFFFAOYSA-N 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 19
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 18
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 16
- 229910019142 PO4 Inorganic materials 0.000 description 15
- 239000010452 phosphate Substances 0.000 description 15
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 14
- 239000011734 sodium Substances 0.000 description 14
- 229910052708 sodium Inorganic materials 0.000 description 14
- 125000003831 tetrazolyl group Chemical group 0.000 description 14
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 13
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 229910052717 sulfur Inorganic materials 0.000 description 13
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 12
- 201000010099 disease Diseases 0.000 description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 12
- 229920001223 polyethylene glycol Polymers 0.000 description 12
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 11
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 11
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 11
- 229960003767 alanine Drugs 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 11
- 229960003136 leucine Drugs 0.000 description 11
- 229960004452 methionine Drugs 0.000 description 11
- 229960001153 serine Drugs 0.000 description 11
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 9
- HVXBOLULGPECHP-WAYWQWQTSA-N Combretastatin A4 Chemical compound C1=C(O)C(OC)=CC=C1\C=C/C1=CC(OC)=C(OC)C(OC)=C1 HVXBOLULGPECHP-WAYWQWQTSA-N 0.000 description 9
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 9
- 239000004471 Glycine Substances 0.000 description 9
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 9
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 9
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 9
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 9
- 235000004279 alanine Nutrition 0.000 description 9
- 125000003275 alpha amino acid group Chemical group 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 9
- 229960005537 combretastatin A-4 Drugs 0.000 description 9
- HVXBOLULGPECHP-UHFFFAOYSA-N combretastatin A4 Natural products C1=C(O)C(OC)=CC=C1C=CC1=CC(OC)=C(OC)C(OC)=C1 HVXBOLULGPECHP-UHFFFAOYSA-N 0.000 description 9
- 208000035475 disorder Diseases 0.000 description 9
- 229960002449 glycine Drugs 0.000 description 9
- 125000005842 heteroatom Chemical group 0.000 description 9
- 229930182817 methionine Natural products 0.000 description 9
- 229960005190 phenylalanine Drugs 0.000 description 9
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 9
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 8
- QLVDOJZFRXIUJX-UHFFFAOYSA-N dimethoxyphosphoryl-(3,4,5-trimethoxyphenyl)methanol Chemical compound COC1=CC(C(O)P(=O)(OC)OC)=CC(OC)=C1OC QLVDOJZFRXIUJX-UHFFFAOYSA-N 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- ACYNRPCVKNPNPN-UHFFFAOYSA-N 2-amino-n-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]acetamide Chemical compound C1=C(NC(=O)CN)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 ACYNRPCVKNPNPN-UHFFFAOYSA-N 0.000 description 7
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 7
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 7
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 7
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 7
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 7
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 7
- 150000001408 amides Chemical class 0.000 description 7
- 208000025113 myeloid leukemia Diseases 0.000 description 7
- 125000006239 protecting group Chemical group 0.000 description 7
- 125000005415 substituted alkoxy group Chemical group 0.000 description 7
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 6
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 6
- 239000004472 Lysine Substances 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 229960002989 glutamic acid Drugs 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 208000032839 leukemia Diseases 0.000 description 6
- 230000002062 proliferating effect Effects 0.000 description 6
- VHWJSJBTUWUEAL-UHFFFAOYSA-N propanamide;hydrochloride Chemical compound Cl.CCC(N)=O VHWJSJBTUWUEAL-UHFFFAOYSA-N 0.000 description 6
- MQLACMBJVPINKE-UHFFFAOYSA-N 10-[(3-hydroxy-4-methoxyphenyl)methylidene]anthracen-9-one Chemical compound C1=C(O)C(OC)=CC=C1C=C1C2=CC=CC=C2C(=O)C2=CC=CC=C21 MQLACMBJVPINKE-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- 150000008574 D-amino acids Chemical class 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 5
- 150000008575 L-amino acids Chemical class 0.000 description 5
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 5
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 5
- 239000004473 Threonine Substances 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 229960001230 asparagine Drugs 0.000 description 5
- 229960005261 aspartic acid Drugs 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 5
- 229960002743 glutamine Drugs 0.000 description 5
- 229960002885 histidine Drugs 0.000 description 5
- 229960000310 isoleucine Drugs 0.000 description 5
- 229960003646 lysine Drugs 0.000 description 5
- 229960002429 proline Drugs 0.000 description 5
- 229960002898 threonine Drugs 0.000 description 5
- 229960004441 tyrosine Drugs 0.000 description 5
- 229960004295 valine Drugs 0.000 description 5
- HUSHQKIWDTXROP-UHFFFAOYSA-N 2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]aniline Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC=C(OC)C(N)=C1 HUSHQKIWDTXROP-UHFFFAOYSA-N 0.000 description 4
- VPYMDRXNYFGVSI-UHFFFAOYSA-N 4-(5-methoxypyridin-2-yl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound N1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 VPYMDRXNYFGVSI-UHFFFAOYSA-N 0.000 description 4
- ATAFKTCSJZTBGL-UHFFFAOYSA-N 4-(6-methoxypyridin-3-yl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=NC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 ATAFKTCSJZTBGL-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 4
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- 208000000389 T-cell leukemia Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 235000009697 arginine Nutrition 0.000 description 4
- 229960003121 arginine Drugs 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 239000004220 glutamic acid Substances 0.000 description 4
- 235000013922 glutamic acid Nutrition 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 206010020718 hyperplasia Diseases 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 125000004531 indol-5-yl group Chemical group [H]N1C([H])=C([H])C2=C([H])C(*)=C([H])C([H])=C12 0.000 description 4
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical group C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 4
- 235000018977 lysine Nutrition 0.000 description 4
- 208000002780 macular degeneration Diseases 0.000 description 4
- 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- UTMPLFGURKPCGT-UHFFFAOYSA-N 1-methyl-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]indole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=C3C=CN(C)C3=CC=2)=C1 UTMPLFGURKPCGT-UHFFFAOYSA-N 0.000 description 3
- XTQYCTJDBBUZKD-UHFFFAOYSA-N 4-(1-methylindol-5-yl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=C3C=CN(C)C3=CC=2)=C1 XTQYCTJDBBUZKD-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 3
- 208000004736 B-Cell Leukemia Diseases 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- 201000009030 Carcinoma Diseases 0.000 description 3
- 206010012689 Diabetic retinopathy Diseases 0.000 description 3
- 201000009273 Endometriosis Diseases 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- 206010039491 Sarcoma Diseases 0.000 description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 125000005163 aryl sulfanyl group Chemical group 0.000 description 3
- 235000009582 asparagine Nutrition 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 3
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- 229960002433 cysteine Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- 235000004554 glutamine Nutrition 0.000 description 3
- 235000014304 histidine Nutrition 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
- 206010023332 keratitis Diseases 0.000 description 3
- 208000003747 lymphoid leukemia Diseases 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical class [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000013930 proline Nutrition 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 229960004799 tryptophan Drugs 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- IROYKOZAFVCDMV-UHFFFAOYSA-N 1-(1,3-benzodioxol-5-yl)-5-(4-methoxyphenyl)triazole Chemical compound C1=CC(OC)=CC=C1C1=CN=NN1C1=CC=C(OCO2)C2=C1 IROYKOZAFVCDMV-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- PWQRTBBMZZHDAB-UHFFFAOYSA-N 2-[4-(4-aminophenyl)-1,2-oxazol-5-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(C=NO2)C=2C=CC(N)=CC=2)=C1O PWQRTBBMZZHDAB-UHFFFAOYSA-N 0.000 description 2
- ZDXKTWZRFMCNIO-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-1,2-oxazol-5-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(C=NO2)C=2C=CC(Cl)=CC=2)=C1O ZDXKTWZRFMCNIO-UHFFFAOYSA-N 0.000 description 2
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 2
- KVVWMSWUJFQBLZ-UHFFFAOYSA-N 2-amino-n-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]phenyl]-4-methylpentanamide;hydrochloride Chemical compound Cl.C1=C(NC(=O)C(N)CC(C)C)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 KVVWMSWUJFQBLZ-UHFFFAOYSA-N 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- RYSNQRZTJZKMHL-UHFFFAOYSA-N 2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]pyridine Chemical compound C1=NC(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 RYSNQRZTJZKMHL-UHFFFAOYSA-N 0.000 description 2
- BPJVAQLVAHNYPH-UHFFFAOYSA-N 2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]aniline Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC=C(OC)C(N)=C1 BPJVAQLVAHNYPH-UHFFFAOYSA-N 0.000 description 2
- AOBMLJOWVTWPGK-UHFFFAOYSA-N 2-methoxy-5-[4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazol-5-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NO1 AOBMLJOWVTWPGK-UHFFFAOYSA-N 0.000 description 2
- PGGUSAATYZXGBJ-UHFFFAOYSA-N 2-methoxy-5-[5-(2,3,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenol Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NO2)C=2C=C(O)C(OC)=CC=2)=C1 PGGUSAATYZXGBJ-UHFFFAOYSA-N 0.000 description 2
- YQMGTRQPLYNDDV-UHFFFAOYSA-N 2-methoxy-5-[5-(2,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)ON=C1 YQMGTRQPLYNDDV-UHFFFAOYSA-N 0.000 description 2
- PIXLSTRIFCYWHY-UHFFFAOYSA-N 2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]aniline Chemical compound C1=C(N)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 PIXLSTRIFCYWHY-UHFFFAOYSA-N 0.000 description 2
- SWMKNIPFYOBUKC-UHFFFAOYSA-N 2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]benzenethiol Chemical compound C1=C(S)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 SWMKNIPFYOBUKC-UHFFFAOYSA-N 0.000 description 2
- DDNUDWBYMWLRJN-UHFFFAOYSA-N 2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]benzoic acid Chemical compound C1=C(C(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 DDNUDWBYMWLRJN-UHFFFAOYSA-N 0.000 description 2
- FIAQFUWVHGNSDW-UHFFFAOYSA-N 2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 FIAQFUWVHGNSDW-UHFFFAOYSA-N 0.000 description 2
- UWEVBNMDTFZIHD-UHFFFAOYSA-N 2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]pyridine Chemical compound C1=NC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 UWEVBNMDTFZIHD-UHFFFAOYSA-N 0.000 description 2
- YSWDXJUCDHTIMU-UHFFFAOYSA-N 2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]benzenethiol Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC=C(OC)C(S)=C1 YSWDXJUCDHTIMU-UHFFFAOYSA-N 0.000 description 2
- PXJUFGPCLVVHBB-UHFFFAOYSA-N 2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]aniline Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC=C(OC)C(N)=C1 PXJUFGPCLVVHBB-UHFFFAOYSA-N 0.000 description 2
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
- DLDOPMSVBRGKHV-UHFFFAOYSA-N 2-methylsulfanyl-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=C(N)C(SC)=CC=2)=C1 DLDOPMSVBRGKHV-UHFFFAOYSA-N 0.000 description 2
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 2
- VSGCSFMHLXEJMA-UHFFFAOYSA-N 4-(1,3-benzodioxol-5-yl)-5-(4-methoxyphenyl)-2h-triazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=C3OCOC3=CC=2)N=NN1 VSGCSFMHLXEJMA-UHFFFAOYSA-N 0.000 description 2
- BSWAEWJDAKTZRQ-UHFFFAOYSA-N 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=C3OCCOC3=CC=2)=C1 BSWAEWJDAKTZRQ-UHFFFAOYSA-N 0.000 description 2
- AYMCLNFBPGDCLP-UHFFFAOYSA-N 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(3,4-dimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(C=2C=C3OCCOC3=CC=2)C=NO1 AYMCLNFBPGDCLP-UHFFFAOYSA-N 0.000 description 2
- IEIRMEBXDMEFBX-UHFFFAOYSA-N 4-(2,3-dihydro-1-benzofuran-6-yl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=C3OCCC3=CC=2)=C1 IEIRMEBXDMEFBX-UHFFFAOYSA-N 0.000 description 2
- YGSFMAOCVZHZMX-UHFFFAOYSA-N 4-(2,3-dihydro-1-benzofuran-6-yl)-5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazole Chemical compound C1=C2CCOC2=CC(C=2C=NOC=2C=2C=C(C=3OCOC=3C=2)OC)=C1 YGSFMAOCVZHZMX-UHFFFAOYSA-N 0.000 description 2
- BGHIESAQLSZMLP-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NO2)C=2C=C(OC)C(OC)=CC=2)=C1 BGHIESAQLSZMLP-UHFFFAOYSA-N 0.000 description 2
- MDRZLWUHVCZSGU-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)ON=C1 MDRZLWUHVCZSGU-UHFFFAOYSA-N 0.000 description 2
- MNGYEYPPXUDYFI-UHFFFAOYSA-N 4-(4-bromophenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(Br)=CC=2)C=NO1 MNGYEYPPXUDYFI-UHFFFAOYSA-N 0.000 description 2
- XYAABHGXWJEYQS-UHFFFAOYSA-N 4-(4-bromophenyl)-5-(3,4,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(Br)=CC=2)=C1 XYAABHGXWJEYQS-UHFFFAOYSA-N 0.000 description 2
- QFQYKJIXZKBDDK-UHFFFAOYSA-N 4-(4-butoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCCCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)ON=C1 QFQYKJIXZKBDDK-UHFFFAOYSA-N 0.000 description 2
- PYZOWQRWWRBUFK-UHFFFAOYSA-N 4-(4-butoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCCCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)ON=C1 PYZOWQRWWRBUFK-UHFFFAOYSA-N 0.000 description 2
- ZXOLRWQJQZDCDI-UHFFFAOYSA-N 4-(4-butylphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CCCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)ON=C1 ZXOLRWQJQZDCDI-UHFFFAOYSA-N 0.000 description 2
- ZBJVXJMBGPCUCT-UHFFFAOYSA-N 4-(4-butylphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CCCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)ON=C1 ZBJVXJMBGPCUCT-UHFFFAOYSA-N 0.000 description 2
- RUMJVALBITYWCS-UHFFFAOYSA-N 4-(4-chlorophenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NO2)C=2C=CC(Cl)=CC=2)=C1 RUMJVALBITYWCS-UHFFFAOYSA-N 0.000 description 2
- DINBLFPCSMDLDR-UHFFFAOYSA-N 4-(4-chlorophenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(Cl)=CC=2)C=NO1 DINBLFPCSMDLDR-UHFFFAOYSA-N 0.000 description 2
- DEYNSOLSBDLJMY-UHFFFAOYSA-N 4-(4-ethoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)ON=C1 DEYNSOLSBDLJMY-UHFFFAOYSA-N 0.000 description 2
- GLBXCLKYNWMPDJ-UHFFFAOYSA-N 4-(4-ethoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)ON=C1 GLBXCLKYNWMPDJ-UHFFFAOYSA-N 0.000 description 2
- BAHZEQZXXNFOKN-UHFFFAOYSA-N 4-(4-ethylphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)ON=C1 BAHZEQZXXNFOKN-UHFFFAOYSA-N 0.000 description 2
- XIDHYLWGCAILAJ-UHFFFAOYSA-N 4-(4-ethylphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)ON=C1 XIDHYLWGCAILAJ-UHFFFAOYSA-N 0.000 description 2
- GSWOVTVBVIIMDY-UHFFFAOYSA-N 4-(4-ethylphenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 GSWOVTVBVIIMDY-UHFFFAOYSA-N 0.000 description 2
- TXCXXZYXPGHSRD-UHFFFAOYSA-N 4-(4-fluorophenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NO2)C=2C=CC(F)=CC=2)=C1 TXCXXZYXPGHSRD-UHFFFAOYSA-N 0.000 description 2
- CLWUVAFSVBSPDW-UHFFFAOYSA-N 4-(4-fluorophenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(F)=CC=2)C=NO1 CLWUVAFSVBSPDW-UHFFFAOYSA-N 0.000 description 2
- BLKYHNLTPBZSPF-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(2,3,4-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=CC=2)OC)ON=C1 BLKYHNLTPBZSPF-UHFFFAOYSA-N 0.000 description 2
- LWIQAQPGUWWEFC-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)ON=C1 LWIQAQPGUWWEFC-UHFFFAOYSA-N 0.000 description 2
- QWBBADVRYIENRY-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)ON=C1 QWBBADVRYIENRY-UHFFFAOYSA-N 0.000 description 2
- XUGSPERSQBCGJK-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 XUGSPERSQBCGJK-UHFFFAOYSA-N 0.000 description 2
- JEKSTTPLVGEMPJ-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(4,5,6-trimethoxypyridin-2-yl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2N=C(OC)C(OC)=C(OC)C=2)ON=C1 JEKSTTPLVGEMPJ-UHFFFAOYSA-N 0.000 description 2
- GSHBOLZYCORNGP-UHFFFAOYSA-N 4-(4-methylphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NO2)C=2C=CC(C)=CC=2)=C1 GSHBOLZYCORNGP-UHFFFAOYSA-N 0.000 description 2
- DOPAURQJVKBKOP-UHFFFAOYSA-N 4-(4-methylphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(C)=CC=2)C=NO1 DOPAURQJVKBKOP-UHFFFAOYSA-N 0.000 description 2
- UKVZPAFHWGGCHQ-UHFFFAOYSA-N 4-(4-methylsulfanylphenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CC(SC)=CC=2)=C1 UKVZPAFHWGGCHQ-UHFFFAOYSA-N 0.000 description 2
- BLWWWMUHPUOEHS-UHFFFAOYSA-N 4-(4-nitrophenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NO2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 BLWWWMUHPUOEHS-UHFFFAOYSA-N 0.000 description 2
- BVMHCZJJGIZRSF-UHFFFAOYSA-N 4-(4-nitrophenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(=CC=2)[N+]([O-])=O)C=NO1 BVMHCZJJGIZRSF-UHFFFAOYSA-N 0.000 description 2
- RUKMRZYVZNNVIS-UHFFFAOYSA-N 4-(4-propan-2-ylphenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CC(=CC=2)C(C)C)=C1 RUKMRZYVZNNVIS-UHFFFAOYSA-N 0.000 description 2
- WRTXRMQOQHWDOK-UHFFFAOYSA-N 4-(4-propoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)ON=C1 WRTXRMQOQHWDOK-UHFFFAOYSA-N 0.000 description 2
- BUVBQFNRGOAJKP-UHFFFAOYSA-N 4-(4-propoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)ON=C1 BUVBQFNRGOAJKP-UHFFFAOYSA-N 0.000 description 2
- XZBAPJANXDEMBN-UHFFFAOYSA-N 4-(4-propylphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)ON=C1 XZBAPJANXDEMBN-UHFFFAOYSA-N 0.000 description 2
- YWIUXCGRNABDDN-UHFFFAOYSA-N 4-(4-propylphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)ON=C1 YWIUXCGRNABDDN-UHFFFAOYSA-N 0.000 description 2
- XSGJEBLNZOHWAC-UHFFFAOYSA-N 4-(5-methoxypyridin-2-yl)-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound N1=CC(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 XSGJEBLNZOHWAC-UHFFFAOYSA-N 0.000 description 2
- ZQGNIMPBNCOTLH-UHFFFAOYSA-N 4-(5-methoxypyridin-2-yl)-5-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound N1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)SN=C1 ZQGNIMPBNCOTLH-UHFFFAOYSA-N 0.000 description 2
- ZHBJJIZHWKGVLR-UHFFFAOYSA-N 4-(6-methoxypyridin-3-yl)-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=NC(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 ZHBJJIZHWKGVLR-UHFFFAOYSA-N 0.000 description 2
- KPEZJYCJYQKTSV-UHFFFAOYSA-N 4-[4-(1-methyltetrazol-5-yl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CC(=CC=2)C=2N(N=NN=2)C)=C1 KPEZJYCJYQKTSV-UHFFFAOYSA-N 0.000 description 2
- WJNXXKAJIIVWCQ-UHFFFAOYSA-N 4-[4-(2h-tetrazol-5-yl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CC(=CC=2)C=2NN=NN=2)=C1 WJNXXKAJIIVWCQ-UHFFFAOYSA-N 0.000 description 2
- RDHNNJULSHRZEA-UHFFFAOYSA-N 4-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenol Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CC(O)=CC=2)=C1 RDHNNJULSHRZEA-UHFFFAOYSA-N 0.000 description 2
- SLCMOHSPSDTZNX-UHFFFAOYSA-N 4-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenol Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC=C(O)C=C1 SLCMOHSPSDTZNX-UHFFFAOYSA-N 0.000 description 2
- SNHCUNNQGFKFPW-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-(4-naphthalen-2-yl-1,2-oxazol-5-yl)phenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(C=NO2)C=2C=C3C=CC=CC3=CC=2)=C1O SNHCUNNQGFKFPW-UHFFFAOYSA-N 0.000 description 2
- NYYMEQYQOSNDPX-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[4-(4-methoxyphenyl)-1,2-oxazol-3-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(C=2C(=CON=2)C=2C=CC(OC)=CC=2)=C1O NYYMEQYQOSNDPX-UHFFFAOYSA-N 0.000 description 2
- PFOQNHCIJFIQEK-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[4-(4-methoxyphenyl)-1,2-thiazol-5-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(C=NS2)C=2C=CC(OC)=CC=2)=C1O PFOQNHCIJFIQEK-UHFFFAOYSA-N 0.000 description 2
- PEEMSHYALIEEBB-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[4-(4-methylphenyl)-1,2-oxazol-5-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(C=NO2)C=2C=CC(C)=CC=2)=C1O PEEMSHYALIEEBB-UHFFFAOYSA-N 0.000 description 2
- GQAQMMACXNWZLG-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[4-[4-(trifluoromethyl)phenyl]-1,2-oxazol-5-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(C=NO2)C=2C=CC(=CC=2)C(F)(F)F)=C1O GQAQMMACXNWZLG-UHFFFAOYSA-N 0.000 description 2
- GMTSNDCKZBUYDA-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[5-(4-methoxyphenyl)-2H-triazol-4-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(OC)=CC=2)=C1O GMTSNDCKZBUYDA-UHFFFAOYSA-N 0.000 description 2
- HBSCCXMEADWRHM-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[5-(4-methoxyphenyl)triazol-1-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(OC)=CC=2)=C1O HBSCCXMEADWRHM-UHFFFAOYSA-N 0.000 description 2
- USQIJNREKWOANM-UHFFFAOYSA-N 4-pyridazin-4-yl-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=NN=CC=2)=C1 USQIJNREKWOANM-UHFFFAOYSA-N 0.000 description 2
- ZETCLKPJMQKUOD-UHFFFAOYSA-N 4-pyridin-3-yl-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=NC=CC=2)=C1 ZETCLKPJMQKUOD-UHFFFAOYSA-N 0.000 description 2
- NIZLGOWLPPEWBU-UHFFFAOYSA-N 4-pyrimidin-5-yl-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=NC=NC=2)=C1 NIZLGOWLPPEWBU-UHFFFAOYSA-N 0.000 description 2
- UXBALNFXRIRBLY-UHFFFAOYSA-N 5-(1,3-benzodioxol-4-yl)-4-(4-methoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=3OCOC=3C=CC=2)ON=C1 UXBALNFXRIRBLY-UHFFFAOYSA-N 0.000 description 2
- VCBSNWVZKKQDDI-UHFFFAOYSA-N 5-(1-ethylindol-7-yl)-4-(4-methoxyphenyl)-1,2-oxazole Chemical compound C=12N(CC)C=CC2=CC=CC=1C=1ON=CC=1C1=CC=C(OC)C=C1 VCBSNWVZKKQDDI-UHFFFAOYSA-N 0.000 description 2
- GQOSXOFFYYEWGO-UHFFFAOYSA-N 5-(1-methylindol-5-yl)-4-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(ON=C2)C=2C=C3C=CN(C)C3=CC=2)=C1 GQOSXOFFYYEWGO-UHFFFAOYSA-N 0.000 description 2
- IPWMYNZFNBVJBY-UHFFFAOYSA-N 5-(2,3,5-trimethoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NO2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 IPWMYNZFNBVJBY-UHFFFAOYSA-N 0.000 description 2
- JJIHPMZCKHUWNX-UHFFFAOYSA-N 5-(2,4,5-trimethoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)C=NO1 JJIHPMZCKHUWNX-UHFFFAOYSA-N 0.000 description 2
- GCBUEYSZQVMAKH-UHFFFAOYSA-N 5-(3,4-dimethoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NO1 GCBUEYSZQVMAKH-UHFFFAOYSA-N 0.000 description 2
- BMINATYNWUTRBD-UHFFFAOYSA-N 5-(4-bromophenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(ON=C2)C=2C=CC(Br)=CC=2)=C1OC BMINATYNWUTRBD-UHFFFAOYSA-N 0.000 description 2
- SLSFSPAXWXXNML-UHFFFAOYSA-N 5-(4-butoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCCCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NO1 SLSFSPAXWXXNML-UHFFFAOYSA-N 0.000 description 2
- LOAIFDPRVMRMPL-UHFFFAOYSA-N 5-(4-butylphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CCCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NO1 LOAIFDPRVMRMPL-UHFFFAOYSA-N 0.000 description 2
- FQFHFDQIWOQHIM-UHFFFAOYSA-N 5-(4-chlorophenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(ON=C2)C=2C=CC(Cl)=CC=2)=C1OC FQFHFDQIWOQHIM-UHFFFAOYSA-N 0.000 description 2
- VLFSPAUQKOAIFA-UHFFFAOYSA-N 5-(4-ethoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NO1 VLFSPAUQKOAIFA-UHFFFAOYSA-N 0.000 description 2
- XFDKYOJLQHKRNW-UHFFFAOYSA-N 5-(4-ethylphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NO1 XFDKYOJLQHKRNW-UHFFFAOYSA-N 0.000 description 2
- QUKJFCHQOZQSCW-UHFFFAOYSA-N 5-(4-fluorophenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(ON=C2)C=2C=CC(F)=CC=2)=C1OC QUKJFCHQOZQSCW-UHFFFAOYSA-N 0.000 description 2
- GGMFQZTZAGQXJP-UHFFFAOYSA-N 5-(4-methoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NO1 GGMFQZTZAGQXJP-UHFFFAOYSA-N 0.000 description 2
- CVWULRSTXAVQEM-UHFFFAOYSA-N 5-(4-methylphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(ON=C2)C=2C=CC(C)=CC=2)=C1OC CVWULRSTXAVQEM-UHFFFAOYSA-N 0.000 description 2
- GPSKDGWWGNKOTQ-UHFFFAOYSA-N 5-(4-nitrophenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(ON=C2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1OC GPSKDGWWGNKOTQ-UHFFFAOYSA-N 0.000 description 2
- NZIXOAPDXNSASS-UHFFFAOYSA-N 5-(4-propoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NO1 NZIXOAPDXNSASS-UHFFFAOYSA-N 0.000 description 2
- HASYHWIVDZMVTP-UHFFFAOYSA-N 5-(4-propylphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NO1 HASYHWIVDZMVTP-UHFFFAOYSA-N 0.000 description 2
- PMGHYQCWASKWIE-UHFFFAOYSA-N 5-(5-methoxy-1-methylindol-7-yl)-4-(4-methoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=3N(C)C=CC=3C=C(OC)C=2)ON=C1 PMGHYQCWASKWIE-UHFFFAOYSA-N 0.000 description 2
- KIXFYKYCVMJXFO-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-(1-methylindol-5-yl)-1,2-oxazole Chemical compound C1=C2N(C)C=CC2=CC(C=2C=NOC=2C=2C=C(C=3OCOC=3C=2)OC)=C1 KIXFYKYCVMJXFO-UHFFFAOYSA-N 0.000 description 2
- PIUCZLQDXAXJHX-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-(4-methylsulfanylphenyl)-1,2-oxazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC=C(SC)C=C1 PIUCZLQDXAXJHX-UHFFFAOYSA-N 0.000 description 2
- DLIZNLIATYGABO-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-(5-methoxypyridin-2-yl)-1,2-oxazole Chemical compound N1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C=3OCOC=3C=2)ON=C1 DLIZNLIATYGABO-UHFFFAOYSA-N 0.000 description 2
- ZVKPTASFYAPNLS-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-(6-methoxypyridin-3-yl)-1,2-oxazole Chemical compound C1=NC(OC)=CC=C1C1=C(C=2C=C(OC)C=3OCOC=3C=2)ON=C1 ZVKPTASFYAPNLS-UHFFFAOYSA-N 0.000 description 2
- RJGGBHCZSOTINA-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-[4-(1-methyltetrazol-5-yl)phenyl]-1,2-oxazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C(C=C1)=CC=C1C1=NN=NN1C RJGGBHCZSOTINA-UHFFFAOYSA-N 0.000 description 2
- SGLOFTHUQJLDIR-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-[4-(2h-tetrazol-5-yl)phenyl]-1,2-oxazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C(C=C1)=CC=C1C1=NN=NN1 SGLOFTHUQJLDIR-UHFFFAOYSA-N 0.000 description 2
- JQHBEUCPFBMOBM-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-pyridazin-4-yl-1,2-oxazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC=NN=C1 JQHBEUCPFBMOBM-UHFFFAOYSA-N 0.000 description 2
- WHNMNBRIORZCOX-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-pyridin-3-yl-1,2-oxazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC=CN=C1 WHNMNBRIORZCOX-UHFFFAOYSA-N 0.000 description 2
- AYOTZNVOLKTQHE-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-pyrimidin-5-yl-1,2-oxazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CN=CN=C1 AYOTZNVOLKTQHE-UHFFFAOYSA-N 0.000 description 2
- DLEVBIHPFVIAMF-UHFFFAOYSA-N 5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]-2-methylsulfanylaniline Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC=C(SC)C(N)=C1 DLEVBIHPFVIAMF-UHFFFAOYSA-N 0.000 description 2
- GOQPKCQRYDPPPT-UHFFFAOYSA-N 5-methoxy-2-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]pyridine Chemical compound N1=CC(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 GOQPKCQRYDPPPT-UHFFFAOYSA-N 0.000 description 2
- ILJLPUAQPVIHMH-UHFFFAOYSA-N 5-methoxy-2-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenol Chemical compound OC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 ILJLPUAQPVIHMH-UHFFFAOYSA-N 0.000 description 2
- SQMJSFAPOLTYSI-UHFFFAOYSA-N 5-methoxy-2-[5-(3,4,5-trimethoxyphenyl)-2H-triazol-4-yl]phenol Chemical compound OC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 SQMJSFAPOLTYSI-UHFFFAOYSA-N 0.000 description 2
- NFBPIENSTMMTCH-UHFFFAOYSA-N 5-methoxy-2-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]pyridine Chemical compound N1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 NFBPIENSTMMTCH-UHFFFAOYSA-N 0.000 description 2
- QYZIMBJNFILDPY-UHFFFAOYSA-N 5-methoxy-2-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenol Chemical compound OC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C=3OCOC=3C=2)ON=C1 QYZIMBJNFILDPY-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 206010011017 Corneal graft rejection Diseases 0.000 description 2
- DCXYFEDJOCDNAF-UWTATZPHSA-N D-Asparagine Chemical compound OC(=O)[C@H](N)CC(N)=O DCXYFEDJOCDNAF-UWTATZPHSA-N 0.000 description 2
- XUJNEKJLAYXESH-UWTATZPHSA-N D-Cysteine Chemical compound SC[C@@H](N)C(O)=O XUJNEKJLAYXESH-UWTATZPHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-RFZPGFLSSA-N D-Isoleucine Chemical compound CC[C@@H](C)[C@@H](N)C(O)=O AGPKZVBTJJNPAG-RFZPGFLSSA-N 0.000 description 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-SCSAIBSYSA-N D-Proline Chemical compound OC(=O)[C@H]1CCCN1 ONIBWKKTOPOVIA-SCSAIBSYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 2
- 229930195711 D-Serine Natural products 0.000 description 2
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 description 2
- 229930028154 D-arginine Natural products 0.000 description 2
- 229930182846 D-asparagine Natural products 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 description 2
- 229930182847 D-glutamic acid Natural products 0.000 description 2
- ZDXPYRJPNDTMRX-GSVOUGTGSA-N D-glutamine Chemical compound OC(=O)[C@H](N)CCC(N)=O ZDXPYRJPNDTMRX-GSVOUGTGSA-N 0.000 description 2
- 229930195715 D-glutamine Natural products 0.000 description 2
- HNDVDQJCIGZPNO-RXMQYKEDSA-N D-histidine Chemical compound OC(=O)[C@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-RXMQYKEDSA-N 0.000 description 2
- 229930195721 D-histidine Natural products 0.000 description 2
- 229930182845 D-isoleucine Natural products 0.000 description 2
- ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 description 2
- 229930182819 D-leucine Natural products 0.000 description 2
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 2
- FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 description 2
- 229930182818 D-methionine Natural products 0.000 description 2
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 description 2
- 229930182832 D-phenylalanine Natural products 0.000 description 2
- 229930182820 D-proline Natural products 0.000 description 2
- AYFVYJQAPQTCCC-STHAYSLISA-N D-threonine Chemical compound C[C@H](O)[C@@H](N)C(O)=O AYFVYJQAPQTCCC-STHAYSLISA-N 0.000 description 2
- 229930182822 D-threonine Natural products 0.000 description 2
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 2
- OUYCCCASQSFEME-MRVPVSSYSA-N D-tyrosine Chemical compound OC(=O)[C@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-MRVPVSSYSA-N 0.000 description 2
- 229930195709 D-tyrosine Natural products 0.000 description 2
- KZSNJWFQEVHDMF-SCSAIBSYSA-N D-valine Chemical compound CC(C)[C@@H](N)C(O)=O KZSNJWFQEVHDMF-SCSAIBSYSA-N 0.000 description 2
- 229930182831 D-valine Natural products 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 229930195710 D‐cysteine Natural products 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 208000017604 Hodgkin disease Diseases 0.000 description 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- 206010023421 Kidney fibrosis Diseases 0.000 description 2
- 235000019766 L-Lysine Nutrition 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 229930064664 L-arginine Natural products 0.000 description 2
- 235000014852 L-arginine Nutrition 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 229930182844 L-isoleucine Natural products 0.000 description 2
- 239000004395 L-leucine Substances 0.000 description 2
- 235000019454 L-leucine Nutrition 0.000 description 2
- 229930195722 L-methionine Natural products 0.000 description 2
- 229930182821 L-proline Natural products 0.000 description 2
- 206010024305 Leukaemia monocytic Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000029749 Microtubule Human genes 0.000 description 2
- 108091022875 Microtubule Proteins 0.000 description 2
- 102000009664 Microtubule-Associated Proteins Human genes 0.000 description 2
- 108010020004 Microtubule-Associated Proteins Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- LKJPYSCBVHEWIU-UHFFFAOYSA-N N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide Chemical compound C=1C=C(C#N)C(C(F)(F)F)=CC=1NC(=O)C(O)(C)CS(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-UHFFFAOYSA-N 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 208000017442 Retinal disease Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- 206010038933 Retinopathy of prematurity Diseases 0.000 description 2
- 102000004243 Tubulin Human genes 0.000 description 2
- 108090000704 Tubulin Proteins 0.000 description 2
- VGNJDHHBZPFOKE-UHFFFAOYSA-N [2,3-dimethoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(OC)C(OC)=CC(C2=C(ON=C2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 VGNJDHHBZPFOKE-UHFFFAOYSA-N 0.000 description 2
- OVBJCLIGZPLMDM-UHFFFAOYSA-N [2,3-dimethoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC(OC)=C(OC)C(OP(O)(O)=O)=C1 OVBJCLIGZPLMDM-UHFFFAOYSA-N 0.000 description 2
- CYLXDRNECNWPBD-UHFFFAOYSA-N [2-methoxy-5-[4-(3,4,5-trimethoxyphenyl)-1,2-oxazol-5-yl]phenyl] dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)C=NO1 CYLXDRNECNWPBD-UHFFFAOYSA-N 0.000 description 2
- JJCRRLJAFKXNPY-UHFFFAOYSA-N [2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl] hydrogen sulfate Chemical compound C1=C(OS(O)(=O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 JJCRRLJAFKXNPY-UHFFFAOYSA-N 0.000 description 2
- OIYWEMXKACGPOR-UHFFFAOYSA-N [2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]sulfanylphosphonic acid Chemical compound C1=C(SP(O)(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 OIYWEMXKACGPOR-UHFFFAOYSA-N 0.000 description 2
- BHROBTGZHNQSRY-UHFFFAOYSA-N [2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]phenyl]azanium;chloride Chemical compound [Cl-].C1=C([NH3+])C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 BHROBTGZHNQSRY-UHFFFAOYSA-N 0.000 description 2
- IZVVAMWOUVBSSL-UHFFFAOYSA-N [2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenyl] hydrogen sulfate Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC=C(OC)C(OS(O)(=O)=O)=C1 IZVVAMWOUVBSSL-UHFFFAOYSA-N 0.000 description 2
- BUBSLKBFUBVARP-UHFFFAOYSA-N [2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenyl]sulfanylphosphonic acid Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC=C(OC)C(SP(O)(O)=O)=C1 BUBSLKBFUBVARP-UHFFFAOYSA-N 0.000 description 2
- RUINJXRFZYNQRK-UHFFFAOYSA-N [2-methylsulfanyl-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=C(OP(O)(O)=O)C(SC)=CC=2)=C1 RUINJXRFZYNQRK-UHFFFAOYSA-N 0.000 description 2
- VMXBLEYRLXOBHC-UHFFFAOYSA-N [3-acetyloxy-5-[4-(4-methoxyphenyl)-1,2-oxazol-5-yl]phenyl] acetate Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=C(OC(C)=O)C=C(OC(C)=O)C=2)ON=C1 VMXBLEYRLXOBHC-UHFFFAOYSA-N 0.000 description 2
- BKIIZBLKQLBLST-UHFFFAOYSA-N [4-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CC(OP(O)(O)=O)=CC=2)=C1 BKIIZBLKQLBLST-UHFFFAOYSA-N 0.000 description 2
- SRIRHXFKKUWEGR-UHFFFAOYSA-N [4-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC=C(OP(O)(O)=O)C=C1 SRIRHXFKKUWEGR-UHFFFAOYSA-N 0.000 description 2
- GEGAGNUZLMAPKH-UHFFFAOYSA-N [5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]-2-methylsulfanylphenyl] dihydrogen phosphate Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC=C(SC)C(OP(O)(O)=O)=C1 GEGAGNUZLMAPKH-UHFFFAOYSA-N 0.000 description 2
- JNDKZFCGVYCRHO-UHFFFAOYSA-N [5-methoxy-2-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 JNDKZFCGVYCRHO-UHFFFAOYSA-N 0.000 description 2
- DSTKZEGMTWBBDL-UHFFFAOYSA-N [5-methoxy-2-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C=3OCOC=3C=2)ON=C1 DSTKZEGMTWBBDL-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 125000002015 acyclic group Chemical group 0.000 description 2
- 208000009956 adenocarcinoma Diseases 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 239000004037 angiogenesis inhibitor Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000006664 bond formation reaction Methods 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- BNBHIGLOMVMJDB-UHFFFAOYSA-N chembl1552019 Chemical compound C1=C(OC)C(CC)=CC(C2=C(C=NO2)C=2C=CC(OC)=CC=2)=C1O BNBHIGLOMVMJDB-UHFFFAOYSA-N 0.000 description 2
- YOMVTNUTNPBUEI-UHFFFAOYSA-N chembl1946537 Chemical compound OC1=CC(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 YOMVTNUTNPBUEI-UHFFFAOYSA-N 0.000 description 2
- 208000024207 chronic leukemia Diseases 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 230000003511 endothelial effect Effects 0.000 description 2
- MACPEZZTLVQKJT-UHFFFAOYSA-N ethyl-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenoxy]phosphinic acid Chemical compound C1=C(OC)C(OP(O)(=O)CC)=CC(C2=C(ON=C2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 MACPEZZTLVQKJT-UHFFFAOYSA-N 0.000 description 2
- NLDDHTPQRDVHBZ-UHFFFAOYSA-N ethyl-[5-methoxy-2-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenoxy]phosphinic acid Chemical compound CCP(O)(=O)OC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 NLDDHTPQRDVHBZ-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 2
- 230000003463 hyperproliferative effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 125000002249 indol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([*])=C([H])C2=C1[H] 0.000 description 2
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- CDWBEPJXMKZKTD-UHFFFAOYSA-N methyl 2,6-dimethoxy-4-[4-(4-methoxyphenyl)-1,2-oxazol-5-yl]benzoate Chemical compound C1=C(OC)C(C(=O)OC)=C(OC)C=C1C1=C(C=2C=CC(OC)=CC=2)C=NO1 CDWBEPJXMKZKTD-UHFFFAOYSA-N 0.000 description 2
- LKDATJJBYBHGHR-UHFFFAOYSA-N methyl 2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]benzoate Chemical compound C1=C(OC)C(C(=O)OC)=CC(C2=C(ON=C2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 LKDATJJBYBHGHR-UHFFFAOYSA-N 0.000 description 2
- XMKKDZOQLYZDNJ-UHFFFAOYSA-N methyl 2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]benzoate Chemical compound C1=C(OC)C(C(=O)OC)=CC(C2=C(ON=C2)C=2C=C(OC)C=3OCOC=3C=2)=C1 XMKKDZOQLYZDNJ-UHFFFAOYSA-N 0.000 description 2
- 210000004688 microtubule Anatomy 0.000 description 2
- 201000006894 monocytic leukemia Diseases 0.000 description 2
- ISOJINPRQMEZQA-UHFFFAOYSA-N n,n-dimethyl-2-[4-(3,4,5-trimethoxyphenyl)-1,2-oxazol-5-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(C2=C(ON=C2)C=2C(=CC=CC=2)N(C)C)=C1 ISOJINPRQMEZQA-UHFFFAOYSA-N 0.000 description 2
- NVNOBTXLLZDEOQ-UHFFFAOYSA-N n,n-dimethyl-4-[5-(2,3,5-trimethoxyphenyl)-1,2-oxazol-4-yl]aniline Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NO2)C=2C=CC(=CC=2)N(C)C)=C1 NVNOBTXLLZDEOQ-UHFFFAOYSA-N 0.000 description 2
- BXNCQHBBHYUBID-UHFFFAOYSA-N n,n-dimethyl-4-[5-(2,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]aniline Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(=CC=2)N(C)C)C=NO1 BXNCQHBBHYUBID-UHFFFAOYSA-N 0.000 description 2
- BGSKVYCDHBCIKW-UHFFFAOYSA-N n,n-dimethyl-4-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)N(C)C)=C1 BGSKVYCDHBCIKW-UHFFFAOYSA-N 0.000 description 2
- JXXSVGZJCRWTSY-UHFFFAOYSA-N n-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]acetamide Chemical compound C1=C(NC(C)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 JXXSVGZJCRWTSY-UHFFFAOYSA-N 0.000 description 2
- FZZAZYULKZUKOE-UHFFFAOYSA-N n-[2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenyl]acetamide Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC=C(OC)C(NC(C)=O)=C1 FZZAZYULKZUKOE-UHFFFAOYSA-N 0.000 description 2
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 229940080818 propionamide Drugs 0.000 description 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 201000000306 sarcoidosis Diseases 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229930195734 saturated hydrocarbon Natural products 0.000 description 2
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- RIWLPSIAFBLILR-WVNGMBSFSA-N (2s)-1-[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[(2s,3r)-2-[[(2r,3s)-2-[[(2s)-2-[[2-[[2-[acetyl(methyl)amino]acetyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]pentanoyl]amino]-3-methylpentanoyl]amino]-5-(diaminomethy Chemical compound CC(=O)N(C)CC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC RIWLPSIAFBLILR-WVNGMBSFSA-N 0.000 description 1
- MMHDBUJXLOFTLC-WOYTXXSLSA-N (2s)-2-[[(2r)-2-[[(2s)-2-[[(2s)-2-[[(2s)-1-acetylpyrrolidine-2-carbonyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-sulfanylpropanoyl]amino]butanediamide Chemical compound CC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O)CC1=CN=CN1 MMHDBUJXLOFTLC-WOYTXXSLSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-M 1,1-dioxo-1,2-benzothiazol-3-olate Chemical compound C1=CC=C2C([O-])=NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-M 0.000 description 1
- AEBWATHAIVJLTA-UHFFFAOYSA-N 1,2,3,3a,4,5,6,6a-octahydropentalene Chemical compound C1CCC2CCCC21 AEBWATHAIVJLTA-UHFFFAOYSA-N 0.000 description 1
- LYAXFELGZLPTKA-UHFFFAOYSA-N 1-(1,3-benzodioxol-4-yl)-5-(4-methoxyphenyl)triazole Chemical compound C1=CC(OC)=CC=C1C1=CN=NN1C1=CC=CC2=C1OCO2 LYAXFELGZLPTKA-UHFFFAOYSA-N 0.000 description 1
- MZPZFLKUKPSXPO-UHFFFAOYSA-N 1-(2,3,5-trimethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)triazole Chemical compound COC1=CC(OC)=C(OC)C(N2C(=CN=N2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 MZPZFLKUKPSXPO-UHFFFAOYSA-N 0.000 description 1
- PSVJWSHDOUYPMT-UHFFFAOYSA-N 1-(2,4,5-trimethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)triazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1N1C(C=2C=C(OC)C(OC)=C(OC)C=2)=CN=N1 PSVJWSHDOUYPMT-UHFFFAOYSA-N 0.000 description 1
- PEADEPRDUVAKGO-UHFFFAOYSA-N 1-(3,4-dimethoxyphenyl)-5-(2,3,4,5-tetramethoxyphenyl)triazole Chemical compound C1=C(OC)C(OC)=CC=C1N1C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=CN=N1 PEADEPRDUVAKGO-UHFFFAOYSA-N 0.000 description 1
- MHLHQWAZZBONOH-UHFFFAOYSA-N 1-(4-bromophenyl)-5-(2,3,4,5-tetramethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(C=2N(N=NC=2)C=2C=CC(Br)=CC=2)=C1OC MHLHQWAZZBONOH-UHFFFAOYSA-N 0.000 description 1
- HUEGJLRNMXFGFO-UHFFFAOYSA-N 1-(4-bromophenyl)-5-(3,4,5-trimethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(C=2N(N=NC=2)C=2C=CC(Br)=CC=2)=C1 HUEGJLRNMXFGFO-UHFFFAOYSA-N 0.000 description 1
- VHKWQEHIGQYWNR-UHFFFAOYSA-N 1-(4-butoxyphenyl)-5-(2,3,4,5-tetramethoxyphenyl)triazole Chemical compound C1=CC(OCCCC)=CC=C1N1C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=CN=N1 VHKWQEHIGQYWNR-UHFFFAOYSA-N 0.000 description 1
- CLQACFCSCKYWKC-UHFFFAOYSA-N 1-(4-butylphenyl)-5-(2,3,4,5-tetramethoxyphenyl)triazole Chemical compound C1=CC(CCCC)=CC=C1N1C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=CN=N1 CLQACFCSCKYWKC-UHFFFAOYSA-N 0.000 description 1
- HIYNRMILOFDDDL-UHFFFAOYSA-N 1-(4-chlorophenyl)-5-(2,3,4,5-tetramethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(C=2N(N=NC=2)C=2C=CC(Cl)=CC=2)=C1OC HIYNRMILOFDDDL-UHFFFAOYSA-N 0.000 description 1
- JBKGKEVNQOZVSY-UHFFFAOYSA-N 1-(4-ethoxyphenyl)-5-(2,3,4,5-tetramethoxyphenyl)triazole Chemical compound C1=CC(OCC)=CC=C1N1C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=CN=N1 JBKGKEVNQOZVSY-UHFFFAOYSA-N 0.000 description 1
- RNWMMAAFODCGNA-UHFFFAOYSA-N 1-(4-ethylphenyl)-5-(2,3,4,5-tetramethoxyphenyl)triazole Chemical compound C1=CC(CC)=CC=C1N1C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=CN=N1 RNWMMAAFODCGNA-UHFFFAOYSA-N 0.000 description 1
- IHBYYJDUUVBGMV-UHFFFAOYSA-N 1-(4-fluorophenyl)-5-(2,3,4,5-tetramethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(C=2N(N=NC=2)C=2C=CC(F)=CC=2)=C1OC IHBYYJDUUVBGMV-UHFFFAOYSA-N 0.000 description 1
- NKCSREZSRVDHEF-UHFFFAOYSA-N 1-(4-methoxyphenyl)-5-(2,3,4,5-tetramethoxyphenyl)triazole Chemical compound C1=CC(OC)=CC=C1N1C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=CN=N1 NKCSREZSRVDHEF-UHFFFAOYSA-N 0.000 description 1
- SUFCETSSBWWSCO-UHFFFAOYSA-N 1-(4-methylphenyl)-5-(2,3,4,5-tetramethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(C=2N(N=NC=2)C=2C=CC(C)=CC=2)=C1OC SUFCETSSBWWSCO-UHFFFAOYSA-N 0.000 description 1
- SSEJMFZNJOQVND-UHFFFAOYSA-N 1-(4-nitrophenyl)-5-(2,3,4,5-tetramethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(C=2N(N=NC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1OC SSEJMFZNJOQVND-UHFFFAOYSA-N 0.000 description 1
- HQAMKPDEDDYVSL-UHFFFAOYSA-N 1-(4-propoxyphenyl)-5-(2,3,4,5-tetramethoxyphenyl)triazole Chemical compound C1=CC(OCCC)=CC=C1N1C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=CN=N1 HQAMKPDEDDYVSL-UHFFFAOYSA-N 0.000 description 1
- HUZSYXVAJPOZDI-UHFFFAOYSA-N 1-(4-propylphenyl)-5-(2,3,4,5-tetramethoxyphenyl)triazole Chemical compound C1=CC(CCC)=CC=C1N1C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=CN=N1 HUZSYXVAJPOZDI-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
- DFDYIUDSOQRHKM-UHFFFAOYSA-N 1-ethyl-6-[5-(4-methoxyphenyl)-2h-triazol-4-yl]indole Chemical compound C1=C2N(CC)C=CC2=CC=C1C=1N=NNC=1C1=CC=C(OC)C=C1 DFDYIUDSOQRHKM-UHFFFAOYSA-N 0.000 description 1
- KVYHGNVCCDTMRC-UHFFFAOYSA-N 1-ethyl-6-[5-(4-methoxyphenyl)triazol-1-yl]indole Chemical compound C1=C2N(CC)C=CC2=CC=C1N1N=NC=C1C1=CC=C(OC)C=C1 KVYHGNVCCDTMRC-UHFFFAOYSA-N 0.000 description 1
- SBMVWRARPDCZDE-UHFFFAOYSA-N 1-ethyl-7-[5-(4-methoxyphenyl)-2h-triazol-4-yl]indole Chemical compound C=12N(CC)C=CC2=CC=CC=1C=1N=NNC=1C1=CC=C(OC)C=C1 SBMVWRARPDCZDE-UHFFFAOYSA-N 0.000 description 1
- 125000006039 1-hexenyl group Chemical group 0.000 description 1
- 125000006028 1-methyl-2-butenyl group Chemical group 0.000 description 1
- VBOQOVFWFLJJOK-UHFFFAOYSA-N 1-methyl-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]indole Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=C3C=CN(C)C3=CC=2)=C1 VBOQOVFWFLJJOK-UHFFFAOYSA-N 0.000 description 1
- BMFPCNWZSRXPLM-UHFFFAOYSA-N 1-methyl-5-[4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl]tetrazole Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)C=2N(N=NN=2)C)=C1 BMFPCNWZSRXPLM-UHFFFAOYSA-N 0.000 description 1
- KIFGRPCMPYFWMJ-UHFFFAOYSA-N 1-methyl-5-[4-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]phenyl]tetrazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)C=2N(N=NN=2)C)=C1 KIFGRPCMPYFWMJ-UHFFFAOYSA-N 0.000 description 1
- UUZGBRCCUYLFHG-UHFFFAOYSA-N 1-methyl-5-[5-(3,4,5-trimethoxyphenyl)triazol-1-yl]indole Chemical compound COC1=C(OC)C(OC)=CC(C=2N(N=NC=2)C=2C=C3C=CN(C)C3=CC=2)=C1 UUZGBRCCUYLFHG-UHFFFAOYSA-N 0.000 description 1
- 125000006023 1-pentenyl group Chemical group 0.000 description 1
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- 125000003562 2,2-dimethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- FNHGUHBLIZVJFG-UHFFFAOYSA-N 2,3,4-trimethoxy-6-[5-(4-methoxyphenyl)-2h-triazol-4-yl]pyridine Chemical compound C1=CC(OC)=CC=C1C1=C(C=2N=C(OC)C(OC)=C(OC)C=2)N=NN1 FNHGUHBLIZVJFG-UHFFFAOYSA-N 0.000 description 1
- UTRWUGNIOQBIHK-UHFFFAOYSA-N 2,3,4-trimethoxy-6-[5-(4-methoxyphenyl)triazol-1-yl]pyridine Chemical compound C1=CC(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=N1 UTRWUGNIOQBIHK-UHFFFAOYSA-N 0.000 description 1
- 125000006069 2,3-dimethyl-2-butenyl group Chemical group 0.000 description 1
- 125000003660 2,3-dimethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000003764 2,4-dimethylpentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- UEJJHQNACJXSKW-UHFFFAOYSA-N 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C1CCC(=O)NC1=O UEJJHQNACJXSKW-UHFFFAOYSA-N 0.000 description 1
- MYZJAWPRNFFPKY-UHFFFAOYSA-N 2-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]pyridine Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2N=CC=CC=2)=C1 MYZJAWPRNFFPKY-UHFFFAOYSA-N 0.000 description 1
- DAXVJDIJHFJPBZ-UHFFFAOYSA-N 2-[4-(4-aminophenyl)-1,2-oxazol-3-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(C=2C(=CON=2)C=2C=CC(N)=CC=2)=C1O DAXVJDIJHFJPBZ-UHFFFAOYSA-N 0.000 description 1
- WEQMPEVEACGKBD-UHFFFAOYSA-N 2-[4-(4-aminophenyl)-1,2-thiazol-5-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(C=NS2)C=2C=CC(N)=CC=2)=C1O WEQMPEVEACGKBD-UHFFFAOYSA-N 0.000 description 1
- IXAFZPGKNWGNPM-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-1,2-oxazol-3-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(C=2C(=CON=2)C=2C=CC(Cl)=CC=2)=C1O IXAFZPGKNWGNPM-UHFFFAOYSA-N 0.000 description 1
- XLEWUKILGFHHJP-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-1,2-thiazol-5-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(C=NS2)C=2C=CC(Cl)=CC=2)=C1O XLEWUKILGFHHJP-UHFFFAOYSA-N 0.000 description 1
- UGGBPTIRERNVLY-UHFFFAOYSA-N 2-[4-[3-(3,4,5-triethylphenyl)triazol-4-yl]phenyl]pyridine Chemical compound CCC1=C(CC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)C=2N=CC=CC=2)=C1 UGGBPTIRERNVLY-UHFFFAOYSA-N 0.000 description 1
- BUEPQAVUZIZAEX-UHFFFAOYSA-N 2-[4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl]-1,3-oxazole Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)C=2OC=CN=2)=C1 BUEPQAVUZIZAEX-UHFFFAOYSA-N 0.000 description 1
- BQWCGDKEPRETIY-UHFFFAOYSA-N 2-[4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl]pyridine Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)C=2N=CC=CC=2)=C1 BQWCGDKEPRETIY-UHFFFAOYSA-N 0.000 description 1
- JJDNLIFQMMGXRF-UHFFFAOYSA-N 2-[4-[5-(3,4,5-triethylphenyl)-2h-triazol-4-yl]phenyl]pyridine Chemical compound CCC1=C(CC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)C=2N=CC=CC=2)=C1 JJDNLIFQMMGXRF-UHFFFAOYSA-N 0.000 description 1
- BTPYNXVVMASWCF-UHFFFAOYSA-N 2-[4-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]phenyl]-1,3-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)C=2OC=CN=2)=C1 BTPYNXVVMASWCF-UHFFFAOYSA-N 0.000 description 1
- AVEBIAQCTGEGPK-UHFFFAOYSA-N 2-[4-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]phenyl]pyridine Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)C=2N=CC=CC=2)=C1 AVEBIAQCTGEGPK-UHFFFAOYSA-N 0.000 description 1
- OZKXKNHTXVUFTI-UHFFFAOYSA-N 2-[5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2H-triazol-4-yl]-5-methoxy-4-propylphenol Chemical compound C1=C(OC)C(CCC)=CC(C2=C(NN=N2)C=2C=C3OCCOC3=CC=2)=C1O OZKXKNHTXVUFTI-UHFFFAOYSA-N 0.000 description 1
- KOBZRENVULMRDF-UHFFFAOYSA-N 2-[5-(3,4-dimethylphenyl)-2H-triazol-4-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(NN=N2)C=2C=C(C)C(C)=CC=2)=C1O KOBZRENVULMRDF-UHFFFAOYSA-N 0.000 description 1
- OSGZCJQGFDQEHQ-UHFFFAOYSA-N 2-[5-(3,4-dimethylphenyl)triazol-1-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(N2C(=CN=N2)C=2C=C(C)C(C)=CC=2)=C1O OSGZCJQGFDQEHQ-UHFFFAOYSA-N 0.000 description 1
- VYTSDGUAEKWCRR-UHFFFAOYSA-N 2-[5-(4-aminophenyl)-2H-triazol-4-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(N)=CC=2)=C1O VYTSDGUAEKWCRR-UHFFFAOYSA-N 0.000 description 1
- TYLQBXQMPNRCPY-UHFFFAOYSA-N 2-[5-(4-aminophenyl)triazol-1-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(N)=CC=2)=C1O TYLQBXQMPNRCPY-UHFFFAOYSA-N 0.000 description 1
- OJSAESGJINCERP-UHFFFAOYSA-N 2-[5-(4-bromophenyl)-2H-triazol-4-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(Br)=CC=2)=C1O OJSAESGJINCERP-UHFFFAOYSA-N 0.000 description 1
- MSVYCLMOBFPYJY-UHFFFAOYSA-N 2-[5-(4-bromophenyl)triazol-1-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(Br)=CC=2)=C1O MSVYCLMOBFPYJY-UHFFFAOYSA-N 0.000 description 1
- POLMOTUBSNNKJZ-UHFFFAOYSA-N 2-[5-(4-chlorophenyl)-2H-triazol-4-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(Cl)=CC=2)=C1O POLMOTUBSNNKJZ-UHFFFAOYSA-N 0.000 description 1
- LEVJANUAUFXAOS-UHFFFAOYSA-N 2-[5-(4-chlorophenyl)triazol-1-yl]-4-ethyl-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(Cl)=CC=2)=C1O LEVJANUAUFXAOS-UHFFFAOYSA-N 0.000 description 1
- KTPICSCHSGGBLE-UHFFFAOYSA-N 2-amino-n-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl]-3-phenylpropanamide;hydrochloride Chemical compound Cl.COC1=CC=C(C=2N(N=NC=2)C=2C=C(OC)C(OC)=C(OC)C=2)C=C1NC(=O)C(N)CC1=CC=CC=C1 KTPICSCHSGGBLE-UHFFFAOYSA-N 0.000 description 1
- XEKIQTDSUOBYGL-UHFFFAOYSA-N 2-amino-n-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl]-4-methylpentanamide;hydrochloride Chemical compound Cl.C1=C(NC(=O)C(N)CC(C)C)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 XEKIQTDSUOBYGL-UHFFFAOYSA-N 0.000 description 1
- KTDGPQSXHUXEAL-UHFFFAOYSA-N 2-amino-n-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]phenyl]-3-phenylpropanamide;hydrochloride Chemical compound Cl.COC1=CC=C(C2=C(N=NN2)C=2C=C(OC)C(OC)=C(OC)C=2)C=C1NC(=O)C(N)CC1=CC=CC=C1 KTDGPQSXHUXEAL-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- BHTPKFYVOBULSU-UHFFFAOYSA-N 2-methoxy-5-[3-(2,3,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenol Chemical compound COC1=CC(OC)=C(OC)C(C=2C(=CON=2)C=2C=C(O)C(OC)=CC=2)=C1 BHTPKFYVOBULSU-UHFFFAOYSA-N 0.000 description 1
- WXYVSVHMCAAYJT-UHFFFAOYSA-N 2-methoxy-5-[3-(2,3,5-trimethoxyphenyl)triazol-4-yl]phenol Chemical compound COC1=CC(OC)=C(OC)C(N2C(=CN=N2)C=2C=C(O)C(OC)=CC=2)=C1 WXYVSVHMCAAYJT-UHFFFAOYSA-N 0.000 description 1
- VKEJFSHGHCHYRS-UHFFFAOYSA-N 2-methoxy-5-[3-(2,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C=C1OC VKEJFSHGHCHYRS-UHFFFAOYSA-N 0.000 description 1
- VXPRCRUQFYKUJP-UHFFFAOYSA-N 2-methoxy-5-[3-(2,4,5-trimethoxyphenyl)triazol-4-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C=C1OC VXPRCRUQFYKUJP-UHFFFAOYSA-N 0.000 description 1
- PTJJVQXQDOAPFN-UHFFFAOYSA-N 2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]aniline Chemical compound C1=C(N)C(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 PTJJVQXQDOAPFN-UHFFFAOYSA-N 0.000 description 1
- ILUOHIFUZKIHLP-UHFFFAOYSA-N 2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]benzenethiol Chemical compound C1=C(S)C(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 ILUOHIFUZKIHLP-UHFFFAOYSA-N 0.000 description 1
- WGRKEBKKDZRMKL-UHFFFAOYSA-N 2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]benzoic acid Chemical compound C1=C(C(O)=O)C(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 WGRKEBKKDZRMKL-UHFFFAOYSA-N 0.000 description 1
- NXEOMXIFTDFGRA-UHFFFAOYSA-N 2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 NXEOMXIFTDFGRA-UHFFFAOYSA-N 0.000 description 1
- VKMMSKMOFCQNBK-UHFFFAOYSA-N 2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]aniline Chemical compound C1=C(N)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 VKMMSKMOFCQNBK-UHFFFAOYSA-N 0.000 description 1
- RBFAISRHJJVHIW-UHFFFAOYSA-N 2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]benzoic acid Chemical compound C1=C(C(O)=O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 RBFAISRHJJVHIW-UHFFFAOYSA-N 0.000 description 1
- DCEBFZXQYUBEHY-UHFFFAOYSA-N 2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 DCEBFZXQYUBEHY-UHFFFAOYSA-N 0.000 description 1
- HJFYLBFYFWACFU-UHFFFAOYSA-N 2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]benzenethiol Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC=C(OC)C(S)=C1 HJFYLBFYFWACFU-UHFFFAOYSA-N 0.000 description 1
- RPBYMMRIWWMRHD-UHFFFAOYSA-N 2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]benzoic acid Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC=C(OC)C(C(O)=O)=C1 RPBYMMRIWWMRHD-UHFFFAOYSA-N 0.000 description 1
- VYMPGNDMDOSUER-UHFFFAOYSA-N 2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)triazol-4-yl]aniline Chemical compound C=1C=2OCOC=2C(OC)=CC=1N1N=NC=C1C1=CC=C(OC)C(N)=C1 VYMPGNDMDOSUER-UHFFFAOYSA-N 0.000 description 1
- DAQHPQDZTWRGCM-UHFFFAOYSA-N 2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)triazol-4-yl]benzenethiol Chemical compound C=1C=2OCOC=2C(OC)=CC=1N1N=NC=C1C1=CC=C(OC)C(S)=C1 DAQHPQDZTWRGCM-UHFFFAOYSA-N 0.000 description 1
- KOCZDWQPXJARTF-UHFFFAOYSA-N 2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)triazol-4-yl]benzoic acid Chemical compound C=1C=2OCOC=2C(OC)=CC=1N1N=NC=C1C1=CC=C(OC)C(C(O)=O)=C1 KOCZDWQPXJARTF-UHFFFAOYSA-N 0.000 description 1
- KSCFMNUIXARIBI-UHFFFAOYSA-N 2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)triazol-4-yl]pyridine Chemical compound C1=NC(OC)=CC=C1C1=CN=NN1C(C=C1OC)=CC2=C1OCO2 KSCFMNUIXARIBI-UHFFFAOYSA-N 0.000 description 1
- XPDLSGHCBJEOFW-UHFFFAOYSA-N 2-methoxy-5-[4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazol-3-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=NOC=C1C1=CC(OC)=C(OC)C(OC)=C1OC XPDLSGHCBJEOFW-UHFFFAOYSA-N 0.000 description 1
- RFJOIYRILWEJGZ-UHFFFAOYSA-N 2-methoxy-5-[4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazol-5-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NS1 RFJOIYRILWEJGZ-UHFFFAOYSA-N 0.000 description 1
- UCLAOCJHCVFFSR-UHFFFAOYSA-N 2-methoxy-5-[4-(3,4,5-trimethoxyphenyl)-1,2-oxazol-3-yl]aniline Chemical compound C1=C(N)C(OC)=CC=C1C1=NOC=C1C1=CC(OC)=C(OC)C(OC)=C1 UCLAOCJHCVFFSR-UHFFFAOYSA-N 0.000 description 1
- FNBJUJNDXGOZCC-UHFFFAOYSA-N 2-methoxy-5-[4-(3,4,5-trimethoxyphenyl)-1,2-oxazol-5-yl]aniline Chemical compound C1=C(N)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)C=NO1 FNBJUJNDXGOZCC-UHFFFAOYSA-N 0.000 description 1
- TXRDRANDZHLHJL-UHFFFAOYSA-N 2-methoxy-5-[4-(3,4,5-trimethoxyphenyl)-1,2-thiazol-5-yl]aniline Chemical compound C1=C(N)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)C=NS1 TXRDRANDZHLHJL-UHFFFAOYSA-N 0.000 description 1
- VBHDXBIAISMQPM-UHFFFAOYSA-N 2-methoxy-5-[5-(2,3,4,5-tetramethoxyphenyl)-2h-triazol-4-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)NN=N1 VBHDXBIAISMQPM-UHFFFAOYSA-N 0.000 description 1
- CPRXRPXQJKJUOC-UHFFFAOYSA-N 2-methoxy-5-[5-(2,3,4,5-tetramethoxyphenyl)triazol-1-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1N1C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=CN=N1 CPRXRPXQJKJUOC-UHFFFAOYSA-N 0.000 description 1
- KCCZQERRRGDFEE-UHFFFAOYSA-N 2-methoxy-5-[5-(2,3,5-trimethoxyphenyl)-1,2-thiazol-4-yl]phenol Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NS2)C=2C=C(O)C(OC)=CC=2)=C1 KCCZQERRRGDFEE-UHFFFAOYSA-N 0.000 description 1
- QHUPCVYGHUJQSO-UHFFFAOYSA-N 2-methoxy-5-[5-(2,3,5-trimethoxyphenyl)-2h-triazol-4-yl]phenol Chemical compound COC1=CC(OC)=C(OC)C(C2=C(NN=N2)C=2C=C(O)C(OC)=CC=2)=C1 QHUPCVYGHUJQSO-UHFFFAOYSA-N 0.000 description 1
- CASVCTHYDVEBHP-UHFFFAOYSA-N 2-methoxy-5-[5-(2,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)SN=C1 CASVCTHYDVEBHP-UHFFFAOYSA-N 0.000 description 1
- URDOGQBRNWXDLK-UHFFFAOYSA-N 2-methoxy-5-[5-(2,4,5-trimethoxyphenyl)-2h-triazol-4-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)N=NN1 URDOGQBRNWXDLK-UHFFFAOYSA-N 0.000 description 1
- DYPCBISEPUZSHV-UHFFFAOYSA-N 2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]benzoic acid Chemical compound C1=C(C(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)SN=C1 DYPCBISEPUZSHV-UHFFFAOYSA-N 0.000 description 1
- LXCMEPRZJMOTGP-UHFFFAOYSA-N 2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)SN=C1 LXCMEPRZJMOTGP-UHFFFAOYSA-N 0.000 description 1
- PRHZDPOVDXOVJL-UHFFFAOYSA-N 2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]benzenethiol Chemical compound C1=C(S)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 PRHZDPOVDXOVJL-UHFFFAOYSA-N 0.000 description 1
- XSXPMVJCVGFTBL-UHFFFAOYSA-N 2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]phenol Chemical compound C1=C(O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 XSXPMVJCVGFTBL-UHFFFAOYSA-N 0.000 description 1
- KYZLWCQZSHKNIM-UHFFFAOYSA-N 2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)triazol-1-yl]aniline Chemical compound C1=C(N)C(OC)=CC=C1N1C(C=2C=C(OC)C(OC)=C(OC)C=2)=CN=N1 KYZLWCQZSHKNIM-UHFFFAOYSA-N 0.000 description 1
- MZUHOJYUDSZJPU-UHFFFAOYSA-N 2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]benzoic acid Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1ON=CC=1C1=CC=C(OC)C(C(O)=O)=C1 MZUHOJYUDSZJPU-UHFFFAOYSA-N 0.000 description 1
- KQABVXZWCCNUMQ-UHFFFAOYSA-N 2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]benzenethiol Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC=C(OC)C(S)=C1 KQABVXZWCCNUMQ-UHFFFAOYSA-N 0.000 description 1
- NVEVQOIWNUTACF-UHFFFAOYSA-N 2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]benzoic acid Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC=C(OC)C(C(O)=O)=C1 NVEVQOIWNUTACF-UHFFFAOYSA-N 0.000 description 1
- RDGWLHTVLXDCNM-UHFFFAOYSA-N 2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]benzenethiol Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1N=NNC=1C1=CC=C(OC)C(S)=C1 RDGWLHTVLXDCNM-UHFFFAOYSA-N 0.000 description 1
- IQMIHWJHQWJIEA-UHFFFAOYSA-N 2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]pyridine Chemical compound C1=NC(OC)=CC=C1C1=C(C=2C=C(OC)C=3OCOC=3C=2)N=NN1 IQMIHWJHQWJIEA-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- SQADVZZWVOEVMJ-UHFFFAOYSA-N 2-methylsulfanyl-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=C(N)C(SC)=CC=2)=C1 SQADVZZWVOEVMJ-UHFFFAOYSA-N 0.000 description 1
- KTECLFPCXVQEHP-UHFFFAOYSA-N 2-methylsulfanyl-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=C(N)C(SC)=CC=2)=C1 KTECLFPCXVQEHP-UHFFFAOYSA-N 0.000 description 1
- IFMIMDWDUJFOKV-UHFFFAOYSA-N 2-methylsulfanyl-5-[5-(3,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NS2)C=2C=C(N)C(SC)=CC=2)=C1 IFMIMDWDUJFOKV-UHFFFAOYSA-N 0.000 description 1
- CVMRONMPHSSMEI-UHFFFAOYSA-N 2-methylsulfanyl-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=C(N)C(SC)=CC=2)=C1 CVMRONMPHSSMEI-UHFFFAOYSA-N 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- YIAIQKIYXQFPSP-UHFFFAOYSA-N 3-(1,3-benzodioxol-4-yl)-4-(4-methoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=CON=C1C1=CC=CC2=C1OCO2 YIAIQKIYXQFPSP-UHFFFAOYSA-N 0.000 description 1
- RWVAAQOATPUHRL-UHFFFAOYSA-N 3-(1-ethylindol-7-yl)-4-(4-methoxyphenyl)-1,2-oxazole Chemical compound C=12N(CC)C=CC2=CC=CC=1C1=NOC=C1C1=CC=C(OC)C=C1 RWVAAQOATPUHRL-UHFFFAOYSA-N 0.000 description 1
- AXRCEOKUDYDWLF-UHFFFAOYSA-N 3-(1-methyl-3-indolyl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-3-indolyl]pyrrole-2,5-dione Chemical compound C12=CC=CC=C2N(C)C=C1C(C(NC1=O)=O)=C1C(C1=CC=CC=C11)=CN1C(CC1)CCN1CC1=CC=CC=N1 AXRCEOKUDYDWLF-UHFFFAOYSA-N 0.000 description 1
- XFRDEPJIJXFAKK-UHFFFAOYSA-N 3-(1-methylindol-5-yl)-4-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=NOC=2)C=2C=C3C=CN(C)C3=CC=2)=C1 XFRDEPJIJXFAKK-UHFFFAOYSA-N 0.000 description 1
- IEVUDXAUWOWPSU-UHFFFAOYSA-N 3-(2,3,5-trimethoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=CC(OC)=C(OC)C(C=2C(=CON=2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 IEVUDXAUWOWPSU-UHFFFAOYSA-N 0.000 description 1
- OAAJCXQPEIDSDA-UHFFFAOYSA-N 3-(2,4,5-trimethoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=NOC=C1C1=CC(OC)=C(OC)C(OC)=C1 OAAJCXQPEIDSDA-UHFFFAOYSA-N 0.000 description 1
- SIQBIFMWHGKQKZ-UHFFFAOYSA-N 3-(2-methoxyethoxy)-n-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]propanamide Chemical compound C1=C(OC)C(NC(=O)CCOCCOC)=CC(C=2C(=NOC=2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 SIQBIFMWHGKQKZ-UHFFFAOYSA-N 0.000 description 1
- XWPXYTXYADFILK-UHFFFAOYSA-N 3-(2-methoxyethoxy)-n-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]propanamide Chemical compound C1=C(OC)C(NC(=O)CCOCCOC)=CC(C2=C(ON=C2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 XWPXYTXYADFILK-UHFFFAOYSA-N 0.000 description 1
- CTKUOBQQQYJTNV-UHFFFAOYSA-N 3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=NOC=C2)=C1 CTKUOBQQQYJTNV-UHFFFAOYSA-N 0.000 description 1
- HFDJEFUROGNEAZ-UHFFFAOYSA-N 3-(3,4-dimethoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=NOC=C1C1=CC(OC)=C(OC)C(OC)=C1OC HFDJEFUROGNEAZ-UHFFFAOYSA-N 0.000 description 1
- ZPCBNZIXIIMRON-UHFFFAOYSA-N 3-(4-bromophenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=NOC=2)C=2C=CC(Br)=CC=2)=C1OC ZPCBNZIXIIMRON-UHFFFAOYSA-N 0.000 description 1
- LVCGOVXZKFHBTB-UHFFFAOYSA-N 3-(4-bromophenyl)-4-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=NOC=2)C=2C=CC(Br)=CC=2)=C1 LVCGOVXZKFHBTB-UHFFFAOYSA-N 0.000 description 1
- FJCOPHHLCMHCGH-UHFFFAOYSA-N 3-(4-butoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCCCC)=CC=C1C1=NOC=C1C1=CC(OC)=C(OC)C(OC)=C1OC FJCOPHHLCMHCGH-UHFFFAOYSA-N 0.000 description 1
- JATZBGBDOHQZHO-UHFFFAOYSA-N 3-(4-butylphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CCCC)=CC=C1C1=NOC=C1C1=CC(OC)=C(OC)C(OC)=C1OC JATZBGBDOHQZHO-UHFFFAOYSA-N 0.000 description 1
- OATHYSDLRMEKKC-UHFFFAOYSA-N 3-(4-chlorophenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=NOC=2)C=2C=CC(Cl)=CC=2)=C1OC OATHYSDLRMEKKC-UHFFFAOYSA-N 0.000 description 1
- AIWIJKDLDREOER-UHFFFAOYSA-N 3-(4-ethoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCC)=CC=C1C1=NOC=C1C1=CC(OC)=C(OC)C(OC)=C1OC AIWIJKDLDREOER-UHFFFAOYSA-N 0.000 description 1
- SZAKBNLXDGIHNN-UHFFFAOYSA-N 3-(4-ethylphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CC)=CC=C1C1=NOC=C1C1=CC(OC)=C(OC)C(OC)=C1OC SZAKBNLXDGIHNN-UHFFFAOYSA-N 0.000 description 1
- PQEYRIFHQUWYCZ-UHFFFAOYSA-N 3-(4-fluorophenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=NOC=2)C=2C=CC(F)=CC=2)=C1OC PQEYRIFHQUWYCZ-UHFFFAOYSA-N 0.000 description 1
- BEFHCDFMGBPLNY-UHFFFAOYSA-N 3-(4-methoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=NOC=C1C1=CC(OC)=C(OC)C(OC)=C1OC BEFHCDFMGBPLNY-UHFFFAOYSA-N 0.000 description 1
- FVOKJQYUTAPTAT-UHFFFAOYSA-N 3-(4-methylphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=NOC=2)C=2C=CC(C)=CC=2)=C1OC FVOKJQYUTAPTAT-UHFFFAOYSA-N 0.000 description 1
- VINPZKUVIYMHJM-UHFFFAOYSA-N 3-(4-nitrophenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=NOC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1OC VINPZKUVIYMHJM-UHFFFAOYSA-N 0.000 description 1
- USHROHDJUFLFRF-UHFFFAOYSA-N 3-(4-propoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCCC)=CC=C1C1=NOC=C1C1=CC(OC)=C(OC)C(OC)=C1OC USHROHDJUFLFRF-UHFFFAOYSA-N 0.000 description 1
- OHGWMIGTGKRLNT-UHFFFAOYSA-N 3-(4-propylphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CCC)=CC=C1C1=NOC=C1C1=CC(OC)=C(OC)C(OC)=C1OC OHGWMIGTGKRLNT-UHFFFAOYSA-N 0.000 description 1
- DQMCMNZPAUVBEN-UHFFFAOYSA-N 3-(5-methoxy-1-methylindol-7-yl)-4-(4-methoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=CON=C1C1=CC(OC)=CC2=C1N(C)C=C2 DQMCMNZPAUVBEN-UHFFFAOYSA-N 0.000 description 1
- NXEJJFIRDUHJBC-UHFFFAOYSA-N 3-(7-methoxy-1,3-benzodioxol-5-yl)-4-(1-methylindol-5-yl)-1,2-oxazole Chemical compound C1=C2N(C)C=CC2=CC(C2=CON=C2C=2C=C(C=3OCOC=3C=2)OC)=C1 NXEJJFIRDUHJBC-UHFFFAOYSA-N 0.000 description 1
- UAVWDRDMMKEDII-UHFFFAOYSA-N 3-(7-methoxy-1,3-benzodioxol-5-yl)-4-(4-methylsulfanylphenyl)-1,2-oxazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC=C(SC)C=C1 UAVWDRDMMKEDII-UHFFFAOYSA-N 0.000 description 1
- ZXWQAXWSBPNGSU-UHFFFAOYSA-N 3-(7-methoxy-1,3-benzodioxol-5-yl)-4-(5-methoxypyridin-2-yl)-1,2-oxazole Chemical compound N1=CC(OC)=CC=C1C1=CON=C1C(C=C1OC)=CC2=C1OCO2 ZXWQAXWSBPNGSU-UHFFFAOYSA-N 0.000 description 1
- UVUCJZVPDSWHSW-UHFFFAOYSA-N 3-(7-methoxy-1,3-benzodioxol-5-yl)-4-(6-methoxypyridin-3-yl)-1,2-oxazole Chemical compound C1=NC(OC)=CC=C1C1=CON=C1C(C=C1OC)=CC2=C1OCO2 UVUCJZVPDSWHSW-UHFFFAOYSA-N 0.000 description 1
- CDLRTWLRNPSSMH-UHFFFAOYSA-N 3-(7-methoxy-1,3-benzodioxol-5-yl)-4-[4-(1-methyltetrazol-5-yl)phenyl]-1,2-oxazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C(C=C1)=CC=C1C1=NN=NN1C CDLRTWLRNPSSMH-UHFFFAOYSA-N 0.000 description 1
- QRHLCDODYTVGFT-UHFFFAOYSA-N 3-(7-methoxy-1,3-benzodioxol-5-yl)-4-[4-(2h-tetrazol-5-yl)phenyl]-1,2-oxazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C(C=C1)=CC=C1C1=NN=NN1 QRHLCDODYTVGFT-UHFFFAOYSA-N 0.000 description 1
- JQTKHPYRTMBYIO-UHFFFAOYSA-N 3-(7-methoxy-1,3-benzodioxol-5-yl)-4-pyridazin-4-yl-1,2-oxazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC=NN=C1 JQTKHPYRTMBYIO-UHFFFAOYSA-N 0.000 description 1
- RDHZMYNTZLIFID-UHFFFAOYSA-N 3-(7-methoxy-1,3-benzodioxol-5-yl)-4-pyridin-3-yl-1,2-oxazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC=CN=C1 RDHZMYNTZLIFID-UHFFFAOYSA-N 0.000 description 1
- OQMOOXVFMUEYAY-UHFFFAOYSA-N 3-(7-methoxy-1,3-benzodioxol-5-yl)-4-pyrimidin-5-yl-1,2-oxazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CN=CN=C1 OQMOOXVFMUEYAY-UHFFFAOYSA-N 0.000 description 1
- ALKYHXVLJMQRLQ-UHFFFAOYSA-N 3-Hydroxy-2-naphthoate Chemical class C1=CC=C2C=C(O)C(C(=O)O)=CC2=C1 ALKYHXVLJMQRLQ-UHFFFAOYSA-N 0.000 description 1
- JYRNNBQLTBUGQU-UHFFFAOYSA-N 3-[3-(7-methoxy-1,3-benzodioxol-5-yl)triazol-4-yl]pyridine Chemical compound C=1C=2OCOC=2C(OC)=CC=1N1N=NC=C1C1=CC=CN=C1 JYRNNBQLTBUGQU-UHFFFAOYSA-N 0.000 description 1
- XMQFXGHHVBMLFS-UHFFFAOYSA-N 3-[4-[3-(3,4,5-triethylphenyl)triazol-4-yl]phenyl]pyridine Chemical compound CCC1=C(CC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)C=2C=NC=CC=2)=C1 XMQFXGHHVBMLFS-UHFFFAOYSA-N 0.000 description 1
- IMPWBRWRSUIVME-UHFFFAOYSA-N 3-[4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl]pyridine Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)C=2C=NC=CC=2)=C1 IMPWBRWRSUIVME-UHFFFAOYSA-N 0.000 description 1
- NMWIDNQEJGRSTL-UHFFFAOYSA-N 3-[4-[5-(3,4,5-triethylphenyl)-2h-triazol-4-yl]phenyl]pyridine Chemical compound CCC1=C(CC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)C=2C=NC=CC=2)=C1 NMWIDNQEJGRSTL-UHFFFAOYSA-N 0.000 description 1
- ULTHCJQMTKXPGO-UHFFFAOYSA-N 3-[4-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]phenyl]pyridine Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)C=2C=NC=CC=2)=C1 ULTHCJQMTKXPGO-UHFFFAOYSA-N 0.000 description 1
- NEBWLJRADZEUFR-UHFFFAOYSA-N 3-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]pyridine;hydrochloride Chemical compound Cl.COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=NC=CC=2)=C1 NEBWLJRADZEUFR-UHFFFAOYSA-N 0.000 description 1
- JTPMTSXALDVPTI-UHFFFAOYSA-N 3-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]pyridine;hydrochloride Chemical compound Cl.C=1C=2OCOC=2C(OC)=CC=1C=1N=NNC=1C1=CC=CN=C1 JTPMTSXALDVPTI-UHFFFAOYSA-N 0.000 description 1
- VDAUCEVAJTUCSA-MUMRKEEXSA-N 3-amino-4-[[2-[[(2r)-5-(diaminomethylideneamino)-1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-4-oxobutanoic acid Chemical compound C1=C(NC(=O)[C@@H](CCCNC(N)=N)NC(=O)CNC(=O)C(N)CC(O)=O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 VDAUCEVAJTUCSA-MUMRKEEXSA-N 0.000 description 1
- WSTYZPNKMOZYCU-UHFFFAOYSA-N 3-amino-4-[[2-[[5-(diaminomethylideneamino)-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-4-oxobutanoic acid Chemical compound C1=C(NC(=O)C(CCCNC(N)=N)NC(=O)CNC(=O)C(N)CC(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 WSTYZPNKMOZYCU-UHFFFAOYSA-N 0.000 description 1
- DONBOJXLJJTXSS-UHFFFAOYSA-N 3-amino-n-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]-4-methylpentanamide;hydrochloride Chemical compound Cl.C1=C(NC(=O)CC(N)C(C)C)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 DONBOJXLJJTXSS-UHFFFAOYSA-N 0.000 description 1
- 125000004337 3-ethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006041 3-hexenyl group Chemical group 0.000 description 1
- 125000006027 3-methyl-1-butenyl group Chemical group 0.000 description 1
- 125000003469 3-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- PIWGIHXMIUQJHE-UHFFFAOYSA-N 4-(1,3-benzodioxol-4-yl)-5-(4-methoxyphenyl)-2h-triazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=3OCOC=3C=CC=2)N=NN1 PIWGIHXMIUQJHE-UHFFFAOYSA-N 0.000 description 1
- KXHRDKSINUUQPT-UHFFFAOYSA-N 4-(1-methylindol-5-yl)-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=C3C=CN(C)C3=CC=2)=C1 KXHRDKSINUUQPT-UHFFFAOYSA-N 0.000 description 1
- RBFVAUJFNIVVEO-UHFFFAOYSA-N 4-(1-methylindol-5-yl)-5-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NS2)C=2C=C3C=CN(C)C3=CC=2)=C1 RBFVAUJFNIVVEO-UHFFFAOYSA-N 0.000 description 1
- VLWSKPOEKYXYLB-UHFFFAOYSA-N 4-(2,3,4,5-tetramethoxyphenyl)-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=C1 VLWSKPOEKYXYLB-UHFFFAOYSA-N 0.000 description 1
- QSIQAHUZBYVFGE-UHFFFAOYSA-N 4-(2,3,4,5-tetramethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=C1 QSIQAHUZBYVFGE-UHFFFAOYSA-N 0.000 description 1
- GKKIJYXZJRXGKG-UHFFFAOYSA-N 4-(2,3,4,5-tetramethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NS2)C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=C1 GKKIJYXZJRXGKG-UHFFFAOYSA-N 0.000 description 1
- SPNSHLYBFAPISR-UHFFFAOYSA-N 4-(2,3,4,5-tetramethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=C1 SPNSHLYBFAPISR-UHFFFAOYSA-N 0.000 description 1
- FTURSXDVVNKSBL-UHFFFAOYSA-N 4-(2,3,5-trimethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(NN=N2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 FTURSXDVVNKSBL-UHFFFAOYSA-N 0.000 description 1
- AQDMHPMLVMZPAA-UHFFFAOYSA-N 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=C3OCCOC3=CC=2)=C1 AQDMHPMLVMZPAA-UHFFFAOYSA-N 0.000 description 1
- UWUXTPUGFOXDEG-UHFFFAOYSA-N 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3,4-dimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=NOC=C1C1=CC=C(OCCO2)C2=C1 UWUXTPUGFOXDEG-UHFFFAOYSA-N 0.000 description 1
- OQMSUBIMPYHXFD-UHFFFAOYSA-N 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NS2)C=2C=C3OCCOC3=CC=2)=C1 OQMSUBIMPYHXFD-UHFFFAOYSA-N 0.000 description 1
- RGUMBORGTRIONZ-UHFFFAOYSA-N 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(3,4-dimethoxyphenyl)-1,2-thiazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(C=2C=C3OCCOC3=CC=2)C=NS1 RGUMBORGTRIONZ-UHFFFAOYSA-N 0.000 description 1
- VVVLNQHKPZXPGP-UHFFFAOYSA-N 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(3,4-dimethoxyphenyl)-2h-triazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(C=2C=C3OCCOC3=CC=2)NN=N1 VVVLNQHKPZXPGP-UHFFFAOYSA-N 0.000 description 1
- IRSVKXJVSLXCTD-UHFFFAOYSA-N 4-(2,3-dihydro-1-benzofuran-6-yl)-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=C3OCCC3=CC=2)=C1 IRSVKXJVSLXCTD-UHFFFAOYSA-N 0.000 description 1
- GTRDSDJKCSMBIR-UHFFFAOYSA-N 4-(2,3-dihydro-1-benzofuran-6-yl)-3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazole Chemical compound C1=C2CCOC2=CC(C2=CON=C2C=2C=C(C=3OCOC=3C=2)OC)=C1 GTRDSDJKCSMBIR-UHFFFAOYSA-N 0.000 description 1
- TYOQYHZIWUULAD-UHFFFAOYSA-N 4-(2,3-dihydro-1-benzofuran-6-yl)-5-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NS2)C=2C=C3OCCC3=CC=2)=C1 TYOQYHZIWUULAD-UHFFFAOYSA-N 0.000 description 1
- DEZYSJVQOXVNKJ-UHFFFAOYSA-N 4-(2,3-dihydro-1-benzofuran-6-yl)-5-(3,4,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=C3OCCC3=CC=2)=C1 DEZYSJVQOXVNKJ-UHFFFAOYSA-N 0.000 description 1
- XHVKGXIHADGOLV-UHFFFAOYSA-N 4-(2,3-dihydro-1-benzofuran-6-yl)-5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazole Chemical compound C1=C2CCOC2=CC(C=2C=NSC=2C=2C=C(C=3OCOC=3C=2)OC)=C1 XHVKGXIHADGOLV-UHFFFAOYSA-N 0.000 description 1
- RCYMMMHNNDMERW-UHFFFAOYSA-N 4-(2,3-dihydro-1-benzofuran-6-yl)-5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazole Chemical compound C1=C2CCOC2=CC(C=2NN=NC=2C=2C=C(C=3OCOC=3C=2)OC)=C1 RCYMMMHNNDMERW-UHFFFAOYSA-N 0.000 description 1
- VNTDXNOZBVZEIC-UHFFFAOYSA-N 4-(2,4,5-trimethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)NN=N1 VNTDXNOZBVZEIC-UHFFFAOYSA-N 0.000 description 1
- YXPQSBOKYHCHNS-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-3-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=CC(OC)=C(OC)C(C=2C(=CON=2)C=2C=C(OC)C(OC)=CC=2)=C1 YXPQSBOKYHCHNS-UHFFFAOYSA-N 0.000 description 1
- JGOPTHMFTFBIPV-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-3-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C=C1OC JGOPTHMFTFBIPV-UHFFFAOYSA-N 0.000 description 1
- QLVPQJLKFDTNIP-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-5-(2,3,4,5-tetramethoxyphenyl)-2h-triazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)NN=N1 QLVPQJLKFDTNIP-UHFFFAOYSA-N 0.000 description 1
- WXPRMXRVCVEMTA-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NS2)C=2C=C(OC)C(OC)=CC=2)=C1 WXPRMXRVCVEMTA-UHFFFAOYSA-N 0.000 description 1
- FOQSNIUACJLRAU-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(NN=N2)C=2C=C(OC)C(OC)=CC=2)=C1 FOQSNIUACJLRAU-UHFFFAOYSA-N 0.000 description 1
- QXZUTSMHKAAQLB-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)SN=C1 QXZUTSMHKAAQLB-UHFFFAOYSA-N 0.000 description 1
- CHSZYLRZXLBLMD-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)N=NN1 CHSZYLRZXLBLMD-UHFFFAOYSA-N 0.000 description 1
- HTOIERNVGWFBDJ-UHFFFAOYSA-N 4-(3-fluoro-4-methoxyphenyl)-5-(3,4,5-triethylphenyl)-2h-triazole Chemical compound CCC1=C(CC)C(CC)=CC(C2=C(NN=N2)C=2C=C(F)C(OC)=CC=2)=C1 HTOIERNVGWFBDJ-UHFFFAOYSA-N 0.000 description 1
- IWZXWBJWCRZVIO-UHFFFAOYSA-N 4-(3-fluoro-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(F)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 IWZXWBJWCRZVIO-UHFFFAOYSA-N 0.000 description 1
- YCIXTLALWSZTGV-UHFFFAOYSA-N 4-(3-fluoro-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=C(F)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 YCIXTLALWSZTGV-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- UQEHBCMWMHRPKL-UHFFFAOYSA-N 4-(4-bromophenyl)-3-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=NOC=C1C1=CC=C(Br)C=C1 UQEHBCMWMHRPKL-UHFFFAOYSA-N 0.000 description 1
- MSVXDXJKICHUBU-UHFFFAOYSA-N 4-(4-bromophenyl)-5-(2,3,4,5-tetramethoxyphenyl)-2h-triazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(N=NN2)C=2C=CC(Br)=CC=2)=C1OC MSVXDXJKICHUBU-UHFFFAOYSA-N 0.000 description 1
- KYHSBRFJFQDMLO-UHFFFAOYSA-N 4-(4-bromophenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NO2)C=2C=CC(Br)=CC=2)=C1 KYHSBRFJFQDMLO-UHFFFAOYSA-N 0.000 description 1
- LLBDIQHRQADDEN-UHFFFAOYSA-N 4-(4-bromophenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NS2)C=2C=CC(Br)=CC=2)=C1 LLBDIQHRQADDEN-UHFFFAOYSA-N 0.000 description 1
- MJJUAFVKNMWDRE-UHFFFAOYSA-N 4-(4-bromophenyl)-5-(2,3,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(NN=N2)C=2C=CC(Br)=CC=2)=C1 MJJUAFVKNMWDRE-UHFFFAOYSA-N 0.000 description 1
- FIVBFKPKTZNBNW-UHFFFAOYSA-N 4-(4-bromophenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(Br)=CC=2)C=NS1 FIVBFKPKTZNBNW-UHFFFAOYSA-N 0.000 description 1
- UBJZFRSHXGHUBS-UHFFFAOYSA-N 4-(4-bromophenyl)-5-(2,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(Br)=CC=2)NN=N1 UBJZFRSHXGHUBS-UHFFFAOYSA-N 0.000 description 1
- BOHJISYLPNEHCY-UHFFFAOYSA-N 4-(4-bromophenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CC(Br)=CC=2)=C1 BOHJISYLPNEHCY-UHFFFAOYSA-N 0.000 description 1
- KZWRAZAKJCMAJX-UHFFFAOYSA-N 4-(4-butoxyphenyl)-3-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCCCC)=CC=C1C1=CON=C1C1=CC(OC)=CC(OC)=C1OC KZWRAZAKJCMAJX-UHFFFAOYSA-N 0.000 description 1
- UTKLXJPZXZAZDW-UHFFFAOYSA-N 4-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCCCC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C=C1OC UTKLXJPZXZAZDW-UHFFFAOYSA-N 0.000 description 1
- ITYARBNCLGQAOL-UHFFFAOYSA-N 4-(4-butoxyphenyl)-5-(2,3,4,5-tetramethoxyphenyl)-2h-triazole Chemical compound C1=CC(OCCCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)NN=N1 ITYARBNCLGQAOL-UHFFFAOYSA-N 0.000 description 1
- QICSEMZYVVUJTB-UHFFFAOYSA-N 4-(4-butoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(OCCCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)N=NN1 QICSEMZYVVUJTB-UHFFFAOYSA-N 0.000 description 1
- KJWQMWZMIGTTMS-UHFFFAOYSA-N 4-(4-butoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(OCCCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)SN=C1 KJWQMWZMIGTTMS-UHFFFAOYSA-N 0.000 description 1
- VNHYBCSVHNZRDT-UHFFFAOYSA-N 4-(4-butoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(OCCCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)N=NN1 VNHYBCSVHNZRDT-UHFFFAOYSA-N 0.000 description 1
- WMGVBXVRRXJUNB-UHFFFAOYSA-N 4-(4-butylphenyl)-3-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CCCC)=CC=C1C1=CON=C1C1=CC(OC)=CC(OC)=C1OC WMGVBXVRRXJUNB-UHFFFAOYSA-N 0.000 description 1
- OWFMRYTXVBCBBG-UHFFFAOYSA-N 4-(4-butylphenyl)-3-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CCCC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C=C1OC OWFMRYTXVBCBBG-UHFFFAOYSA-N 0.000 description 1
- FXFCJACXIIJFSR-UHFFFAOYSA-N 4-(4-butylphenyl)-5-(2,3,4,5-tetramethoxyphenyl)-2h-triazole Chemical compound C1=CC(CCCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)NN=N1 FXFCJACXIIJFSR-UHFFFAOYSA-N 0.000 description 1
- ZXBXKYQHDZJIBT-UHFFFAOYSA-N 4-(4-butylphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(CCCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)SN=C1 ZXBXKYQHDZJIBT-UHFFFAOYSA-N 0.000 description 1
- QWOGOWDMEKBXTD-UHFFFAOYSA-N 4-(4-butylphenyl)-5-(2,3,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(CCCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)N=NN1 QWOGOWDMEKBXTD-UHFFFAOYSA-N 0.000 description 1
- IJZRLTXOFKYGTK-UHFFFAOYSA-N 4-(4-butylphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(CCCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)SN=C1 IJZRLTXOFKYGTK-UHFFFAOYSA-N 0.000 description 1
- DPEBAMIMORYGEZ-UHFFFAOYSA-N 4-(4-butylphenyl)-5-(2,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(CCCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)N=NN1 DPEBAMIMORYGEZ-UHFFFAOYSA-N 0.000 description 1
- XBMONDCJENJFHE-UHFFFAOYSA-N 4-(4-chlorophenyl)-3-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=CC(OC)=C(OC)C(C=2C(=CON=2)C=2C=CC(Cl)=CC=2)=C1 XBMONDCJENJFHE-UHFFFAOYSA-N 0.000 description 1
- XBCVRXJJLZAMFS-UHFFFAOYSA-N 4-(4-chlorophenyl)-3-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=NOC=C1C1=CC=C(Cl)C=C1 XBCVRXJJLZAMFS-UHFFFAOYSA-N 0.000 description 1
- ODCIRVXWEVYJFT-UHFFFAOYSA-N 4-(4-chlorophenyl)-5-(2,3,4,5-tetramethoxyphenyl)-2h-triazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(N=NN2)C=2C=CC(Cl)=CC=2)=C1OC ODCIRVXWEVYJFT-UHFFFAOYSA-N 0.000 description 1
- ZFSAQXSIBCSBBH-UHFFFAOYSA-N 4-(4-chlorophenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NS2)C=2C=CC(Cl)=CC=2)=C1 ZFSAQXSIBCSBBH-UHFFFAOYSA-N 0.000 description 1
- AQUIRQRIYMMZND-UHFFFAOYSA-N 4-(4-chlorophenyl)-5-(2,3,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(NN=N2)C=2C=CC(Cl)=CC=2)=C1 AQUIRQRIYMMZND-UHFFFAOYSA-N 0.000 description 1
- KXASKFAULWEBID-UHFFFAOYSA-N 4-(4-chlorophenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(Cl)=CC=2)C=NS1 KXASKFAULWEBID-UHFFFAOYSA-N 0.000 description 1
- UBOPOJSOYYFJLD-UHFFFAOYSA-N 4-(4-chlorophenyl)-5-(2,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(Cl)=CC=2)NN=N1 UBOPOJSOYYFJLD-UHFFFAOYSA-N 0.000 description 1
- ODUCRIJWGZZNOT-UHFFFAOYSA-N 4-(4-ethoxyphenyl)-3-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCC)=CC=C1C1=CON=C1C1=CC(OC)=CC(OC)=C1OC ODUCRIJWGZZNOT-UHFFFAOYSA-N 0.000 description 1
- PRWXJHHWGDMNLN-UHFFFAOYSA-N 4-(4-ethoxyphenyl)-3-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C=C1OC PRWXJHHWGDMNLN-UHFFFAOYSA-N 0.000 description 1
- QANWYKXWHQOHRP-UHFFFAOYSA-N 4-(4-ethoxyphenyl)-5-(2,3,4,5-tetramethoxyphenyl)-2h-triazole Chemical compound C1=CC(OCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)NN=N1 QANWYKXWHQOHRP-UHFFFAOYSA-N 0.000 description 1
- DXFBUGHGBKXKFL-UHFFFAOYSA-N 4-(4-ethoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(OCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)SN=C1 DXFBUGHGBKXKFL-UHFFFAOYSA-N 0.000 description 1
- WMEIOKAXVYWOGN-UHFFFAOYSA-N 4-(4-ethoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(OCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)N=NN1 WMEIOKAXVYWOGN-UHFFFAOYSA-N 0.000 description 1
- MBAPHGVPJUKGPO-UHFFFAOYSA-N 4-(4-ethoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(OCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)SN=C1 MBAPHGVPJUKGPO-UHFFFAOYSA-N 0.000 description 1
- IUDBERRLPBOLFD-UHFFFAOYSA-N 4-(4-ethoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(OCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)N=NN1 IUDBERRLPBOLFD-UHFFFAOYSA-N 0.000 description 1
- WOBQGBRSRUOBDX-UHFFFAOYSA-N 4-(4-ethylphenyl)-3-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CC)=CC=C1C1=CON=C1C1=CC(OC)=CC(OC)=C1OC WOBQGBRSRUOBDX-UHFFFAOYSA-N 0.000 description 1
- YLLDLCJNYQSKGI-UHFFFAOYSA-N 4-(4-ethylphenyl)-3-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C=C1OC YLLDLCJNYQSKGI-UHFFFAOYSA-N 0.000 description 1
- QMZCFJPQEDTEGO-UHFFFAOYSA-N 4-(4-ethylphenyl)-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 QMZCFJPQEDTEGO-UHFFFAOYSA-N 0.000 description 1
- QYRIQJJIGGBBLE-UHFFFAOYSA-N 4-(4-ethylphenyl)-5-(2,3,4,5-tetramethoxyphenyl)-2h-triazole Chemical compound C1=CC(CC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)NN=N1 QYRIQJJIGGBBLE-UHFFFAOYSA-N 0.000 description 1
- HESYPQRILVQEBT-UHFFFAOYSA-N 4-(4-ethylphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(CC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)SN=C1 HESYPQRILVQEBT-UHFFFAOYSA-N 0.000 description 1
- NCPBEVHEUFNKNV-UHFFFAOYSA-N 4-(4-ethylphenyl)-5-(2,3,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(CC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)N=NN1 NCPBEVHEUFNKNV-UHFFFAOYSA-N 0.000 description 1
- JYIBLTKGXBRTJG-UHFFFAOYSA-N 4-(4-ethylphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(CC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)SN=C1 JYIBLTKGXBRTJG-UHFFFAOYSA-N 0.000 description 1
- DNPYGNQMCCPBAI-UHFFFAOYSA-N 4-(4-ethylphenyl)-5-(2,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(CC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)N=NN1 DNPYGNQMCCPBAI-UHFFFAOYSA-N 0.000 description 1
- QYKFHNJJIRZWHD-UHFFFAOYSA-N 4-(4-ethylphenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(CC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)SN=C1 QYKFHNJJIRZWHD-UHFFFAOYSA-N 0.000 description 1
- QZNNBXPKWNLBAK-UHFFFAOYSA-N 4-(4-ethylphenyl)-5-(3,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(CC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 QZNNBXPKWNLBAK-UHFFFAOYSA-N 0.000 description 1
- XAYBSPCBABOZGA-UHFFFAOYSA-N 4-(4-fluorophenyl)-3-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=CC(OC)=C(OC)C(C=2C(=CON=2)C=2C=CC(F)=CC=2)=C1 XAYBSPCBABOZGA-UHFFFAOYSA-N 0.000 description 1
- GOCBXUCBMHCFPC-UHFFFAOYSA-N 4-(4-fluorophenyl)-3-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=NOC=C1C1=CC=C(F)C=C1 GOCBXUCBMHCFPC-UHFFFAOYSA-N 0.000 description 1
- WKCSFQBROSEQOG-UHFFFAOYSA-N 4-(4-fluorophenyl)-5-(2,3,4,5-tetramethoxyphenyl)-2h-triazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(N=NN2)C=2C=CC(F)=CC=2)=C1OC WKCSFQBROSEQOG-UHFFFAOYSA-N 0.000 description 1
- BPMXDXBFARGVNA-UHFFFAOYSA-N 4-(4-fluorophenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NS2)C=2C=CC(F)=CC=2)=C1 BPMXDXBFARGVNA-UHFFFAOYSA-N 0.000 description 1
- ILIZSTWSHITXAL-UHFFFAOYSA-N 4-(4-fluorophenyl)-5-(2,3,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(NN=N2)C=2C=CC(F)=CC=2)=C1 ILIZSTWSHITXAL-UHFFFAOYSA-N 0.000 description 1
- AVONRNYXHMVVNP-UHFFFAOYSA-N 4-(4-fluorophenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(F)=CC=2)C=NS1 AVONRNYXHMVVNP-UHFFFAOYSA-N 0.000 description 1
- SZDORQADZONQBT-UHFFFAOYSA-N 4-(4-fluorophenyl)-5-(2,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(F)=CC=2)NN=N1 SZDORQADZONQBT-UHFFFAOYSA-N 0.000 description 1
- CWSZQTAYDILCGE-UHFFFAOYSA-N 4-(4-iodophenyl)-5-(3,4,5-triethylphenyl)-2h-triazole Chemical compound CCC1=C(CC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(I)=CC=2)=C1 CWSZQTAYDILCGE-UHFFFAOYSA-N 0.000 description 1
- MEMMCBYJIHTMOD-UHFFFAOYSA-N 4-(4-iodophenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CC(I)=CC=2)=C1 MEMMCBYJIHTMOD-UHFFFAOYSA-N 0.000 description 1
- RNJVTKMLKHMXAK-UHFFFAOYSA-N 4-(4-iodophenyl)-5-(3,4,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(I)=CC=2)=C1 RNJVTKMLKHMXAK-UHFFFAOYSA-N 0.000 description 1
- NBFFVVHEOTXCIF-UHFFFAOYSA-N 4-(4-methoxyphenyl)-3-(2,3,4-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=CON=C1C1=CC=C(OC)C(OC)=C1OC NBFFVVHEOTXCIF-UHFFFAOYSA-N 0.000 description 1
- GUMZDIFBBOHZTH-UHFFFAOYSA-N 4-(4-methoxyphenyl)-3-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=CON=C1C1=CC(OC)=CC(OC)=C1OC GUMZDIFBBOHZTH-UHFFFAOYSA-N 0.000 description 1
- FJGQVTRABREKFW-UHFFFAOYSA-N 4-(4-methoxyphenyl)-3-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C=C1OC FJGQVTRABREKFW-UHFFFAOYSA-N 0.000 description 1
- XNUQQLROADHMKN-UHFFFAOYSA-N 4-(4-methoxyphenyl)-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 XNUQQLROADHMKN-UHFFFAOYSA-N 0.000 description 1
- GMOHIQVUFURZFY-UHFFFAOYSA-N 4-(4-methoxyphenyl)-3-(4,5,6-trimethoxypyridin-2-yl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=N1 GMOHIQVUFURZFY-UHFFFAOYSA-N 0.000 description 1
- HDRDSDVVZLHREA-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(2,3,4,5-tetramethoxyphenyl)-2h-triazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)NN=N1 HDRDSDVVZLHREA-UHFFFAOYSA-N 0.000 description 1
- WGWKYJQUUGUVSI-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(2,3,4-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=CC=2)OC)SN=C1 WGWKYJQUUGUVSI-UHFFFAOYSA-N 0.000 description 1
- WVIXJDGGDRRMLZ-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(2,3,4-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=CC=2)OC)N=NN1 WVIXJDGGDRRMLZ-UHFFFAOYSA-N 0.000 description 1
- XDNDFKCCXANYIB-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)SN=C1 XDNDFKCCXANYIB-UHFFFAOYSA-N 0.000 description 1
- QHGHLIYBDGWCFX-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)N=NN1 QHGHLIYBDGWCFX-UHFFFAOYSA-N 0.000 description 1
- DEVOPOLYGWIPDL-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)SN=C1 DEVOPOLYGWIPDL-UHFFFAOYSA-N 0.000 description 1
- MIBLTUBWNOJOAV-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)N=NN1 MIBLTUBWNOJOAV-UHFFFAOYSA-N 0.000 description 1
- IFHRSXUMYIHZJN-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(3,4,5-triethylphenyl)-2h-triazole Chemical compound CCC1=C(CC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(OC)=CC=2)=C1 IFHRSXUMYIHZJN-UHFFFAOYSA-N 0.000 description 1
- JHZMSGCUGQSNOA-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 JHZMSGCUGQSNOA-UHFFFAOYSA-N 0.000 description 1
- IXERHGTYYHYYHX-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-(3,4,5-trimethylphenyl)-2h-triazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=C(C)C(C)=C(C)C=2)N=NN1 IXERHGTYYHYYHX-UHFFFAOYSA-N 0.000 description 1
- APRJIWWBEKRSAS-UHFFFAOYSA-N 4-(4-methylphenyl)-3-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=CC(OC)=C(OC)C(C=2C(=CON=2)C=2C=CC(C)=CC=2)=C1 APRJIWWBEKRSAS-UHFFFAOYSA-N 0.000 description 1
- XSVFLMZTVVEHSQ-UHFFFAOYSA-N 4-(4-methylphenyl)-3-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=NOC=C1C1=CC=C(C)C=C1 XSVFLMZTVVEHSQ-UHFFFAOYSA-N 0.000 description 1
- QVYPUTSBVFYNMX-UHFFFAOYSA-N 4-(4-methylphenyl)-5-(2,3,4,5-tetramethoxyphenyl)-2h-triazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(N=NN2)C=2C=CC(C)=CC=2)=C1OC QVYPUTSBVFYNMX-UHFFFAOYSA-N 0.000 description 1
- DKLKNANBAMKWHN-UHFFFAOYSA-N 4-(4-methylphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NS2)C=2C=CC(C)=CC=2)=C1 DKLKNANBAMKWHN-UHFFFAOYSA-N 0.000 description 1
- UVOKGTNGUXHINK-UHFFFAOYSA-N 4-(4-methylphenyl)-5-(2,3,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(NN=N2)C=2C=CC(C)=CC=2)=C1 UVOKGTNGUXHINK-UHFFFAOYSA-N 0.000 description 1
- AMSLSPJQVQQVOG-UHFFFAOYSA-N 4-(4-methylphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(C)=CC=2)C=NS1 AMSLSPJQVQQVOG-UHFFFAOYSA-N 0.000 description 1
- UCRDFGMPJKFTNP-UHFFFAOYSA-N 4-(4-methylphenyl)-5-(2,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(C)=CC=2)NN=N1 UCRDFGMPJKFTNP-UHFFFAOYSA-N 0.000 description 1
- WZIFGXOPYSCAKX-UHFFFAOYSA-N 4-(4-methylsulfanylphenyl)-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=CC(SC)=CC=2)=C1 WZIFGXOPYSCAKX-UHFFFAOYSA-N 0.000 description 1
- AGSQPZNZHPFFOD-UHFFFAOYSA-N 4-(4-methylsulfanylphenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-thiazole [2-methylsulfanyl-5-[5-(3,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]phenyl] dihydrogen phosphate Chemical compound P(=O)(O)(O)OC=1C=C(C=CC1SC)C=1C=NSC1C1=CC(=C(C(=C1)OC)OC)OC.CSC1=CC=C(C=C1)C=1C=NSC1C1=CC(=C(C(=C1)OC)OC)OC AGSQPZNZHPFFOD-UHFFFAOYSA-N 0.000 description 1
- HOZXLXOZNOHXEY-UHFFFAOYSA-N 4-(4-methylsulfanylphenyl)-5-(3,4,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(SC)=CC=2)=C1 HOZXLXOZNOHXEY-UHFFFAOYSA-N 0.000 description 1
- AZCDKUKBDDCLMG-UHFFFAOYSA-N 4-(4-nitrophenyl)-3-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=CC(OC)=C(OC)C(C=2C(=CON=2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 AZCDKUKBDDCLMG-UHFFFAOYSA-N 0.000 description 1
- GUAHGOHOOHFXBQ-UHFFFAOYSA-N 4-(4-nitrophenyl)-3-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=NOC=C1C1=CC=C([N+]([O-])=O)C=C1 GUAHGOHOOHFXBQ-UHFFFAOYSA-N 0.000 description 1
- CMEOLIWPLJDSLG-UHFFFAOYSA-N 4-(4-nitrophenyl)-5-(2,3,4,5-tetramethoxyphenyl)-2h-triazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(N=NN2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1OC CMEOLIWPLJDSLG-UHFFFAOYSA-N 0.000 description 1
- KRGXTVNYCVCIIN-UHFFFAOYSA-N 4-(4-nitrophenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NS2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 KRGXTVNYCVCIIN-UHFFFAOYSA-N 0.000 description 1
- SBTSZAINQZVMFA-UHFFFAOYSA-N 4-(4-nitrophenyl)-5-(2,3,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(NN=N2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 SBTSZAINQZVMFA-UHFFFAOYSA-N 0.000 description 1
- DFFAHDHKFMDAGX-UHFFFAOYSA-N 4-(4-nitrophenyl)-5-(2,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=CC(=CC=2)[N+]([O-])=O)NN=N1 DFFAHDHKFMDAGX-UHFFFAOYSA-N 0.000 description 1
- INWJPQSWUHXVQQ-UHFFFAOYSA-N 4-(4-nitrophenyl)-5-(3,4,5-triethylphenyl)-2h-triazole Chemical compound CCC1=C(CC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 INWJPQSWUHXVQQ-UHFFFAOYSA-N 0.000 description 1
- NTAOMJJEPYVHIC-UHFFFAOYSA-N 4-(4-nitrophenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 NTAOMJJEPYVHIC-UHFFFAOYSA-N 0.000 description 1
- NTSJGEHFDZUIGS-UHFFFAOYSA-N 4-(4-nitrophenyl)-5-(3,4,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 NTSJGEHFDZUIGS-UHFFFAOYSA-N 0.000 description 1
- IIQRCXKUVGFUOS-UHFFFAOYSA-N 4-(4-propan-2-ylphenyl)-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=CC(=CC=2)C(C)C)=C1 IIQRCXKUVGFUOS-UHFFFAOYSA-N 0.000 description 1
- VAKAWHRPLZLLKC-UHFFFAOYSA-N 4-(4-propan-2-ylphenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NS2)C=2C=CC(=CC=2)C(C)C)=C1 VAKAWHRPLZLLKC-UHFFFAOYSA-N 0.000 description 1
- MIOZTTCXSKUURG-UHFFFAOYSA-N 4-(4-propan-2-ylphenyl)-5-(3,4,5-trimethoxyphenyl)-2h-triazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)C(C)C)=C1 MIOZTTCXSKUURG-UHFFFAOYSA-N 0.000 description 1
- MZDBJSFMJSYWGQ-UHFFFAOYSA-N 4-(4-propoxyphenyl)-3-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCCC)=CC=C1C1=CON=C1C1=CC(OC)=CC(OC)=C1OC MZDBJSFMJSYWGQ-UHFFFAOYSA-N 0.000 description 1
- KDLRVHKGMNIBOK-UHFFFAOYSA-N 4-(4-propoxyphenyl)-3-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OCCC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C=C1OC KDLRVHKGMNIBOK-UHFFFAOYSA-N 0.000 description 1
- JAGBTAIUUFGWTJ-UHFFFAOYSA-N 4-(4-propoxyphenyl)-5-(2,3,4,5-tetramethoxyphenyl)-2h-triazole Chemical compound C1=CC(OCCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)NN=N1 JAGBTAIUUFGWTJ-UHFFFAOYSA-N 0.000 description 1
- WIRCMSFUPUAUAT-UHFFFAOYSA-N 4-(4-propoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(OCCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)SN=C1 WIRCMSFUPUAUAT-UHFFFAOYSA-N 0.000 description 1
- GWUBLKHWXSTZPY-UHFFFAOYSA-N 4-(4-propoxyphenyl)-5-(2,3,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(OCCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)N=NN1 GWUBLKHWXSTZPY-UHFFFAOYSA-N 0.000 description 1
- AQPDLQXRIZUNAZ-UHFFFAOYSA-N 4-(4-propoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(OCCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)SN=C1 AQPDLQXRIZUNAZ-UHFFFAOYSA-N 0.000 description 1
- VMDYBNGCVBNAIU-UHFFFAOYSA-N 4-(4-propoxyphenyl)-5-(2,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(OCCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)N=NN1 VMDYBNGCVBNAIU-UHFFFAOYSA-N 0.000 description 1
- OPCWHLBMJFIMBK-UHFFFAOYSA-N 4-(4-propylphenyl)-3-(2,3,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CCC)=CC=C1C1=CON=C1C1=CC(OC)=CC(OC)=C1OC OPCWHLBMJFIMBK-UHFFFAOYSA-N 0.000 description 1
- OSPAEVQVYDTBCI-UHFFFAOYSA-N 4-(4-propylphenyl)-3-(2,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(CCC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C=C1OC OSPAEVQVYDTBCI-UHFFFAOYSA-N 0.000 description 1
- ZUNATZIQKKUJKB-UHFFFAOYSA-N 4-(4-propylphenyl)-5-(2,3,4,5-tetramethoxyphenyl)-2h-triazole Chemical compound C1=CC(CCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)NN=N1 ZUNATZIQKKUJKB-UHFFFAOYSA-N 0.000 description 1
- QAIRVLQQIMMTRY-UHFFFAOYSA-N 4-(4-propylphenyl)-5-(2,3,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(CCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)SN=C1 QAIRVLQQIMMTRY-UHFFFAOYSA-N 0.000 description 1
- RCBHKYMVSFHOEN-UHFFFAOYSA-N 4-(4-propylphenyl)-5-(2,3,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(CCC)=CC=C1C1=C(C=2C(=C(OC)C=C(OC)C=2)OC)N=NN1 RCBHKYMVSFHOEN-UHFFFAOYSA-N 0.000 description 1
- JZRYNJSJNZILQM-UHFFFAOYSA-N 4-(4-propylphenyl)-5-(2,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(CCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)SN=C1 JZRYNJSJNZILQM-UHFFFAOYSA-N 0.000 description 1
- NXNBVFLJRKLTIQ-UHFFFAOYSA-N 4-(4-propylphenyl)-5-(2,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(CCC)=CC=C1C1=C(C=2C(=CC(OC)=C(OC)C=2)OC)N=NN1 NXNBVFLJRKLTIQ-UHFFFAOYSA-N 0.000 description 1
- QELLURAYLCEEGT-UHFFFAOYSA-N 4-(4-pyridin-2-ylphenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CC(=CC=2)C=2N=CC=CC=2)=C1 QELLURAYLCEEGT-UHFFFAOYSA-N 0.000 description 1
- BZUXRRAJCLZVMT-UHFFFAOYSA-N 4-(4-pyridin-3-ylphenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CC(=CC=2)C=2C=NC=CC=2)=C1 BZUXRRAJCLZVMT-UHFFFAOYSA-N 0.000 description 1
- DMLHHIDFUZKCJD-UHFFFAOYSA-N 4-(4-pyridin-4-ylphenyl)-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CC(=CC=2)C=2C=CN=CC=2)=C1 DMLHHIDFUZKCJD-UHFFFAOYSA-N 0.000 description 1
- BBBWJXUGBUKUSE-UHFFFAOYSA-N 4-(6-methoxypyridin-3-yl)-5-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=NC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)SN=C1 BBBWJXUGBUKUSE-UHFFFAOYSA-N 0.000 description 1
- BPJHDOKHAWMUNS-UHFFFAOYSA-N 4-(7-methoxy-1,3-benzodioxol-5-yl)-5-(4-methylsulfanylphenyl)-2h-triazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1N=NNC=1C1=CC=C(SC)C=C1 BPJHDOKHAWMUNS-UHFFFAOYSA-N 0.000 description 1
- XXJWYDDUDKYVKI-UHFFFAOYSA-N 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]quinazoline Chemical compound COC1=CC2=C(OC=3C(=C4C=C(C)NC4=CC=3)F)N=CN=C2C=C1OCCCN1CCCC1 XXJWYDDUDKYVKI-UHFFFAOYSA-N 0.000 description 1
- FEFOFVGBLWYRGK-UHFFFAOYSA-N 4-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-4-oxobutanoic acid Chemical compound C1=C(NC(=O)CCC(O)=O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 FEFOFVGBLWYRGK-UHFFFAOYSA-N 0.000 description 1
- CGAQPAVWCRJOPA-UHFFFAOYSA-N 4-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]anilino]-4-oxobutanoic acid Chemical compound C1=C(NC(=O)CCC(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 CGAQPAVWCRJOPA-UHFFFAOYSA-N 0.000 description 1
- FCFOCGIRJTZCMP-UHFFFAOYSA-N 4-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-4-oxobutanoic acid Chemical compound C1=C(NC(=O)CCC(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 FCFOCGIRJTZCMP-UHFFFAOYSA-N 0.000 description 1
- QFMBPUFHYMNUFT-UHFFFAOYSA-N 4-[3-(3,4,5-triethylphenyl)triazol-4-yl]pyridine Chemical compound CCC1=C(CC)C(CC)=CC(N2C(=CN=N2)C=2C=CN=CC=2)=C1 QFMBPUFHYMNUFT-UHFFFAOYSA-N 0.000 description 1
- YJVWIYQRCAWSFM-UHFFFAOYSA-N 4-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenol Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=CC(O)=CC=2)=C1 YJVWIYQRCAWSFM-UHFFFAOYSA-N 0.000 description 1
- UTEUMGBAOMPYEN-UHFFFAOYSA-N 4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(N)=CC=2)=C1 UTEUMGBAOMPYEN-UHFFFAOYSA-N 0.000 description 1
- LQDMSRGQCWOAMZ-UHFFFAOYSA-N 4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]benzoic acid Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)C(O)=O)=C1 LQDMSRGQCWOAMZ-UHFFFAOYSA-N 0.000 description 1
- GBVHDRCTPPHFNN-UHFFFAOYSA-N 4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenol Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(O)=CC=2)=C1 GBVHDRCTPPHFNN-UHFFFAOYSA-N 0.000 description 1
- MWPAOAXTXPGIEU-UHFFFAOYSA-N 4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]pyridazine Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=NN=CC=2)=C1 MWPAOAXTXPGIEU-UHFFFAOYSA-N 0.000 description 1
- PZRTYOQJVBIPFH-UHFFFAOYSA-N 4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]pyridine Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CN=CC=2)=C1 PZRTYOQJVBIPFH-UHFFFAOYSA-N 0.000 description 1
- SVKYOHULZGBDFI-UHFFFAOYSA-N 4-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenol Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC=C(O)C=C1 SVKYOHULZGBDFI-UHFFFAOYSA-N 0.000 description 1
- VSKDFKQPJGOVKA-UHFFFAOYSA-N 4-[3-(7-methoxy-1,3-benzodioxol-5-yl)triazol-4-yl]pyridazine Chemical compound C=1C=2OCOC=2C(OC)=CC=1N1N=NC=C1C1=CC=NN=C1 VSKDFKQPJGOVKA-UHFFFAOYSA-N 0.000 description 1
- QDTJYJXMPLUGHT-UHFFFAOYSA-N 4-[4-(1-methyltetrazol-5-yl)phenyl]-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=CC(=CC=2)C=2N(N=NN=2)C)=C1 QDTJYJXMPLUGHT-UHFFFAOYSA-N 0.000 description 1
- KZADAQINFRVSGP-UHFFFAOYSA-N 4-[4-(1-methyltetrazol-5-yl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NS2)C=2C=CC(=CC=2)C=2N(N=NN=2)C)=C1 KZADAQINFRVSGP-UHFFFAOYSA-N 0.000 description 1
- KAJKAKVUIDAZJA-UHFFFAOYSA-N 4-[4-(2h-tetrazol-5-yl)phenyl]-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=CC(=CC=2)C=2NN=NN=2)=C1 KAJKAKVUIDAZJA-UHFFFAOYSA-N 0.000 description 1
- KSGBVZWNYWDARA-UHFFFAOYSA-N 4-[4-(2h-tetrazol-5-yl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NS2)C=2C=CC(=CC=2)C=2NN=NN=2)=C1 KSGBVZWNYWDARA-UHFFFAOYSA-N 0.000 description 1
- UKAWYASESQRNEV-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=CC=C(C2=C(ON=C2)C=2C=C(OC)C(OC)=C(OC)C=2)C=C1 UKAWYASESQRNEV-UHFFFAOYSA-N 0.000 description 1
- DLCLGNDFPKLBGG-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)phenyl]-5-(3,4,5-trimethoxyphenyl)-2h-triazole Chemical compound C1=CC(OC)=CC=C1C1=CC=C(C2=C(N=NN2)C=2C=C(OC)C(OC)=C(OC)C=2)C=C1 DLCLGNDFPKLBGG-UHFFFAOYSA-N 0.000 description 1
- FGFVVEYOUDHAOJ-UHFFFAOYSA-N 4-[4-[3-(3,4,5-triethylphenyl)triazol-4-yl]phenyl]pyridine Chemical compound CCC1=C(CC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)C=2C=CN=CC=2)=C1 FGFVVEYOUDHAOJ-UHFFFAOYSA-N 0.000 description 1
- DFZGJBVHLKUOBG-UHFFFAOYSA-N 4-[4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl]pyridine Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)C=2C=CN=CC=2)=C1 DFZGJBVHLKUOBG-UHFFFAOYSA-N 0.000 description 1
- BIBYLWVWGZQUKR-UHFFFAOYSA-N 4-[4-[5-(3,4,5-triethylphenyl)-2h-triazol-4-yl]phenyl]pyridine Chemical compound CCC1=C(CC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)C=2C=CN=CC=2)=C1 BIBYLWVWGZQUKR-UHFFFAOYSA-N 0.000 description 1
- GTCAHWHTABTXNA-UHFFFAOYSA-N 4-[4-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]phenyl]pyridine Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)C=2C=CN=CC=2)=C1 GTCAHWHTABTXNA-UHFFFAOYSA-N 0.000 description 1
- NRBUVPKPRZMAPL-UHFFFAOYSA-N 4-[5-(3,4,5-triethylphenyl)-2h-triazol-4-yl]pyridine Chemical compound CCC1=C(CC)C(CC)=CC(C2=C(NN=N2)C=2C=CN=CC=2)=C1 NRBUVPKPRZMAPL-UHFFFAOYSA-N 0.000 description 1
- PAXXFIIUTFQFLL-UHFFFAOYSA-N 4-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CC(N)=CC=2)=C1 PAXXFIIUTFQFLL-UHFFFAOYSA-N 0.000 description 1
- NXFYWZQNCHLAPI-UHFFFAOYSA-N 4-[5-(3,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]phenol Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NS2)C=2C=CC(O)=CC=2)=C1 NXFYWZQNCHLAPI-UHFFFAOYSA-N 0.000 description 1
- LBFKYLZUFKKOMG-UHFFFAOYSA-N 4-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(N)=CC=2)=C1 LBFKYLZUFKKOMG-UHFFFAOYSA-N 0.000 description 1
- VYUCQTLTWXFNLC-UHFFFAOYSA-N 4-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]benzoic acid Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)C(O)=O)=C1 VYUCQTLTWXFNLC-UHFFFAOYSA-N 0.000 description 1
- OEELUSSMJWWIMH-UHFFFAOYSA-N 4-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]pyridazine Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=NN=CC=2)=C1 OEELUSSMJWWIMH-UHFFFAOYSA-N 0.000 description 1
- XUVGJIYZFZVSQI-UHFFFAOYSA-N 4-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]pyridine Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CN=CC=2)=C1 XUVGJIYZFZVSQI-UHFFFAOYSA-N 0.000 description 1
- MDZIKWJQHGNGPP-UHFFFAOYSA-N 4-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]phenol Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC=C(O)C=C1 MDZIKWJQHGNGPP-UHFFFAOYSA-N 0.000 description 1
- BGARTXMMOVVZNH-UHFFFAOYSA-N 4-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]pyridazine Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1N=NNC=1C1=CC=NN=C1 BGARTXMMOVVZNH-UHFFFAOYSA-N 0.000 description 1
- NTZYVAWNZKKMLL-UHFFFAOYSA-N 4-[[2-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-2-oxoethyl]amino]-4-oxobutanoic acid Chemical compound C1=C(NC(=O)CNC(=O)CCC(O)=O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 NTZYVAWNZKKMLL-UHFFFAOYSA-N 0.000 description 1
- SPGJSWVBULSYRB-UHFFFAOYSA-N 4-[[2-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-2-oxoethyl]amino]-4-oxobutanoic acid Chemical compound C1=C(NC(=O)CNC(=O)CCC(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 SPGJSWVBULSYRB-UHFFFAOYSA-N 0.000 description 1
- SPBKZHRBFBNYHP-UHFFFAOYSA-N 4-amino-5-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]anilino]-5-oxopentanoic acid;hydrochloride Chemical compound Cl.C1=C(NC(=O)C(N)CCC(O)=O)C(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 SPBKZHRBFBNYHP-UHFFFAOYSA-N 0.000 description 1
- QIYUQXYYWPRCNN-UHFFFAOYSA-N 4-ethyl-2-[4-(4-iodophenyl)-1,2-oxazol-5-yl]-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(C=NO2)C=2C=CC(I)=CC=2)=C1O QIYUQXYYWPRCNN-UHFFFAOYSA-N 0.000 description 1
- ZBYROJVIJFZHFT-UHFFFAOYSA-N 4-ethyl-2-[5-(4-iodophenyl)-2H-triazol-4-yl]-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(I)=CC=2)=C1O ZBYROJVIJFZHFT-UHFFFAOYSA-N 0.000 description 1
- LRJHFUGFDNBHCA-UHFFFAOYSA-N 4-ethyl-2-[5-(4-iodophenyl)triazol-1-yl]-5-methoxyphenol Chemical compound C1=C(OC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(I)=CC=2)=C1O LRJHFUGFDNBHCA-UHFFFAOYSA-N 0.000 description 1
- PIBJYWXXJCFXRV-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-(5-naphthalen-2-yl-2H-triazol-4-yl)phenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(NN=N2)C=2C=C3C=CC=CC3=CC=2)=C1O PIBJYWXXJCFXRV-UHFFFAOYSA-N 0.000 description 1
- VXXZQBLMJRORRP-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[4-(4-methylphenyl)-1,2-oxazol-3-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(C=2C(=CON=2)C=2C=CC(C)=CC=2)=C1O VXXZQBLMJRORRP-UHFFFAOYSA-N 0.000 description 1
- QCCHVQAKDJYUGP-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[4-(4-methylphenyl)-1,2-thiazol-5-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(C=NS2)C=2C=CC(C)=CC=2)=C1O QCCHVQAKDJYUGP-UHFFFAOYSA-N 0.000 description 1
- NAPQPACAUSIJPB-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[4-[4-(trifluoromethyl)phenyl]-1,2-oxazol-3-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(C=2C(=CON=2)C=2C=CC(=CC=2)C(F)(F)F)=C1O NAPQPACAUSIJPB-UHFFFAOYSA-N 0.000 description 1
- KICSQLRZPRLYJJ-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[4-[4-(trifluoromethyl)phenyl]-1,2-thiazol-5-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(C=NS2)C=2C=CC(=CC=2)C(F)(F)F)=C1O KICSQLRZPRLYJJ-UHFFFAOYSA-N 0.000 description 1
- ZUFIOSRSMAVUGB-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[5-(4-methylphenyl)-2H-triazol-4-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(C)=CC=2)=C1O ZUFIOSRSMAVUGB-UHFFFAOYSA-N 0.000 description 1
- LYJMWORANIZWDB-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[5-(4-methylphenyl)triazol-1-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(C)=CC=2)=C1O LYJMWORANIZWDB-UHFFFAOYSA-N 0.000 description 1
- VJWUMUDOTQUGCS-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[5-[4-(trifluoromethyl)phenyl]-2H-triazol-4-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)C(F)(F)F)=C1O VJWUMUDOTQUGCS-UHFFFAOYSA-N 0.000 description 1
- RYGQBEDNXJHMKV-UHFFFAOYSA-N 4-ethyl-5-methoxy-2-[5-[4-(trifluoromethyl)phenyl]triazol-1-yl]phenol Chemical compound C1=C(OC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)C(F)(F)F)=C1O RYGQBEDNXJHMKV-UHFFFAOYSA-N 0.000 description 1
- PUHZQSXKGDIBNS-UHFFFAOYSA-N 4-isoquinolin-7-yl-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=C3C=NC=CC3=CC=2)=C1 PUHZQSXKGDIBNS-UHFFFAOYSA-N 0.000 description 1
- YPYYGTSUBFXFLF-UHFFFAOYSA-N 4-pyridazin-4-yl-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=NN=CC=2)=C1 YPYYGTSUBFXFLF-UHFFFAOYSA-N 0.000 description 1
- QFSRRPPFUDAKRF-UHFFFAOYSA-N 4-pyridin-3-yl-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=NC=CC=2)=C1 QFSRRPPFUDAKRF-UHFFFAOYSA-N 0.000 description 1
- PGBMKONJYCBHCN-UHFFFAOYSA-N 4-pyridin-4-yl-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=CN=CC=2)=C1 PGBMKONJYCBHCN-UHFFFAOYSA-N 0.000 description 1
- WAKGRGZUXHFQSM-UHFFFAOYSA-N 4-pyrimidin-5-yl-3-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=NC=NC=2)=C1 WAKGRGZUXHFQSM-UHFFFAOYSA-N 0.000 description 1
- IHTKAJMPXAUCEJ-UHFFFAOYSA-N 4-quinolin-7-yl-5-(3,4,5-trimethoxyphenyl)-1,2-oxazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NO2)C=2C=C3N=CC=CC3=CC=2)=C1 IHTKAJMPXAUCEJ-UHFFFAOYSA-N 0.000 description 1
- 125000001826 4H-pyranyl group Chemical group O1C(=CCC=C1)* 0.000 description 1
- TVONJDHVGBFRFG-UHFFFAOYSA-N 5-(1,3-benzodioxol-5-yl)-4-(4-methoxyphenyl)-1,2-oxazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=C3OCOC3=CC=2)ON=C1 TVONJDHVGBFRFG-UHFFFAOYSA-N 0.000 description 1
- CTYXTXIGFMOBEW-UHFFFAOYSA-N 5-(1-methylindol-5-yl)-4-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(SN=C2)C=2C=C3C=CN(C)C3=CC=2)=C1 CTYXTXIGFMOBEW-UHFFFAOYSA-N 0.000 description 1
- BQLCDBLZVZAPQX-UHFFFAOYSA-N 5-(2,3,4,5-tetramethoxyphenyl)-1-(3,4,5-trimethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C(=C(OC)C(OC)=C(OC)C=2)OC)=C1 BQLCDBLZVZAPQX-UHFFFAOYSA-N 0.000 description 1
- ZWDOLYIXRSSLNY-UHFFFAOYSA-N 5-(2,3,5-trimethoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NS2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 ZWDOLYIXRSSLNY-UHFFFAOYSA-N 0.000 description 1
- OOROBESKAUNRFI-UHFFFAOYSA-N 5-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-(3,4,5-trimethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=C3OCCOC3=CC=2)=C1 OOROBESKAUNRFI-UHFFFAOYSA-N 0.000 description 1
- JYUPPYRAIHILMF-UHFFFAOYSA-N 5-(2,3-dihydro-1-benzofuran-6-yl)-1-(3,4,5-trimethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=C3OCCC3=CC=2)=C1 JYUPPYRAIHILMF-UHFFFAOYSA-N 0.000 description 1
- GRHRLQGUXYCGRE-UHFFFAOYSA-N 5-(2,4,5-trimethoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)C=NS1 GRHRLQGUXYCGRE-UHFFFAOYSA-N 0.000 description 1
- VTMXNLPCWHXTPN-UHFFFAOYSA-N 5-(3,4-dimethoxyphenyl)-1-(2,3,5-trimethoxyphenyl)triazole Chemical compound COC1=CC(OC)=C(OC)C(N2C(=CN=N2)C=2C=C(OC)C(OC)=CC=2)=C1 VTMXNLPCWHXTPN-UHFFFAOYSA-N 0.000 description 1
- PTXCINVZSHRIGS-UHFFFAOYSA-N 5-(3,4-dimethoxyphenyl)-1-(2,4,5-trimethoxyphenyl)triazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C=C1OC PTXCINVZSHRIGS-UHFFFAOYSA-N 0.000 description 1
- XKUKWLGCXPRQAP-UHFFFAOYSA-N 5-(3,4-dimethoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NS1 XKUKWLGCXPRQAP-UHFFFAOYSA-N 0.000 description 1
- RWRVJMMQMGVUCB-UHFFFAOYSA-N 5-(3-fluoro-4-methoxyphenyl)-1-(3,4,5-triethylphenyl)triazole Chemical compound CCC1=C(CC)C(CC)=CC(N2C(=CN=N2)C=2C=C(F)C(OC)=CC=2)=C1 RWRVJMMQMGVUCB-UHFFFAOYSA-N 0.000 description 1
- AABNNXDGCVNYHI-UHFFFAOYSA-N 5-(3-fluoro-4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)triazole Chemical compound C1=C(F)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 AABNNXDGCVNYHI-UHFFFAOYSA-N 0.000 description 1
- BVSXIKHLOHKCLR-UHFFFAOYSA-N 5-(4-bromophenyl)-1-(2,3,5-trimethoxyphenyl)triazole Chemical compound COC1=CC(OC)=C(OC)C(N2C(=CN=N2)C=2C=CC(Br)=CC=2)=C1 BVSXIKHLOHKCLR-UHFFFAOYSA-N 0.000 description 1
- ALSQEWJPPNUTHN-UHFFFAOYSA-N 5-(4-bromophenyl)-1-(2,4,5-trimethoxyphenyl)triazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1N1C(C=2C=CC(Br)=CC=2)=CN=N1 ALSQEWJPPNUTHN-UHFFFAOYSA-N 0.000 description 1
- KPLDEXZILPQCMK-UHFFFAOYSA-N 5-(4-bromophenyl)-1-(3,4,5-trimethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(Br)=CC=2)=C1 KPLDEXZILPQCMK-UHFFFAOYSA-N 0.000 description 1
- YKTOFPZHAKCLRS-UHFFFAOYSA-N 5-(4-bromophenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(SN=C2)C=2C=CC(Br)=CC=2)=C1OC YKTOFPZHAKCLRS-UHFFFAOYSA-N 0.000 description 1
- HYPURRDGFXCPDG-UHFFFAOYSA-N 5-(4-bromophenyl)-4-(3,4,5-trimethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(SN=C2)C=2C=CC(Br)=CC=2)=C1 HYPURRDGFXCPDG-UHFFFAOYSA-N 0.000 description 1
- LJLNDSDZZDATQM-UHFFFAOYSA-N 5-(4-butoxyphenyl)-1-(2,3,5-trimethoxyphenyl)triazole Chemical compound C1=CC(OCCCC)=CC=C1C1=CN=NN1C1=CC(OC)=CC(OC)=C1OC LJLNDSDZZDATQM-UHFFFAOYSA-N 0.000 description 1
- JQYSOAMZWSEHAB-UHFFFAOYSA-N 5-(4-butoxyphenyl)-1-(2,4,5-trimethoxyphenyl)triazole Chemical compound C1=CC(OCCCC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C=C1OC JQYSOAMZWSEHAB-UHFFFAOYSA-N 0.000 description 1
- HVDPLDMPVOOPNY-UHFFFAOYSA-N 5-(4-butoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(OCCCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NS1 HVDPLDMPVOOPNY-UHFFFAOYSA-N 0.000 description 1
- MREHXFSZVHMLLK-UHFFFAOYSA-N 5-(4-butylphenyl)-1-(2,3,5-trimethoxyphenyl)triazole Chemical compound C1=CC(CCCC)=CC=C1C1=CN=NN1C1=CC(OC)=CC(OC)=C1OC MREHXFSZVHMLLK-UHFFFAOYSA-N 0.000 description 1
- SSOTZBSMKUMDQR-UHFFFAOYSA-N 5-(4-butylphenyl)-1-(2,4,5-trimethoxyphenyl)triazole Chemical compound C1=CC(CCCC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C=C1OC SSOTZBSMKUMDQR-UHFFFAOYSA-N 0.000 description 1
- CRDWGYRFQDBHME-UHFFFAOYSA-N 5-(4-butylphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(CCCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NS1 CRDWGYRFQDBHME-UHFFFAOYSA-N 0.000 description 1
- ZQLFNAWMJLTKSI-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-(2,3,5-trimethoxyphenyl)triazole Chemical compound COC1=CC(OC)=C(OC)C(N2C(=CN=N2)C=2C=CC(Cl)=CC=2)=C1 ZQLFNAWMJLTKSI-UHFFFAOYSA-N 0.000 description 1
- MUEKRMMKMGDTBP-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-(2,4,5-trimethoxyphenyl)triazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1N1C(C=2C=CC(Cl)=CC=2)=CN=N1 MUEKRMMKMGDTBP-UHFFFAOYSA-N 0.000 description 1
- OOPZXLWTZKFCAU-UHFFFAOYSA-N 5-(4-chlorophenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(SN=C2)C=2C=CC(Cl)=CC=2)=C1OC OOPZXLWTZKFCAU-UHFFFAOYSA-N 0.000 description 1
- KCONVNDRQMSGRB-UHFFFAOYSA-N 5-(4-ethoxyphenyl)-1-(2,3,5-trimethoxyphenyl)triazole Chemical compound C1=CC(OCC)=CC=C1C1=CN=NN1C1=CC(OC)=CC(OC)=C1OC KCONVNDRQMSGRB-UHFFFAOYSA-N 0.000 description 1
- QLYUHZSGHIDOAD-UHFFFAOYSA-N 5-(4-ethoxyphenyl)-1-(2,4,5-trimethoxyphenyl)triazole Chemical compound C1=CC(OCC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C=C1OC QLYUHZSGHIDOAD-UHFFFAOYSA-N 0.000 description 1
- QKIUMTUVJQNMEY-UHFFFAOYSA-N 5-(4-ethoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(OCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NS1 QKIUMTUVJQNMEY-UHFFFAOYSA-N 0.000 description 1
- VDPLRYDDKBMFBV-UHFFFAOYSA-N 5-(4-ethylphenyl)-1-(2,3,5-trimethoxyphenyl)triazole Chemical compound C1=CC(CC)=CC=C1C1=CN=NN1C1=CC(OC)=CC(OC)=C1OC VDPLRYDDKBMFBV-UHFFFAOYSA-N 0.000 description 1
- WBENAHXCDIHIFI-UHFFFAOYSA-N 5-(4-ethylphenyl)-1-(2,4,5-trimethoxyphenyl)triazole Chemical compound C1=CC(CC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C=C1OC WBENAHXCDIHIFI-UHFFFAOYSA-N 0.000 description 1
- IDEKMQQPJXDYEZ-UHFFFAOYSA-N 5-(4-ethylphenyl)-1-(3,4,5-trimethoxyphenyl)triazole Chemical compound C1=CC(CC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 IDEKMQQPJXDYEZ-UHFFFAOYSA-N 0.000 description 1
- MYLNCRZYVWCPSF-UHFFFAOYSA-N 5-(4-ethylphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(CC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NS1 MYLNCRZYVWCPSF-UHFFFAOYSA-N 0.000 description 1
- XKRJAMMUBUKDLQ-UHFFFAOYSA-N 5-(4-fluorophenyl)-1-(2,3,5-trimethoxyphenyl)triazole Chemical compound COC1=CC(OC)=C(OC)C(N2C(=CN=N2)C=2C=CC(F)=CC=2)=C1 XKRJAMMUBUKDLQ-UHFFFAOYSA-N 0.000 description 1
- CZHFGKIMXWVWDH-UHFFFAOYSA-N 5-(4-fluorophenyl)-1-(2,4,5-trimethoxyphenyl)triazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1N1C(C=2C=CC(F)=CC=2)=CN=N1 CZHFGKIMXWVWDH-UHFFFAOYSA-N 0.000 description 1
- QAOVRCNHDUTSEF-UHFFFAOYSA-N 5-(4-fluorophenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(SN=C2)C=2C=CC(F)=CC=2)=C1OC QAOVRCNHDUTSEF-UHFFFAOYSA-N 0.000 description 1
- HNZVEIBBKFAZCJ-UHFFFAOYSA-N 5-(4-iodophenyl)-1-(3,4,5-triethylphenyl)triazole Chemical compound CCC1=C(CC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(I)=CC=2)=C1 HNZVEIBBKFAZCJ-UHFFFAOYSA-N 0.000 description 1
- QKMAFNKGZUWSHW-UHFFFAOYSA-N 5-(4-iodophenyl)-1-(3,4,5-trimethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(I)=CC=2)=C1 QKMAFNKGZUWSHW-UHFFFAOYSA-N 0.000 description 1
- UKGMHGVYLBSZQC-UHFFFAOYSA-N 5-(4-methoxyphenyl)-1-(2,3,4-trimethoxyphenyl)triazole Chemical compound C1=CC(OC)=CC=C1C1=CN=NN1C1=CC=C(OC)C(OC)=C1OC UKGMHGVYLBSZQC-UHFFFAOYSA-N 0.000 description 1
- QJOVXJGQUJDFFE-UHFFFAOYSA-N 5-(4-methoxyphenyl)-1-(2,3,5-trimethoxyphenyl)triazole Chemical compound C1=CC(OC)=CC=C1C1=CN=NN1C1=CC(OC)=CC(OC)=C1OC QJOVXJGQUJDFFE-UHFFFAOYSA-N 0.000 description 1
- GNLVWETZLGTJSG-UHFFFAOYSA-N 5-(4-methoxyphenyl)-1-(2,4,5-trimethoxyphenyl)triazole Chemical compound C1=CC(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C=C1OC GNLVWETZLGTJSG-UHFFFAOYSA-N 0.000 description 1
- OXJKIJZGPAIZRX-UHFFFAOYSA-N 5-(4-methoxyphenyl)-1-(3,4,5-triethylphenyl)triazole Chemical compound CCC1=C(CC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(OC)=CC=2)=C1 OXJKIJZGPAIZRX-UHFFFAOYSA-N 0.000 description 1
- VYIKEPOZDAQBBG-UHFFFAOYSA-N 5-(4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)triazole Chemical compound C1=CC(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 VYIKEPOZDAQBBG-UHFFFAOYSA-N 0.000 description 1
- UGUXSSAKZSFGPZ-UHFFFAOYSA-N 5-(4-methoxyphenyl)-1-(3,4,5-trimethylphenyl)triazole Chemical compound C1=CC(OC)=CC=C1C1=CN=NN1C1=CC(C)=C(C)C(C)=C1 UGUXSSAKZSFGPZ-UHFFFAOYSA-N 0.000 description 1
- QEIGDXBHCDQHTL-UHFFFAOYSA-N 5-(4-methoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NS1 QEIGDXBHCDQHTL-UHFFFAOYSA-N 0.000 description 1
- ACNMDCXHAMCNLG-UHFFFAOYSA-N 5-(4-methylphenyl)-1-(2,3,5-trimethoxyphenyl)triazole Chemical compound COC1=CC(OC)=C(OC)C(N2C(=CN=N2)C=2C=CC(C)=CC=2)=C1 ACNMDCXHAMCNLG-UHFFFAOYSA-N 0.000 description 1
- KHUIQXVGBRIXFT-UHFFFAOYSA-N 5-(4-methylphenyl)-1-(2,4,5-trimethoxyphenyl)triazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1N1C(C=2C=CC(C)=CC=2)=CN=N1 KHUIQXVGBRIXFT-UHFFFAOYSA-N 0.000 description 1
- WHGDFVVCUGYMPF-UHFFFAOYSA-N 5-(4-methylphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(SN=C2)C=2C=CC(C)=CC=2)=C1OC WHGDFVVCUGYMPF-UHFFFAOYSA-N 0.000 description 1
- OFOLGSAVTJOBAN-UHFFFAOYSA-N 5-(4-methylsulfanylphenyl)-1-(3,4,5-trimethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(SC)=CC=2)=C1 OFOLGSAVTJOBAN-UHFFFAOYSA-N 0.000 description 1
- PHHLMLBDDIZKJF-UHFFFAOYSA-N 5-(4-nitrophenyl)-1-(2,3,5-trimethoxyphenyl)triazole Chemical compound COC1=CC(OC)=C(OC)C(N2C(=CN=N2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 PHHLMLBDDIZKJF-UHFFFAOYSA-N 0.000 description 1
- KPELLARYFBURSS-UHFFFAOYSA-N 5-(4-nitrophenyl)-1-(2,4,5-trimethoxyphenyl)triazole Chemical compound C1=C(OC)C(OC)=CC(OC)=C1N1C(C=2C=CC(=CC=2)[N+]([O-])=O)=CN=N1 KPELLARYFBURSS-UHFFFAOYSA-N 0.000 description 1
- GLXPZARVBOWKKU-UHFFFAOYSA-N 5-(4-nitrophenyl)-1-(3,4,5-triethylphenyl)triazole Chemical compound CCC1=C(CC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 GLXPZARVBOWKKU-UHFFFAOYSA-N 0.000 description 1
- NWIHKIHVKKMSFT-UHFFFAOYSA-N 5-(4-nitrophenyl)-1-(3,4,5-trimethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 NWIHKIHVKKMSFT-UHFFFAOYSA-N 0.000 description 1
- BEUHOGBUEXQKAP-UHFFFAOYSA-N 5-(4-nitrophenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(SN=C2)C=2C=CC(=CC=2)[N+]([O-])=O)=C1OC BEUHOGBUEXQKAP-UHFFFAOYSA-N 0.000 description 1
- CVSVBHMLOHDHFR-UHFFFAOYSA-N 5-(4-propan-2-ylphenyl)-1-(3,4,5-trimethoxyphenyl)triazole Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)C(C)C)=C1 CVSVBHMLOHDHFR-UHFFFAOYSA-N 0.000 description 1
- WHMAMSPOHNSDNK-UHFFFAOYSA-N 5-(4-propoxyphenyl)-1-(2,3,5-trimethoxyphenyl)triazole Chemical compound C1=CC(OCCC)=CC=C1C1=CN=NN1C1=CC(OC)=CC(OC)=C1OC WHMAMSPOHNSDNK-UHFFFAOYSA-N 0.000 description 1
- VEOZNZBFAVISNC-UHFFFAOYSA-N 5-(4-propoxyphenyl)-1-(2,4,5-trimethoxyphenyl)triazole Chemical compound C1=CC(OCCC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C=C1OC VEOZNZBFAVISNC-UHFFFAOYSA-N 0.000 description 1
- UDTNKCBRHCJGBN-UHFFFAOYSA-N 5-(4-propoxyphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(OCCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NS1 UDTNKCBRHCJGBN-UHFFFAOYSA-N 0.000 description 1
- BLLHXSBOCWWVPW-UHFFFAOYSA-N 5-(4-propylphenyl)-1-(2,3,5-trimethoxyphenyl)triazole Chemical compound C1=CC(CCC)=CC=C1C1=CN=NN1C1=CC(OC)=CC(OC)=C1OC BLLHXSBOCWWVPW-UHFFFAOYSA-N 0.000 description 1
- LHBDJEXMKFVQNQ-UHFFFAOYSA-N 5-(4-propylphenyl)-1-(2,4,5-trimethoxyphenyl)triazole Chemical compound C1=CC(CCC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C=C1OC LHBDJEXMKFVQNQ-UHFFFAOYSA-N 0.000 description 1
- CWGDKFBKFWLINZ-UHFFFAOYSA-N 5-(4-propylphenyl)-4-(2,3,4,5-tetramethoxyphenyl)-1,2-thiazole Chemical compound C1=CC(CCC)=CC=C1C1=C(C=2C(=C(OC)C(OC)=C(OC)C=2)OC)C=NS1 CWGDKFBKFWLINZ-UHFFFAOYSA-N 0.000 description 1
- IJAUQBRMLRTTDV-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-(1-methylindol-5-yl)-1,2-thiazole Chemical compound C1=C2N(C)C=CC2=CC(C=2C=NSC=2C=2C=C(C=3OCOC=3C=2)OC)=C1 IJAUQBRMLRTTDV-UHFFFAOYSA-N 0.000 description 1
- HLLWECUPALKWHU-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-(4-methylsulfanylphenyl)-1,2-thiazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC=C(SC)C=C1 HLLWECUPALKWHU-UHFFFAOYSA-N 0.000 description 1
- HSDLXEXHHHWNTO-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-(6-methoxypyridin-3-yl)-1,2-thiazole Chemical compound C1=NC(OC)=CC=C1C1=C(C=2C=C(OC)C=3OCOC=3C=2)SN=C1 HSDLXEXHHHWNTO-UHFFFAOYSA-N 0.000 description 1
- KGBVKAFQGFCHOX-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-[4-(1-methyltetrazol-5-yl)phenyl]-1,2-thiazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C(C=C1)=CC=C1C1=NN=NN1C KGBVKAFQGFCHOX-UHFFFAOYSA-N 0.000 description 1
- MVSMXHCYSNITPZ-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-[4-(2h-tetrazol-5-yl)phenyl]-1,2-thiazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C(C=C1)=CC=C1C1=NN=NN1 MVSMXHCYSNITPZ-UHFFFAOYSA-N 0.000 description 1
- XIKDQKPMIAWDFN-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-pyridazin-4-yl-1,2-thiazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC=NN=C1 XIKDQKPMIAWDFN-UHFFFAOYSA-N 0.000 description 1
- VOLHLUNTANLTPF-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-pyridin-3-yl-1,2-thiazole;hydrochloride Chemical compound Cl.C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC=CN=C1 VOLHLUNTANLTPF-UHFFFAOYSA-N 0.000 description 1
- YXPBNLAYMNJYOI-UHFFFAOYSA-N 5-(7-methoxy-1,3-benzodioxol-5-yl)-4-pyrimidin-5-yl-1,2-thiazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CN=CN=C1 YXPBNLAYMNJYOI-UHFFFAOYSA-N 0.000 description 1
- XHJLYXMNLRFOKH-UHFFFAOYSA-N 5-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]anilino]-5-oxopentanoic acid Chemical compound C1=C(NC(=O)CCCC(O)=O)C(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 XHJLYXMNLRFOKH-UHFFFAOYSA-N 0.000 description 1
- DYUDLUWUEIXMKH-UHFFFAOYSA-N 5-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-5-oxopentanoic acid Chemical compound C1=C(NC(=O)CCCC(O)=O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 DYUDLUWUEIXMKH-UHFFFAOYSA-N 0.000 description 1
- KVVGJFZAUGRDBT-UHFFFAOYSA-N 5-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]anilino]-5-oxopentanoic acid Chemical compound C1=C(NC(=O)CCCC(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 KVVGJFZAUGRDBT-UHFFFAOYSA-N 0.000 description 1
- PUHQJOZIEDIHDG-UHFFFAOYSA-N 5-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-5-oxopentanoic acid Chemical compound C1=C(NC(=O)CCCC(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 PUHQJOZIEDIHDG-UHFFFAOYSA-N 0.000 description 1
- MHDVGCCQTQIWCS-UHFFFAOYSA-N 5-[3-(3,4,5-triethylphenyl)triazol-4-yl]-1h-indole Chemical compound CCC1=C(CC)C(CC)=CC(N2C(=CN=N2)C=2C=C3C=CNC3=CC=2)=C1 MHDVGCCQTQIWCS-UHFFFAOYSA-N 0.000 description 1
- LVBRSGMMESFOCJ-UHFFFAOYSA-N 5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]pyrimidine Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=NC=NC=2)=C1 LVBRSGMMESFOCJ-UHFFFAOYSA-N 0.000 description 1
- ZFSVSXRCXYTEJS-UHFFFAOYSA-N 5-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]-2-methylsulfanylaniline Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC=C(SC)C(N)=C1 ZFSVSXRCXYTEJS-UHFFFAOYSA-N 0.000 description 1
- ZLBHFINZLSUIGJ-UHFFFAOYSA-N 5-[3-(7-methoxy-1,3-benzodioxol-5-yl)triazol-4-yl]-1-methylindole Chemical compound C1=C2N(C)C=CC2=CC(C2=CN=NN2C=2C=C(C=3OCOC=3C=2)OC)=C1 ZLBHFINZLSUIGJ-UHFFFAOYSA-N 0.000 description 1
- FTMKFKJQCVQQJZ-UHFFFAOYSA-N 5-[3-(7-methoxy-1,3-benzodioxol-5-yl)triazol-4-yl]pyrimidine Chemical compound C=1C=2OCOC=2C(OC)=CC=1N1N=NC=C1C1=CN=CN=C1 FTMKFKJQCVQQJZ-UHFFFAOYSA-N 0.000 description 1
- ADLDTEKGWJRRIZ-UHFFFAOYSA-N 5-[4-(4-hydroxyphenyl)-1,2-oxazol-5-yl]benzene-1,2,3-triol Chemical compound C1=CC(O)=CC=C1C1=C(C=2C=C(O)C(O)=C(O)C=2)ON=C1 ADLDTEKGWJRRIZ-UHFFFAOYSA-N 0.000 description 1
- WRLIBZOTCYTDEH-UHFFFAOYSA-N 5-[4-(4-methoxyphenyl)phenyl]-1-(3,4,5-trimethoxyphenyl)triazole Chemical compound C1=CC(OC)=CC=C1C1=CC=C(C=2N(N=NC=2)C=2C=C(OC)C(OC)=C(OC)C=2)C=C1 WRLIBZOTCYTDEH-UHFFFAOYSA-N 0.000 description 1
- FYSNOASLDHAWER-UHFFFAOYSA-N 5-[4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl]-2h-tetrazole Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)C=2NN=NN=2)=C1 FYSNOASLDHAWER-UHFFFAOYSA-N 0.000 description 1
- SZOPUDRVAKSBEY-UHFFFAOYSA-N 5-[4-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]phenyl]-2h-tetrazole Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)C=2NN=NN=2)=C1 SZOPUDRVAKSBEY-UHFFFAOYSA-N 0.000 description 1
- FUUQXBSXLARPKC-UHFFFAOYSA-N 5-[4-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]phenyl]-1-methyltetrazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1N=NNC=1C(C=C1)=CC=C1C1=NN=NN1C FUUQXBSXLARPKC-UHFFFAOYSA-N 0.000 description 1
- XJPUELIQSINFTR-UHFFFAOYSA-N 5-[4-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]phenyl]-2h-tetrazole Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1N=NNC=1C(C=C1)=CC=C1C1=NN=NN1 XJPUELIQSINFTR-UHFFFAOYSA-N 0.000 description 1
- RGYLDOPNWSKHBT-UHFFFAOYSA-N 5-[5-(3,4,5-triethylphenyl)-2h-triazol-4-yl]-1h-indole Chemical compound CCC1=C(CC)C(CC)=CC(C2=C(NN=N2)C=2C=C3C=CNC3=CC=2)=C1 RGYLDOPNWSKHBT-UHFFFAOYSA-N 0.000 description 1
- PUYDZVJTMQEGGV-UHFFFAOYSA-N 5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]pyrimidine Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=NC=NC=2)=C1 PUYDZVJTMQEGGV-UHFFFAOYSA-N 0.000 description 1
- CZUGKXTYAVOONS-UHFFFAOYSA-N 5-[5-(4-hydroxyphenyl)-2H-triazol-4-yl]benzene-1,2,3-triol Chemical compound C1=CC(O)=CC=C1C1=C(C=2C=C(O)C(O)=C(O)C=2)N=NN1 CZUGKXTYAVOONS-UHFFFAOYSA-N 0.000 description 1
- MKDOQJWCOXOFNA-UHFFFAOYSA-N 5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]-2-methylsulfanylaniline Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC=C(SC)C(N)=C1 MKDOQJWCOXOFNA-UHFFFAOYSA-N 0.000 description 1
- PWZONVQQQVXHRM-UHFFFAOYSA-N 5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]-1-methylindole Chemical compound C1=C2N(C)C=CC2=CC(C=2NN=NC=2C=2C=C(C=3OCOC=3C=2)OC)=C1 PWZONVQQQVXHRM-UHFFFAOYSA-N 0.000 description 1
- ZNSDCLIUVOUKCX-UHFFFAOYSA-N 5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]-2-methylsulfanylaniline Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1N=NNC=1C1=CC=C(SC)C(N)=C1 ZNSDCLIUVOUKCX-UHFFFAOYSA-N 0.000 description 1
- HPHPYYIVBJXTLJ-UHFFFAOYSA-N 5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]pyrimidine Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1N=NNC=1C1=CN=CN=C1 HPHPYYIVBJXTLJ-UHFFFAOYSA-N 0.000 description 1
- LHKBGKPAWBQQNM-UHFFFAOYSA-N 5-methoxy-2-(5-phenyl-2H-triazol-4-yl)-4-propylphenol Chemical compound C1=C(OC)C(CCC)=CC(C2=C(NN=N2)C=2C=CC=CC=2)=C1O LHKBGKPAWBQQNM-UHFFFAOYSA-N 0.000 description 1
- CABLQPVVHNNTFR-UHFFFAOYSA-N 5-methoxy-2-(5-phenyltriazol-1-yl)-4-propylphenol Chemical compound C1=C(OC)C(CCC)=CC(N2C(=CN=N2)C=2C=CC=CC=2)=C1O CABLQPVVHNNTFR-UHFFFAOYSA-N 0.000 description 1
- HQYUCSKLPYAQIO-UHFFFAOYSA-N 5-methoxy-2-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]aniline Chemical compound NC1=CC(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 HQYUCSKLPYAQIO-UHFFFAOYSA-N 0.000 description 1
- HWOAFWBPZWVQMV-UHFFFAOYSA-N 5-methoxy-2-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenol Chemical compound OC1=CC(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 HWOAFWBPZWVQMV-UHFFFAOYSA-N 0.000 description 1
- VSTXUIYGOBVBNS-UHFFFAOYSA-N 5-methoxy-2-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]aniline Chemical compound NC1=CC(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 VSTXUIYGOBVBNS-UHFFFAOYSA-N 0.000 description 1
- SNRQXNBRCCZUBI-UHFFFAOYSA-N 5-methoxy-2-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]benzenethiol Chemical compound SC1=CC(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 SNRQXNBRCCZUBI-UHFFFAOYSA-N 0.000 description 1
- JIALLNJLSAYARS-UHFFFAOYSA-N 5-methoxy-2-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenol Chemical compound OC1=CC(OC)=CC=C1C1=CON=C1C(C=C1OC)=CC2=C1OCO2 JIALLNJLSAYARS-UHFFFAOYSA-N 0.000 description 1
- DTHIZUCAQCFUPQ-UHFFFAOYSA-N 5-methoxy-2-[3-(7-methoxy-1,3-benzodioxol-5-yl)triazol-4-yl]phenol Chemical compound OC1=CC(OC)=CC=C1C1=CN=NN1C(C=C1OC)=CC2=C1OCO2 DTHIZUCAQCFUPQ-UHFFFAOYSA-N 0.000 description 1
- QHESWMFOKAEEPS-UHFFFAOYSA-N 5-methoxy-2-[3-(7-methoxy-1,3-benzodioxol-5-yl)triazol-4-yl]pyridine Chemical compound N1=CC(OC)=CC=C1C1=CN=NN1C(C=C1OC)=CC2=C1OCO2 QHESWMFOKAEEPS-UHFFFAOYSA-N 0.000 description 1
- BDCRRMWLKOYCSD-UHFFFAOYSA-N 5-methoxy-2-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]aniline Chemical compound NC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 BDCRRMWLKOYCSD-UHFFFAOYSA-N 0.000 description 1
- XXQBMHVZOWQTGP-UHFFFAOYSA-N 5-methoxy-2-[5-(3,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]aniline Chemical compound NC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)SN=C1 XXQBMHVZOWQTGP-UHFFFAOYSA-N 0.000 description 1
- KGKWZZIVPYQFIL-UHFFFAOYSA-N 5-methoxy-2-[5-(3,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]phenol Chemical compound OC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)SN=C1 KGKWZZIVPYQFIL-UHFFFAOYSA-N 0.000 description 1
- GGBSRBOSQPFUJU-UHFFFAOYSA-N 5-methoxy-2-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]aniline Chemical compound NC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 GGBSRBOSQPFUJU-UHFFFAOYSA-N 0.000 description 1
- IJAIVKHYPXTIMI-UHFFFAOYSA-N 5-methoxy-2-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]phenol Chemical compound OC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C=3OCOC=3C=2)SN=C1 IJAIVKHYPXTIMI-UHFFFAOYSA-N 0.000 description 1
- ZAVGLLIHKGXHAW-UHFFFAOYSA-N 5-methoxy-2-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2H-triazol-4-yl]phenol Chemical compound OC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C=3OCOC=3C=2)N=NN1 ZAVGLLIHKGXHAW-UHFFFAOYSA-N 0.000 description 1
- CRSKRBZWHAUFOF-UHFFFAOYSA-N 5-methoxy-2-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]aniline Chemical compound NC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C=3OCOC=3C=2)N=NN1 CRSKRBZWHAUFOF-UHFFFAOYSA-N 0.000 description 1
- FYMPPZRGHNNJJJ-UHFFFAOYSA-N 5-methoxy-2-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]pyridine Chemical compound N1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C=3OCOC=3C=2)N=NN1 FYMPPZRGHNNJJJ-UHFFFAOYSA-N 0.000 description 1
- AOMMLQAKLZATJL-UHFFFAOYSA-N 5-methoxy-7-[5-(4-methoxyphenyl)-2h-triazol-4-yl]-1-methylindole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=3N(C)C=CC=3C=C(OC)C=2)N=NN1 AOMMLQAKLZATJL-UHFFFAOYSA-N 0.000 description 1
- BWFSLXXGFYAVOU-UHFFFAOYSA-N 5-methoxy-7-[5-(4-methoxyphenyl)triazol-1-yl]-1-methylindole Chemical compound C1=CC(OC)=CC=C1C1=CN=NN1C1=CC(OC)=CC2=C1N(C)C=C2 BWFSLXXGFYAVOU-UHFFFAOYSA-N 0.000 description 1
- ZJTFNVUAUIECBJ-UHFFFAOYSA-N 6-[5-(4-methoxyphenyl)-2h-triazol-4-yl]-1-propan-2-ylindole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=C3N(C(C)C)C=CC3=CC=2)N=NN1 ZJTFNVUAUIECBJ-UHFFFAOYSA-N 0.000 description 1
- ZPPRBAZLXIIFLZ-UHFFFAOYSA-N 6-[5-(4-methoxyphenyl)triazol-1-yl]-1-propan-2-ylindole Chemical compound C1=CC(OC)=CC=C1C1=CN=NN1C1=CC=C(C=CN2C(C)C)C2=C1 ZPPRBAZLXIIFLZ-UHFFFAOYSA-N 0.000 description 1
- OIKBKNJZCRZSNT-UHFFFAOYSA-N 7-[3-(3,4,5-triethylphenyl)triazol-4-yl]isoquinoline Chemical compound CCC1=C(CC)C(CC)=CC(N2C(=CN=N2)C=2C=C3C=NC=CC3=CC=2)=C1 OIKBKNJZCRZSNT-UHFFFAOYSA-N 0.000 description 1
- PUXCKGDJOYOTIE-UHFFFAOYSA-N 7-[3-(3,4,5-triethylphenyl)triazol-4-yl]quinoline Chemical compound CCC1=C(CC)C(CC)=CC(N2C(=CN=N2)C=2C=C3N=CC=CC3=CC=2)=C1 PUXCKGDJOYOTIE-UHFFFAOYSA-N 0.000 description 1
- PZEZFSFOGCVZHM-UHFFFAOYSA-N 7-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]isoquinoline Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=C3C=NC=CC3=CC=2)=C1 PZEZFSFOGCVZHM-UHFFFAOYSA-N 0.000 description 1
- ALHBBXZNFORHSM-UHFFFAOYSA-N 7-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]quinoline Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=C3N=CC=CC3=CC=2)=C1 ALHBBXZNFORHSM-UHFFFAOYSA-N 0.000 description 1
- ZFXXFLIAKCDSHS-UHFFFAOYSA-N 7-[5-(3,4,5-triethylphenyl)-2h-triazol-4-yl]isoquinoline Chemical compound CCC1=C(CC)C(CC)=CC(C2=C(NN=N2)C=2C=C3C=NC=CC3=CC=2)=C1 ZFXXFLIAKCDSHS-UHFFFAOYSA-N 0.000 description 1
- IOJUDJRFPSVRHZ-UHFFFAOYSA-N 7-[5-(3,4,5-triethylphenyl)-2h-triazol-4-yl]quinoline Chemical compound CCC1=C(CC)C(CC)=CC(C2=C(NN=N2)C=2C=C3N=CC=CC3=CC=2)=C1 IOJUDJRFPSVRHZ-UHFFFAOYSA-N 0.000 description 1
- OGLKVRZLVAHYQM-UHFFFAOYSA-N 7-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]isoquinoline Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=C3C=NC=CC3=CC=2)=C1 OGLKVRZLVAHYQM-UHFFFAOYSA-N 0.000 description 1
- RIWOOPOCSGAIJK-UHFFFAOYSA-N 7-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]quinoline Chemical compound COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=C3N=CC=CC3=CC=2)=C1 RIWOOPOCSGAIJK-UHFFFAOYSA-N 0.000 description 1
- ACOSCHOKNCGHKX-UHFFFAOYSA-N 7-[5-(4-methoxyphenyl)triazol-1-yl]-1-methylindole Chemical compound C1=CC(OC)=CC=C1C1=CN=NN1C1=CC=CC2=C1N(C)C=C2 ACOSCHOKNCGHKX-UHFFFAOYSA-N 0.000 description 1
- WLCZTRVUXYALDD-IBGZPJMESA-N 7-[[(2s)-2,6-bis(2-methoxyethoxycarbonylamino)hexanoyl]amino]heptoxy-methylphosphinic acid Chemical compound COCCOC(=O)NCCCC[C@H](NC(=O)OCCOC)C(=O)NCCCCCCCOP(C)(O)=O WLCZTRVUXYALDD-IBGZPJMESA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010000830 Acute leukaemia Diseases 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 208000036762 Acute promyelocytic leukaemia Diseases 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 201000003076 Angiosarcoma Diseases 0.000 description 1
- 102400000068 Angiostatin Human genes 0.000 description 1
- 108010079709 Angiostatins Proteins 0.000 description 1
- 101000640990 Arabidopsis thaliana Tryptophan-tRNA ligase, chloroplastic/mitochondrial Proteins 0.000 description 1
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 description 1
- 206010044583 Bartonella Infections Diseases 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 208000009137 Behcet syndrome Diseases 0.000 description 1
- 206010061692 Benign muscle neoplasm Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 208000037663 Best vitelliform macular dystrophy Diseases 0.000 description 1
- 206010056375 Bile duct obstruction Diseases 0.000 description 1
- 208000035462 Biphenotypic Acute Leukemia Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 206010006448 Bronchiolitis Diseases 0.000 description 1
- RHSUTVSKNRTKCF-UHFFFAOYSA-N C1=CC(OCCCC)=CC=C1C1=NSC(C=2C(=C(OC)C=C(OC)C=2)OC)=C1 Chemical compound C1=CC(OCCCC)=CC=C1C1=NSC(C=2C(=C(OC)C=C(OC)C=2)OC)=C1 RHSUTVSKNRTKCF-UHFFFAOYSA-N 0.000 description 1
- SGTHNIHGPQMFSQ-UHFFFAOYSA-N CN(C)C1=CC=C(C=C1)C=1C=NSC1C1=C(C=C(C(=C1)OC)OC)OC.[N+](=O)([O-])C1=CC=C(C=C1)C=1C=NSC1C1=C(C=C(C(=C1)OC)OC)OC Chemical compound CN(C)C1=CC=C(C=C1)C=1C=NSC1C1=C(C=C(C(=C1)OC)OC)OC.[N+](=O)([O-])C1=CC=C(C=C1)C=1C=NSC1C1=C(C=C(C(=C1)OC)OC)OC SGTHNIHGPQMFSQ-UHFFFAOYSA-N 0.000 description 1
- UUZIABQYRQIETE-UHFFFAOYSA-N CN1C=CC2=CC(=CC=C12)N1C=CN=N1 Chemical compound CN1C=CC2=CC(=CC=C12)N1C=CN=N1 UUZIABQYRQIETE-UHFFFAOYSA-N 0.000 description 1
- SLIXRBLNBFYCQK-UHFFFAOYSA-N COC(C=C1)=CN=C1C1=NSC(C(C=C2OC)=CC3=C2OCO3)=C1 Chemical compound COC(C=C1)=CN=C1C1=NSC(C(C=C2OC)=CC3=C2OCO3)=C1 SLIXRBLNBFYCQK-UHFFFAOYSA-N 0.000 description 1
- OBLLTXVZLJTYBS-UHFFFAOYSA-N COC(C=CC(C1=CN=NN1C(C=C1OC)=CC(OC)=C1OC)=C1)=C1[S+]=P([O-])(O)O Chemical compound COC(C=CC(C1=CN=NN1C(C=C1OC)=CC(OC)=C1OC)=C1)=C1[S+]=P([O-])(O)O OBLLTXVZLJTYBS-UHFFFAOYSA-N 0.000 description 1
- USCZOZGSVIKNOS-UHFFFAOYSA-N COC1=C(C=C(C=C1)C1=C(N=NN1)C1=CC(=C(C(=C1)OC)OC)OC)NC(CC1=CC=CC=C1)=O Chemical compound COC1=C(C=C(C=C1)C1=C(N=NN1)C1=CC(=C(C(=C1)OC)OC)OC)NC(CC1=CC=CC=C1)=O USCZOZGSVIKNOS-UHFFFAOYSA-N 0.000 description 1
- WIPZJYGGRLLJRJ-UHFFFAOYSA-N COC1=C(C=C(C=C1)C1=CN=NN1C1=CC(=C(C(=C1)OC)OC)OC)NC(CC1=CC=CC=C1)=O Chemical compound COC1=C(C=C(C=C1)C1=CN=NN1C1=CC(=C(C(=C1)OC)OC)OC)NC(CC1=CC=CC=C1)=O WIPZJYGGRLLJRJ-UHFFFAOYSA-N 0.000 description 1
- JNJYLQIFVSBXKY-UHFFFAOYSA-N COC1=C(OC)C(OC)=CC(N2N=NC=C2)=C1 Chemical compound COC1=C(OC)C(OC)=CC(N2N=NC=C2)=C1 JNJYLQIFVSBXKY-UHFFFAOYSA-N 0.000 description 1
- BJLUCEYUHCLXGA-UHFFFAOYSA-N COC1=NN(O)NC1(C=1C=C2OCCOC2=CC=1)C1=CC=C(Br)C=C1 Chemical compound COC1=NN(O)NC1(C=1C=C2OCCOC2=CC=1)C1=CC=C(Br)C=C1 BJLUCEYUHCLXGA-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 208000014882 Carotid artery disease Diseases 0.000 description 1
- 208000003732 Cat-scratch disease Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 208000005243 Chondrosarcoma Diseases 0.000 description 1
- 201000009047 Chordoma Diseases 0.000 description 1
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- 208000005590 Choroidal Neovascularization Diseases 0.000 description 1
- 206010060823 Choroidal neovascularisation Diseases 0.000 description 1
- 208000002691 Choroiditis Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000009798 Craniopharyngioma Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010059352 Desmoid tumour Diseases 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000019878 Eales disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102400001047 Endostatin Human genes 0.000 description 1
- 108010079505 Endostatins Proteins 0.000 description 1
- 206010014958 Eosinophilic leukaemia Diseases 0.000 description 1
- 206010014967 Ependymoma Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 208000031637 Erythroblastic Acute Leukemia Diseases 0.000 description 1
- 208000036566 Erythroleukaemia Diseases 0.000 description 1
- 208000006168 Ewing Sarcoma Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 208000032612 Glial tumor Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- 208000002927 Hamartoma Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000001258 Hemangiosarcoma Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 201000002563 Histoplasmosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010048643 Hypereosinophilic syndrome Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000007766 Kaposi sarcoma Diseases 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 206010023330 Keloid scar Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-M L-tartrate(1-) Chemical compound OC(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-M 0.000 description 1
- 239000002176 L01XE26 - Cabozantinib Substances 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 208000006404 Large Granular Lymphocytic Leukemia Diseases 0.000 description 1
- 208000018142 Leiomyosarcoma Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010025219 Lymphangioma Diseases 0.000 description 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000000172 Medulloblastoma Diseases 0.000 description 1
- 206010027406 Mesothelioma Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 101000981253 Mus musculus GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010062207 Mycobacterial infection Diseases 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 201000004458 Myoma Diseases 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 108010072915 NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt Proteins 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CXIXODCTOFXPEO-UHFFFAOYSA-N O1CCOC2=C1C=CC(=C2)N1N=NC=C1 Chemical compound O1CCOC2=C1C=CC(=C2)N1N=NC=C1 CXIXODCTOFXPEO-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 201000010133 Oligodendroglioma Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000010191 Osteitis Deformans Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 208000027868 Paget disease Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000721454 Pemphigus Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000007641 Pinealoma Diseases 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 208000003971 Posterior uveitis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000002158 Proliferative Vitreoretinopathy Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000033464 Reiter syndrome Diseases 0.000 description 1
- 208000006265 Renal cell carcinoma Diseases 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 206010038910 Retinitis Diseases 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 206010038934 Retinopathy proliferative Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 201000010208 Seminoma Diseases 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- 208000027073 Stargardt disease Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 201000009594 Systemic Scleroderma Diseases 0.000 description 1
- 206010042953 Systemic sclerosis Diseases 0.000 description 1
- 201000008717 T-cell large granular lymphocyte leukemia Diseases 0.000 description 1
- 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
- 229920002253 Tannate Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 201000005485 Toxoplasmosis Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 102000002501 Tryptophan-tRNA Ligase Human genes 0.000 description 1
- 229940122530 Tubulin polymerization inhibitor Drugs 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 102000008790 VE-cadherin Human genes 0.000 description 1
- 208000024248 Vascular System injury Diseases 0.000 description 1
- 208000012339 Vascular injury Diseases 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- 206010058990 Venous occlusion Diseases 0.000 description 1
- 208000014070 Vestibular schwannoma Diseases 0.000 description 1
- 208000033559 Waldenström macroglobulinemia Diseases 0.000 description 1
- 208000008383 Wilms tumor Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JMNXSNUXDHHTKQ-QVMSTPCGSA-N [(3r,6r)-6-[(3s,5r,7r,8r,9s,10s,13r,14s,17r)-3-[3-(4-aminobutylamino)propylamino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-yl] hydrogen sulfate;(2s)-2-hydroxypropanoic ac Chemical compound C[C@H](O)C(O)=O.C([C@@H]1C[C@H]2O)[C@@H](NCCCNCCCCN)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@H](C(C)C)OS(O)(=O)=O)[C@@]2(C)CC1 JMNXSNUXDHHTKQ-QVMSTPCGSA-N 0.000 description 1
- ZLCSFJBYXWIVMH-UHFFFAOYSA-N [1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-3-methyl-1-oxobutan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])C(C)C)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 ZLCSFJBYXWIVMH-UHFFFAOYSA-N 0.000 description 1
- MNVRPVQEJKQZLR-UHFFFAOYSA-N [1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-3-methyl-1-oxopentan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(OC)C(NC(=O)C([NH3+])C(C)CC)=CC(C=2N(N=NC=2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 MNVRPVQEJKQZLR-UHFFFAOYSA-N 0.000 description 1
- WEBZWTZWCJNYBU-UHFFFAOYSA-N [1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-3-methyl-1-oxobutan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])C(C)C)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 WEBZWTZWCJNYBU-UHFFFAOYSA-N 0.000 description 1
- LNGRACQTCUEXTB-UHFFFAOYSA-N [1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-3-methyl-1-oxopentan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(OC)C(NC(=O)C([NH3+])C(C)CC)=CC(C2=C(N=NN2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 LNGRACQTCUEXTB-UHFFFAOYSA-N 0.000 description 1
- WXRIDNQQEYOVGM-UHFFFAOYSA-N [2,3-dimethoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(OC)C(OC)=CC(C=2C(=NOC=2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 WXRIDNQQEYOVGM-UHFFFAOYSA-N 0.000 description 1
- UPIAIQBKUDZJMO-UHFFFAOYSA-N [2,3-dimethoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(OC)C(OC)=CC(C=2N(N=NC=2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 UPIAIQBKUDZJMO-UHFFFAOYSA-N 0.000 description 1
- YBBRAEBNWDBHJP-UHFFFAOYSA-N [2,3-dimethoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC(OC)=C(OC)C(OP(O)(O)=O)=C1 YBBRAEBNWDBHJP-UHFFFAOYSA-N 0.000 description 1
- HAMQDUONRILWLM-UHFFFAOYSA-N [2,3-dimethoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]phenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(OC)C(OC)=CC(C2=C(SN=C2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 HAMQDUONRILWLM-UHFFFAOYSA-N 0.000 description 1
- RKNQZBAJRVZTGF-UHFFFAOYSA-N [2,3-dimethoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]phenyl] dihydrogen phosphate Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC(OC)=C(OC)C(OP(O)(O)=O)=C1 RKNQZBAJRVZTGF-UHFFFAOYSA-N 0.000 description 1
- APRFRIKHINSFHS-UHFFFAOYSA-N [2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl] hydrogen sulfate Chemical compound C1=C(OS(O)(=O)=O)C(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 APRFRIKHINSFHS-UHFFFAOYSA-N 0.000 description 1
- FLOPHNITPASBHG-UHFFFAOYSA-N [2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]sulfanylphosphonic acid Chemical compound C1=C(SP(O)(O)=O)C(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 FLOPHNITPASBHG-UHFFFAOYSA-N 0.000 description 1
- XDHZLOBQYRWBAY-UHFFFAOYSA-N [2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl] hydrogen sulfate Chemical compound C1=C(OS(O)(=O)=O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 XDHZLOBQYRWBAY-UHFFFAOYSA-N 0.000 description 1
- SNYMVVUCSZNLRQ-UHFFFAOYSA-N [2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenyl] hydrogen sulfate Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC=C(OC)C(OS(O)(=O)=O)=C1 SNYMVVUCSZNLRQ-UHFFFAOYSA-N 0.000 description 1
- QWFLZKBWWSYRCM-UHFFFAOYSA-N [2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenyl]sulfanylphosphonic acid Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC=C(OC)C(SP(O)(O)=O)=C1 QWFLZKBWWSYRCM-UHFFFAOYSA-N 0.000 description 1
- KNRIBJSDXRRNQE-UHFFFAOYSA-N [2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)triazol-4-yl]phenyl] hydrogen sulfate Chemical compound C=1C=2OCOC=2C(OC)=CC=1N1N=NC=C1C1=CC=C(OC)C(OS(O)(=O)=O)=C1 KNRIBJSDXRRNQE-UHFFFAOYSA-N 0.000 description 1
- LLFPKSAEIWLFBR-UHFFFAOYSA-N [2-methoxy-5-[4-(3,4,5-trimethoxyphenyl)-1,2-oxazol-3-yl]phenyl] dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C(OC)=CC=C1C1=NOC=C1C1=CC(OC)=C(OC)C(OC)=C1 LLFPKSAEIWLFBR-UHFFFAOYSA-N 0.000 description 1
- ZRKPNMKVAIXJBV-UHFFFAOYSA-N [2-methoxy-5-[4-(3,4,5-trimethoxyphenyl)-1,2-thiazol-5-yl]phenyl] dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)C=NS1 ZRKPNMKVAIXJBV-UHFFFAOYSA-N 0.000 description 1
- TZBASTGPOQVRGG-UHFFFAOYSA-N [2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]phenyl] hydrogen sulfate Chemical compound C1=C(OS(O)(=O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)SN=C1 TZBASTGPOQVRGG-UHFFFAOYSA-N 0.000 description 1
- HHUSZURNQNCVFL-UHFFFAOYSA-N [2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)triazol-1-yl]phenyl] dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C(OC)=CC=C1N1C(C=2C=C(OC)C(OC)=C(OC)C=2)=CN=N1 HHUSZURNQNCVFL-UHFFFAOYSA-N 0.000 description 1
- AIVVDRZJWLJZDN-UHFFFAOYSA-N [2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]phenyl] hydrogen sulfate Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC=C(OC)C(OS(O)(=O)=O)=C1 AIVVDRZJWLJZDN-UHFFFAOYSA-N 0.000 description 1
- MTIRKTDGCBRDKK-UHFFFAOYSA-N [2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]phenyl]sulfanylphosphonic acid Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC=C(OC)C(SP(O)(O)=O)=C1 MTIRKTDGCBRDKK-UHFFFAOYSA-N 0.000 description 1
- JSRQNUSBBCQKKH-UHFFFAOYSA-N [2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]phenyl]azanium;chloride Chemical compound [Cl-].C=1C=2OCOC=2C(OC)=CC=1C=1N=NNC=1C1=CC=C(OC)C([NH3+])=C1 JSRQNUSBBCQKKH-UHFFFAOYSA-N 0.000 description 1
- NZNLOLLRHZCQQC-UHFFFAOYSA-N [2-methylsulfanyl-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=C(OP(O)(O)=O)C(SC)=CC=2)=C1 NZNLOLLRHZCQQC-UHFFFAOYSA-N 0.000 description 1
- XCCPERLAQQEUAM-UHFFFAOYSA-N [2-methylsulfanyl-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl] dihydrogen phosphate Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=C(OP(O)(O)=O)C(SC)=CC=2)=C1 XCCPERLAQQEUAM-UHFFFAOYSA-N 0.000 description 1
- HHKBMUIQINGABE-UHFFFAOYSA-N [3-(1-benzofuran-2-yl)-1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-1-oxopropan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CC=2OC3=CC=CC=C3C=2)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 HHKBMUIQINGABE-UHFFFAOYSA-N 0.000 description 1
- ZXNFRSOEHGXHRE-UHFFFAOYSA-N [3-(1-benzofuran-2-yl)-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-1-oxopropan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CC=2OC3=CC=CC=C3C=2)C(OC)=CC=C1C=1NN=NC=1C1=CC(OC)=C(OC)C(OC)=C1 ZXNFRSOEHGXHRE-UHFFFAOYSA-N 0.000 description 1
- AZGRRUYLHHYYGW-UHFFFAOYSA-N [3-(1h-imidazol-5-yl)-1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-1-oxopropan-2-yl]azanium;chloride Chemical compound [Cl-].COC1=CC=C(C=2N(N=NC=2)C=2C=C(OC)C(OC)=C(OC)C=2)C=C1NC(=O)C([NH3+])CC1=CN=CN1 AZGRRUYLHHYYGW-UHFFFAOYSA-N 0.000 description 1
- MXBYUHNDCNNEHF-UHFFFAOYSA-N [3-(1h-imidazol-5-yl)-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-1-oxopropan-2-yl]azanium;chloride Chemical compound [Cl-].COC1=CC=C(C2=C(N=NN2)C=2C=C(OC)C(OC)=C(OC)C=2)C=C1NC(=O)C([NH3+])CC1=CN=CN1 MXBYUHNDCNNEHF-UHFFFAOYSA-N 0.000 description 1
- ZZPIOCHRHSPGPK-UHFFFAOYSA-N [3-(1h-indol-2-yl)-1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-1-oxopropan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CC=2NC3=CC=CC=C3C=2)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 ZZPIOCHRHSPGPK-UHFFFAOYSA-N 0.000 description 1
- ISDIMWUFCHGEDZ-UHFFFAOYSA-N [3-(1h-indol-2-yl)-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-1-oxopropan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CC=2NC3=CC=CC=C3C=2)C(OC)=CC=C1C=1NN=NC=1C1=CC(OC)=C(OC)C(OC)=C1 ISDIMWUFCHGEDZ-UHFFFAOYSA-N 0.000 description 1
- RXHJZIWTXGJHGV-UHFFFAOYSA-N [3-(4-hydroxyphenyl)-1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-1-oxopropan-2-yl]azanium;chloride Chemical compound [Cl-].COC1=CC=C(C=2N(N=NC=2)C=2C=C(OC)C(OC)=C(OC)C=2)C=C1NC(=O)C([NH3+])CC1=CC=C(O)C=C1 RXHJZIWTXGJHGV-UHFFFAOYSA-N 0.000 description 1
- JMCJKQUOPRJMKA-UHFFFAOYSA-N [3-(4-hydroxyphenyl)-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-1-oxopropan-2-yl]azanium;chloride Chemical compound [Cl-].COC1=CC=C(C2=C(N=NN2)C=2C=C(OC)C(OC)=C(OC)C=2)C=C1NC(=O)C([NH3+])CC1=CC=C(O)C=C1 JMCJKQUOPRJMKA-UHFFFAOYSA-N 0.000 description 1
- BXIDEXLELKJLOV-UHFFFAOYSA-N [3-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]anilino]-3-oxopropyl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)CC[NH3+])C(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 BXIDEXLELKJLOV-UHFFFAOYSA-N 0.000 description 1
- IVRHAIDNQBFRNI-UHFFFAOYSA-N [3-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]anilino]-3-oxopropyl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)CC[NH3+])C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 IVRHAIDNQBFRNI-UHFFFAOYSA-N 0.000 description 1
- HGRFGWYZXZYEJM-UHFFFAOYSA-N [3-acetyloxy-5-[4-(4-methoxyphenyl)-1,2-oxazol-3-yl]phenyl] acetate Chemical compound C1=CC(OC)=CC=C1C1=CON=C1C1=CC(OC(C)=O)=CC(OC(C)=O)=C1 HGRFGWYZXZYEJM-UHFFFAOYSA-N 0.000 description 1
- FWJFDVWLFNHXGD-UHFFFAOYSA-N [3-acetyloxy-5-[5-(4-methoxyphenyl)-2h-triazol-4-yl]phenyl] acetate Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=C(OC(C)=O)C=C(OC(C)=O)C=2)N=NN1 FWJFDVWLFNHXGD-UHFFFAOYSA-N 0.000 description 1
- NDBMIXXRYOTJJU-UHFFFAOYSA-N [3-acetyloxy-5-[5-(4-methoxyphenyl)triazol-1-yl]phenyl] acetate Chemical compound C1=CC(OC)=CC=C1C1=CN=NN1C1=CC(OC(C)=O)=CC(OC(C)=O)=C1 NDBMIXXRYOTJJU-UHFFFAOYSA-N 0.000 description 1
- ZJKFVTZKXNZAPU-UHFFFAOYSA-N [3-carboxy-1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-1-oxopropan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CC(O)=O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 ZJKFVTZKXNZAPU-UHFFFAOYSA-N 0.000 description 1
- PSRBLIRFTQIIGZ-UHFFFAOYSA-N [3-carboxy-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-1-oxopropan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CC(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 PSRBLIRFTQIIGZ-UHFFFAOYSA-N 0.000 description 1
- XGMRDZMSDCOHFY-UHFFFAOYSA-N [3-hydroxy-1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-1-oxobutan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])C(C)O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 XGMRDZMSDCOHFY-UHFFFAOYSA-N 0.000 description 1
- IWCDLZISUSSAPC-UHFFFAOYSA-N [3-hydroxy-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-1-oxobutan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])C(C)O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 IWCDLZISUSSAPC-UHFFFAOYSA-N 0.000 description 1
- YVKJJEVTFFYQDB-UHFFFAOYSA-N [3-hydroxy-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-1-oxopropan-2-yl]azanium;chloride Chemical compound Cl.C1=C(NC(=O)C(N)CO)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 YVKJJEVTFFYQDB-UHFFFAOYSA-N 0.000 description 1
- RQDLLYMXRGPOGF-UHFFFAOYSA-N [3-hydroxy-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)triazol-1-yl]anilino]-1-oxopropan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CO)C(OC)=CC=C1N1C(C=2C=C(OC)C(OC)=C(OC)C=2)=CN=N1 RQDLLYMXRGPOGF-UHFFFAOYSA-N 0.000 description 1
- SPAKKHNNVYGOAQ-UHFFFAOYSA-N [4-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=CON=2)C=2C=CC(OP(O)(O)=O)=CC=2)=C1 SPAKKHNNVYGOAQ-UHFFFAOYSA-N 0.000 description 1
- UUKJUJQVDLOARR-UHFFFAOYSA-N [4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl] dihydrogen phosphate Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(OP(O)(O)=O)=CC=2)=C1 UUKJUJQVDLOARR-UHFFFAOYSA-N 0.000 description 1
- SBKUDACXOKWTCB-UHFFFAOYSA-N [4-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC=C(OP(O)(O)=O)C=C1 SBKUDACXOKWTCB-UHFFFAOYSA-N 0.000 description 1
- SIKHZGGSCAYENA-UHFFFAOYSA-N [4-[5-(3,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]phenyl] dihydrogen phosphate Chemical compound COC1=C(OC)C(OC)=CC(C2=C(C=NS2)C=2C=CC(OP(O)(O)=O)=CC=2)=C1 SIKHZGGSCAYENA-UHFFFAOYSA-N 0.000 description 1
- MATMVSMRTRAIFO-UHFFFAOYSA-N [4-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]phenyl] dihydrogen phosphate Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC=C(OP(O)(O)=O)C=C1 MATMVSMRTRAIFO-UHFFFAOYSA-N 0.000 description 1
- HVSFYCUIBMTPMG-UHFFFAOYSA-N [4-amino-1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-1,4-dioxobutan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CC(N)=O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 HVSFYCUIBMTPMG-UHFFFAOYSA-N 0.000 description 1
- BWCTYVBGSSHIPF-UHFFFAOYSA-N [4-amino-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-1,4-dioxobutan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CC(N)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 BWCTYVBGSSHIPF-UHFFFAOYSA-N 0.000 description 1
- JCSROHSUJFMFFJ-UHFFFAOYSA-N [4-carboxy-1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-1-oxobutan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CCC(O)=O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 JCSROHSUJFMFFJ-UHFFFAOYSA-N 0.000 description 1
- ZEBJSGPCWOFKPK-UHFFFAOYSA-N [4-carboxy-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]anilino]-1-oxobutan-2-yl]azanium;chloride Chemical compound Cl.C1=C(NC(=O)C(N)CCC(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 ZEBJSGPCWOFKPK-UHFFFAOYSA-N 0.000 description 1
- ZGLHHGPLOYFNDK-UHFFFAOYSA-N [4-carboxy-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-1-oxobutan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CCC(O)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 ZGLHHGPLOYFNDK-UHFFFAOYSA-N 0.000 description 1
- JMGXJHWTVBGOKG-UHFFFAOYSA-N [4-chloro-3-[5-methyl-3-[4-(2-pyrrolidin-1-ylethoxy)anilino]-1,2,4-benzotriazin-7-yl]phenyl] benzoate Chemical compound N1=C2C(C)=CC(C=3C(=CC=C(OC(=O)C=4C=CC=CC=4)C=3)Cl)=CC2=NN=C1NC(C=C1)=CC=C1OCCN1CCCC1 JMGXJHWTVBGOKG-UHFFFAOYSA-N 0.000 description 1
- IWRUJBYEPLFMQP-UHFFFAOYSA-N [5-(diaminomethylideneamino)-1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-1-oxopentan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CCCNC(N)=N)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 IWRUJBYEPLFMQP-UHFFFAOYSA-N 0.000 description 1
- UAFGJBQDARTSDY-UHFFFAOYSA-N [5-(diaminomethylideneamino)-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-1-oxopentan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CCCNC(N)=N)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 UAFGJBQDARTSDY-UHFFFAOYSA-N 0.000 description 1
- HZOBKJKCXSDIJY-UHFFFAOYSA-N [5-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]-2-methylsulfanylphenyl] dihydrogen phosphate Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC=C(SC)C(OP(O)(O)=O)=C1 HZOBKJKCXSDIJY-UHFFFAOYSA-N 0.000 description 1
- GVEDAOFBZWJAIK-UHFFFAOYSA-N [5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]-2-methylsulfanylphenyl] dihydrogen phosphate Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC=C(SC)C(OP(O)(O)=O)=C1 GVEDAOFBZWJAIK-UHFFFAOYSA-N 0.000 description 1
- JRURLZLXCYXVRV-UHFFFAOYSA-N [5-amino-1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-1,5-dioxopentan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CCC(N)=O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 JRURLZLXCYXVRV-UHFFFAOYSA-N 0.000 description 1
- PFDLMXAQLRBNNV-UHFFFAOYSA-N [5-amino-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-1,5-dioxopentan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CCC(N)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 PFDLMXAQLRBNNV-UHFFFAOYSA-N 0.000 description 1
- DDAYFBQJTPEUFB-UHFFFAOYSA-N [5-methoxy-2-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=CC(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 DDAYFBQJTPEUFB-UHFFFAOYSA-N 0.000 description 1
- CPAZEXXXMVXBMW-UHFFFAOYSA-N [5-methoxy-2-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=CC(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 CPAZEXXXMVXBMW-UHFFFAOYSA-N 0.000 description 1
- VTVBUKKPLLGOAM-UHFFFAOYSA-N [5-methoxy-2-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=CC(OC)=CC=C1C1=CON=C1C(C=C1OC)=CC2=C1OCO2 VTVBUKKPLLGOAM-UHFFFAOYSA-N 0.000 description 1
- MSTLSRGLOUKRLF-UHFFFAOYSA-N [5-methoxy-2-[5-(3,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]phenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)SN=C1 MSTLSRGLOUKRLF-UHFFFAOYSA-N 0.000 description 1
- HZESPELOHIDNJE-UHFFFAOYSA-N [5-methoxy-2-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]phenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=CC(OC)=CC=C1C1=C(C=2C=C(OC)C=3OCOC=3C=2)SN=C1 HZESPELOHIDNJE-UHFFFAOYSA-N 0.000 description 1
- SFBWTEXIQYTNCI-UHFFFAOYSA-N [6-amino-1-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]anilino]-1-oxohexan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CCCCN)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 SFBWTEXIQYTNCI-UHFFFAOYSA-N 0.000 description 1
- DTDLSDJSLMAWSN-UHFFFAOYSA-N [6-amino-1-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]anilino]-1-oxohexan-2-yl]azanium;chloride Chemical compound [Cl-].C1=C(NC(=O)C([NH3+])CCCCN)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 DTDLSDJSLMAWSN-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 108010011755 acetyl-prolyl-histidyl-seryl-cysteinyl-asparaginamide Proteins 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 208000004064 acoustic neuroma Diseases 0.000 description 1
- 208000017733 acquired polycythemia vera Diseases 0.000 description 1
- 208000009621 actinic keratosis Diseases 0.000 description 1
- 208000021841 acute erythroid leukemia Diseases 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 108010081667 aflibercept Proteins 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 230000003527 anti-angiogenesis Effects 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 208000021328 arterial occlusion Diseases 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229940120638 avastin Drugs 0.000 description 1
- 125000005334 azaindolyl group Chemical group N1N=C(C2=CC=CC=C12)* 0.000 description 1
- 125000003828 azulenyl group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 206010004145 bartonellosis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 229960000397 bevacizumab Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- HFCFMRYTXDINDK-WNQIDUERSA-N cabozantinib malate Chemical compound OC(=O)[C@@H](O)CC(O)=O.C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)C1(C(=O)NC=2C=CC(F)=CC=2)CC1 HFCFMRYTXDINDK-WNQIDUERSA-N 0.000 description 1
- 108010018828 cadherin 5 Proteins 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 125000004452 carbocyclyl group Chemical group 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229960002412 cediranib Drugs 0.000 description 1
- 229960000590 celecoxib Drugs 0.000 description 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 238000004296 chiral HPLC Methods 0.000 description 1
- 238000000633 chiral stationary phase gas chromatography Methods 0.000 description 1
- 208000006990 cholangiocarcinoma Diseases 0.000 description 1
- 208000021668 chronic eosinophilic leukemia Diseases 0.000 description 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
- 201000010903 chronic neutrophilic leukemia Diseases 0.000 description 1
- 229950009003 cilengitide Drugs 0.000 description 1
- AMLYAMJWYAIXIA-VWNVYAMZSA-N cilengitide Chemical compound N1C(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C(C)C)N(C)C(=O)[C@H]1CC1=CC=CC=C1 AMLYAMJWYAIXIA-VWNVYAMZSA-N 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- 229960002626 clarithromycin Drugs 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000002188 cycloheptatrienyl group Chemical group C1(=CC=CC=CC1)* 0.000 description 1
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000003678 cyclohexadienyl group Chemical group C1(=CC=CCC1)* 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004090 cyclononenyl group Chemical group C1(=CCCCCCCC1)* 0.000 description 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001945 cyclooctatrienyl group Chemical group C1(=CC=CC=CCC1)* 0.000 description 1
- 125000000522 cyclooctenyl group Chemical group C1(=CCCCCCC1)* 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 208000002445 cystadenocarcinoma Diseases 0.000 description 1
- 229960004969 dalteparin Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 125000005070 decynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000006827 desmoid tumor Diseases 0.000 description 1
- 230000009547 development abnormality Effects 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- VXNQMUVMEIGUJW-XNOMRPDFSA-L disodium;[2-methoxy-5-[(z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl] phosphate Chemical compound [Na+].[Na+].C1=C(OP([O-])([O-])=O)C(OC)=CC=C1\C=C/C1=CC(OC)=C(OC)C(OC)=C1 VXNQMUVMEIGUJW-XNOMRPDFSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- ZCRMNZVIAVGMFU-UHFFFAOYSA-N ethyl-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenoxy]phosphinic acid Chemical compound C1=C(OC)C(OP(O)(=O)CC)=CC(C=2C(=NOC=2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 ZCRMNZVIAVGMFU-UHFFFAOYSA-N 0.000 description 1
- PQJSVUJBXYAZLS-UHFFFAOYSA-N ethyl-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]phenoxy]phosphinic acid Chemical compound C1=C(OC)C(OP(O)(=O)CC)=CC(C2=C(SN=C2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 PQJSVUJBXYAZLS-UHFFFAOYSA-N 0.000 description 1
- FUHLDSJNWIRJEQ-UHFFFAOYSA-N ethyl-[5-methoxy-2-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenoxy]phosphinic acid Chemical compound CCP(O)(=O)OC1=CC(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 FUHLDSJNWIRJEQ-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 206010016629 fibroma Diseases 0.000 description 1
- 206010049444 fibromatosis Diseases 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229940013688 formic acid Drugs 0.000 description 1
- 229940050411 fumarate Drugs 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 229940114119 gentisate Drugs 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000025750 heavy chain disease Diseases 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 201000002222 hemangioblastoma Diseases 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 125000005844 heterocyclyloxy group Chemical group 0.000 description 1
- 125000004468 heterocyclylthio group Chemical group 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 229910000043 hydrogen iodide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 208000022368 idiopathic cardiomyopathy Diseases 0.000 description 1
- 125000004857 imidazopyridinyl group Chemical group N1C(=NC2=C1C=CC=N2)* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- TWBYWOBDOCUKOW-UHFFFAOYSA-M isonicotinate Chemical compound [O-]C(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-M 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 201000010666 keratoconjunctivitis Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 229940063711 lasix Drugs 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229960004942 lenalidomide Drugs 0.000 description 1
- GOTYRUGSSMKFNF-UHFFFAOYSA-N lenalidomide Chemical compound C1C=2C(N)=CC=CC=2C(=O)N1C1CCC(=O)NC1=O GOTYRUGSSMKFNF-UHFFFAOYSA-N 0.000 description 1
- 230000002197 limbic effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 206010024627 liposarcoma Diseases 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229940076783 lucentis Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 208000012804 lymphangiosarcoma Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 208000027202 mammary Paget disease Diseases 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 206010027191 meningioma Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- DVWAUEZIBXHAPW-UHFFFAOYSA-N methyl 2,6-dimethoxy-4-[4-(4-methoxyphenyl)-1,2-oxazol-3-yl]benzoate Chemical compound C1=C(OC)C(C(=O)OC)=C(OC)C=C1C1=NOC=C1C1=CC=C(OC)C=C1 DVWAUEZIBXHAPW-UHFFFAOYSA-N 0.000 description 1
- RTOPSVWTSGIQMH-UHFFFAOYSA-N methyl 2,6-dimethoxy-4-[5-(4-methoxyphenyl)triazol-1-yl]benzoate Chemical compound C1=C(OC)C(C(=O)OC)=C(OC)C=C1N1C(C=2C=CC(OC)=CC=2)=CN=N1 RTOPSVWTSGIQMH-UHFFFAOYSA-N 0.000 description 1
- NMBTZZBPBVKIFA-UHFFFAOYSA-N methyl 2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]benzoate Chemical compound C1=C(OC)C(C(=O)OC)=CC(C=2C(=NOC=2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 NMBTZZBPBVKIFA-UHFFFAOYSA-N 0.000 description 1
- QDPUTDIGBUFUJV-UHFFFAOYSA-N methyl 2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]benzoate Chemical compound C1=C(OC)C(C(=O)OC)=CC(C=2N(N=NC=2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 QDPUTDIGBUFUJV-UHFFFAOYSA-N 0.000 description 1
- RNGLVMXECVVUEF-UHFFFAOYSA-N methyl 2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]benzoate Chemical compound C1=C(OC)C(C(=O)OC)=CC(C=2C(=NOC=2)C=2C=C(OC)C=3OCOC=3C=2)=C1 RNGLVMXECVVUEF-UHFFFAOYSA-N 0.000 description 1
- VNAGCIXLWOAERJ-UHFFFAOYSA-N methyl 2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)triazol-4-yl]benzoate Chemical compound C1=C(OC)C(C(=O)OC)=CC(C=2N(N=NC=2)C=2C=C(OC)C=3OCOC=3C=2)=C1 VNAGCIXLWOAERJ-UHFFFAOYSA-N 0.000 description 1
- QCLXZNOCKVJQKZ-UHFFFAOYSA-N methyl 2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-thiazol-4-yl]benzoate Chemical compound C1=C(OC)C(C(=O)OC)=CC(C2=C(SN=C2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 QCLXZNOCKVJQKZ-UHFFFAOYSA-N 0.000 description 1
- CBNZQKFXIRQIJR-UHFFFAOYSA-N methyl 2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]benzoate Chemical compound C1=C(OC)C(C(=O)OC)=CC(C2=C(SN=C2)C=2C=C(OC)C=3OCOC=3C=2)=C1 CBNZQKFXIRQIJR-UHFFFAOYSA-N 0.000 description 1
- JQULXXXNJLTIKQ-UHFFFAOYSA-N methyl 4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 JQULXXXNJLTIKQ-UHFFFAOYSA-N 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 244000309715 mini pig Species 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 208000001611 myxosarcoma Diseases 0.000 description 1
- FUUVBSMTGPOTMW-UHFFFAOYSA-N n,n-dimethyl-2-[4-(3,4,5-trimethoxyphenyl)-1,2-oxazol-3-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(C=2C(=NOC=2)C=2C(=CC=CC=2)N(C)C)=C1 FUUVBSMTGPOTMW-UHFFFAOYSA-N 0.000 description 1
- YJMZNZJVJFATTF-UHFFFAOYSA-N n,n-dimethyl-2-[4-(3,4,5-trimethoxyphenyl)-1,2-thiazol-5-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(C2=C(SN=C2)C=2C(=CC=CC=2)N(C)C)=C1 YJMZNZJVJFATTF-UHFFFAOYSA-N 0.000 description 1
- AVUOHFWLWQAZPO-UHFFFAOYSA-N n,n-dimethyl-4-[3-(2,3,5-trimethoxyphenyl)-1,2-oxazol-4-yl]aniline Chemical compound COC1=CC(OC)=C(OC)C(C=2C(=CON=2)C=2C=CC(=CC=2)N(C)C)=C1 AVUOHFWLWQAZPO-UHFFFAOYSA-N 0.000 description 1
- FFTOTCPDNUGTAA-UHFFFAOYSA-N n,n-dimethyl-4-[3-(2,3,5-trimethoxyphenyl)triazol-4-yl]aniline Chemical compound COC1=CC(OC)=C(OC)C(N2C(=CN=N2)C=2C=CC(=CC=2)N(C)C)=C1 FFTOTCPDNUGTAA-UHFFFAOYSA-N 0.000 description 1
- QBQKCLOGCGRZCC-UHFFFAOYSA-N n,n-dimethyl-4-[3-(2,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]aniline Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1=NOC=C1C1=CC=C(N(C)C)C=C1 QBQKCLOGCGRZCC-UHFFFAOYSA-N 0.000 description 1
- OWGAZDZFSHDQSN-UHFFFAOYSA-N n,n-dimethyl-4-[3-(2,4,5-trimethoxyphenyl)triazol-4-yl]aniline Chemical compound C1=C(OC)C(OC)=CC(OC)=C1N1C(C=2C=CC(=CC=2)N(C)C)=CN=N1 OWGAZDZFSHDQSN-UHFFFAOYSA-N 0.000 description 1
- YROPRMVIOWUVCJ-UHFFFAOYSA-N n,n-dimethyl-4-[3-(3,4,5-triethylphenyl)triazol-4-yl]aniline Chemical compound CCC1=C(CC)C(CC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)N(C)C)=C1 YROPRMVIOWUVCJ-UHFFFAOYSA-N 0.000 description 1
- BRDBXIMVKPLMTL-UHFFFAOYSA-N n,n-dimethyl-4-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(N2C(=CN=N2)C=2C=CC(=CC=2)N(C)C)=C1 BRDBXIMVKPLMTL-UHFFFAOYSA-N 0.000 description 1
- GTFQPPNOKOJWSB-UHFFFAOYSA-N n,n-dimethyl-4-[5-(2,3,4,5-tetramethoxyphenyl)-2h-triazol-4-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(C2=C(N=NN2)C=2C=CC(=CC=2)N(C)C)=C1OC GTFQPPNOKOJWSB-UHFFFAOYSA-N 0.000 description 1
- YDDOMMYBVFTWIJ-UHFFFAOYSA-N n,n-dimethyl-4-[5-(2,3,4,5-tetramethoxyphenyl)triazol-1-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(C=2N(N=NC=2)C=2C=CC(=CC=2)N(C)C)=C1OC YDDOMMYBVFTWIJ-UHFFFAOYSA-N 0.000 description 1
- GTBUXFAHNLLLQV-UHFFFAOYSA-N n,n-dimethyl-4-[5-(2,3,5-trimethoxyphenyl)-1,2-thiazol-4-yl]aniline Chemical compound COC1=CC(OC)=C(OC)C(C2=C(C=NS2)C=2C=CC(=CC=2)N(C)C)=C1 GTBUXFAHNLLLQV-UHFFFAOYSA-N 0.000 description 1
- PCUZRHXSMMFASF-UHFFFAOYSA-N n,n-dimethyl-4-[5-(2,3,5-trimethoxyphenyl)-2h-triazol-4-yl]aniline Chemical compound COC1=CC(OC)=C(OC)C(C2=C(NN=N2)C=2C=CC(=CC=2)N(C)C)=C1 PCUZRHXSMMFASF-UHFFFAOYSA-N 0.000 description 1
- ILBPODSIQHXXTE-UHFFFAOYSA-N n,n-dimethyl-4-[5-(3,4,5-triethylphenyl)-2h-triazol-4-yl]aniline Chemical compound CCC1=C(CC)C(CC)=CC(C2=C(NN=N2)C=2C=CC(=CC=2)N(C)C)=C1 ILBPODSIQHXXTE-UHFFFAOYSA-N 0.000 description 1
- GLAXWIHBIHUCBO-UHFFFAOYSA-N n,n-dimethyl-4-[5-(3,4,5-trimethoxyphenyl)triazol-1-yl]aniline Chemical compound COC1=C(OC)C(OC)=CC(C=2N(N=NC=2)C=2C=CC(=CC=2)N(C)C)=C1 GLAXWIHBIHUCBO-UHFFFAOYSA-N 0.000 description 1
- ONDPWWDPQDCQNJ-UHFFFAOYSA-N n-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;phosphoric acid Chemical compound OP(O)(O)=O.OP(O)(O)=O.C=1C=C2C(C)(C)CNC2=CC=1NC(=O)C1=CC=CN=C1NCC1=CC=NC=C1 ONDPWWDPQDCQNJ-UHFFFAOYSA-N 0.000 description 1
- LBWFXVZLPYTWQI-IPOVEDGCSA-N n-[2-(diethylamino)ethyl]-5-[(z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C LBWFXVZLPYTWQI-IPOVEDGCSA-N 0.000 description 1
- PZDDSZNXNWYHDQ-UHFFFAOYSA-N n-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]-3-[2-(methylamino)ethylamino]propanamide Chemical compound C1=C(OC)C(NC(=O)CCNCCNC)=CC(C=2C(=NOC=2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 PZDDSZNXNWYHDQ-UHFFFAOYSA-N 0.000 description 1
- PFXYEEWWJSRHNU-UHFFFAOYSA-N n-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]acetamide Chemical compound C1=C(NC(C)=O)C(OC)=CC=C1C1=CON=C1C1=CC(OC)=C(OC)C(OC)=C1 PFXYEEWWJSRHNU-UHFFFAOYSA-N 0.000 description 1
- ZPLNUNUWDMIRFQ-UHFFFAOYSA-N n-[2-methoxy-5-[3-(3,4,5-trimethoxyphenyl)triazol-4-yl]phenyl]acetamide Chemical compound C1=C(NC(C)=O)C(OC)=CC=C1C1=CN=NN1C1=CC(OC)=C(OC)C(OC)=C1 ZPLNUNUWDMIRFQ-UHFFFAOYSA-N 0.000 description 1
- ZAPMLUGIRFZXBA-UHFFFAOYSA-N n-[2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-oxazol-4-yl]phenyl]acetamide Chemical compound C=1C=2OCOC=2C(OC)=CC=1C1=NOC=C1C1=CC=C(OC)C(NC(C)=O)=C1 ZAPMLUGIRFZXBA-UHFFFAOYSA-N 0.000 description 1
- ITAHQHKIZXHNFD-UHFFFAOYSA-N n-[2-methoxy-5-[3-(7-methoxy-1,3-benzodioxol-5-yl)triazol-4-yl]phenyl]acetamide Chemical compound C=1C=2OCOC=2C(OC)=CC=1N1N=NC=C1C1=CC=C(OC)C(NC(C)=O)=C1 ITAHQHKIZXHNFD-UHFFFAOYSA-N 0.000 description 1
- HUWNXPVCNHSXPN-UHFFFAOYSA-N n-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]-3-[2-(methylamino)ethylamino]propanamide Chemical compound C1=C(OC)C(NC(=O)CCNCCNC)=CC(C2=C(ON=C2)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 HUWNXPVCNHSXPN-UHFFFAOYSA-N 0.000 description 1
- KTKLMORPVFHTIN-UHFFFAOYSA-N n-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]phenyl]acetamide Chemical compound C1=C(NC(C)=O)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)N=NN1 KTKLMORPVFHTIN-UHFFFAOYSA-N 0.000 description 1
- WZONXNLWGLGBBJ-UHFFFAOYSA-N n-[2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-1,2-thiazol-4-yl]phenyl]acetamide Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1SN=CC=1C1=CC=C(OC)C(NC(C)=O)=C1 WZONXNLWGLGBBJ-UHFFFAOYSA-N 0.000 description 1
- HJVFPXYRXCPMOV-UHFFFAOYSA-N n-[2-methoxy-5-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]phenyl]acetamide Chemical compound C=1C=2OCOC=2C(OC)=CC=1C=1N=NNC=1C1=CC=C(OC)C(NC(C)=O)=C1 HJVFPXYRXCPMOV-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 208000025189 neoplasm of testis Diseases 0.000 description 1
- 201000003142 neovascular glaucoma Diseases 0.000 description 1
- 208000021971 neovascular inflammatory vitreoretinopathy Diseases 0.000 description 1
- 201000008026 nephroblastoma Diseases 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 230000021368 organ growth Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 208000025661 ovarian cyst Diseases 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000003566 oxetanyl group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- WRUUGTRCQOWXEG-UHFFFAOYSA-N pamidronate Chemical compound NCCC(O)(P(O)(O)=O)P(O)(O)=O WRUUGTRCQOWXEG-UHFFFAOYSA-N 0.000 description 1
- 229940046231 pamidronate Drugs 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 208000004019 papillary adenocarcinoma Diseases 0.000 description 1
- 229940055076 parasympathomimetics choline ester Drugs 0.000 description 1
- 230000009589 pathological growth Effects 0.000 description 1
- 229940005014 pegaptanib sodium Drugs 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 208000024724 pineal body neoplasm Diseases 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 125000004585 polycyclic heterocycle group Chemical group 0.000 description 1
- 208000037244 polycythemia vera Diseases 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000006785 proliferative vitreoretinopathy Effects 0.000 description 1
- 210000004765 promyelocyte Anatomy 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 208000028172 protozoa infectious disease Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000001725 pyrenyl group Chemical group 0.000 description 1
- 125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 208000002574 reactive arthritis Diseases 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 208000018964 sebaceous gland cancer Diseases 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- BOIGDTDDTGAZNQ-UHFFFAOYSA-M sodium;4-[5-(3,4,5-trimethoxyphenyl)-2h-triazol-4-yl]phenolate Chemical compound [Na+].COC1=C(OC)C(OC)=CC(C2=C(NN=N2)C=2C=CC([O-])=CC=2)=C1 BOIGDTDDTGAZNQ-UHFFFAOYSA-M 0.000 description 1
- DOGPUMLRNGSPJV-UHFFFAOYSA-M sodium;4-[5-(7-methoxy-1,3-benzodioxol-5-yl)-2h-triazol-4-yl]phenolate Chemical compound [Na+].C=1C=2OCOC=2C(OC)=CC=1C=1N=NNC=1C1=CC=C([O-])C=C1 DOGPUMLRNGSPJV-UHFFFAOYSA-M 0.000 description 1
- 229960003787 sorafenib Drugs 0.000 description 1
- IVDHYUQIDRJSTI-UHFFFAOYSA-N sorafenib tosylate Chemical compound [H+].CC1=CC=C(S([O-])(=O)=O)C=C1.C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 IVDHYUQIDRJSTI-UHFFFAOYSA-N 0.000 description 1
- 229960000487 sorafenib tosylate Drugs 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- JDVPQXZIJDEHAN-UHFFFAOYSA-N succinamic acid Chemical compound NC(=O)CCC(O)=O JDVPQXZIJDEHAN-UHFFFAOYSA-N 0.000 description 1
- 229940086735 succinate Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 description 1
- 229960002812 sunitinib malate Drugs 0.000 description 1
- FIAFUQMPZJWCLV-UHFFFAOYSA-N suramin Chemical compound OS(=O)(=O)C1=CC(S(O)(=O)=O)=C2C(NC(=O)C3=CC=C(C(=C3)NC(=O)C=3C=C(NC(=O)NC=4C=C(C=CC=4)C(=O)NC=4C(=CC=C(C=4)C(=O)NC=4C5=C(C=C(C=C5C(=CC=4)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)C)C=CC=3)C)=CC=C(S(O)(=O)=O)C2=C1 FIAFUQMPZJWCLV-UHFFFAOYSA-N 0.000 description 1
- 229960005314 suramin Drugs 0.000 description 1
- 201000008759 sweat gland cancer Diseases 0.000 description 1
- 201000008753 synovium neoplasm Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940066765 systemic antihistamines substituted ethylene diamines Drugs 0.000 description 1
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- KFJUWTKPSDYKNI-UHFFFAOYSA-N tert-butyl n-[2-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]anilino]-2-oxoethyl]carbamate Chemical compound C1=C(NC(=O)CNC(=O)OC(C)(C)C)C(OC)=CC=C1C1=C(C=2C=C(OC)C(OC)=C(OC)C=2)ON=C1 KFJUWTKPSDYKNI-UHFFFAOYSA-N 0.000 description 1
- 201000003120 testicular cancer Diseases 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000005888 tetrahydroindolyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000004632 tetrahydrothiopyranyl group Chemical group S1C(CCCC1)* 0.000 description 1
- 229960003433 thalidomide Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- UHTHHESEBZOYNR-UHFFFAOYSA-N vandetanib Chemical compound COC1=CC(C(/N=CN2)=N/C=3C(=CC(Br)=CC=3)F)=C2C=C1OCC1CCN(C)CC1 UHTHHESEBZOYNR-UHFFFAOYSA-N 0.000 description 1
- 229960000241 vandetanib Drugs 0.000 description 1
- 230000003966 vascular damage Effects 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
- LLDWLPRYLVPDTG-UHFFFAOYSA-N vatalanib succinate Chemical compound OC(=O)CCC(O)=O.C1=CC(Cl)=CC=C1NC(C1=CC=CC=C11)=NN=C1CC1=CC=NC=C1 LLDWLPRYLVPDTG-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 201000007790 vitelliform macular dystrophy Diseases 0.000 description 1
- 208000020938 vitelliform macular dystrophy 2 Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84455006P | 2006-09-14 | 2006-09-14 | |
| PCT/US2007/019905 WO2008033449A2 (en) | 2006-09-14 | 2007-09-13 | Compounds for the treatment of angiogenesis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010503674A true JP2010503674A (ja) | 2010-02-04 |
| JP2010503674A5 JP2010503674A5 (enExample) | 2010-10-21 |
Family
ID=39092063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009528287A Withdrawn JP2010503674A (ja) | 2006-09-14 | 2007-09-13 | 血管形成治療用化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20100093670A1 (enExample) |
| EP (1) | EP2059250A2 (enExample) |
| JP (1) | JP2010503674A (enExample) |
| AU (1) | AU2007294752A1 (enExample) |
| CA (1) | CA2662554A1 (enExample) |
| WO (1) | WO2008033449A2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015166860A1 (ja) * | 2014-04-30 | 2015-11-05 | 日本カーバイド工業株式会社 | オキシラン化合物及びそれを用いた含窒素複素環式化合物を製造する方法 |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI297335B (en) | 2001-07-10 | 2008-06-01 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
| TWI252847B (en) | 2001-07-10 | 2006-04-11 | Synta Pharmaceuticals Corp | Synthesis of taxol enhancers |
| TWI332943B (en) | 2001-07-10 | 2010-11-11 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
| TWI330079B (en) | 2003-01-15 | 2010-09-11 | Synta Pharmaceuticals Corp | Treatment for cancers |
| ES2430373T3 (es) | 2004-06-23 | 2013-11-20 | Synta Pharmaceuticals Corp. | Sales de bis(tio-hidrazida amida) para tratamiento de cánceres |
| NZ562572A (en) | 2005-04-15 | 2011-01-28 | Synta Pharmaceuticals Corp | Combination cancer therapy with BIS (thiohydrazide) amide compounds |
| TW200735866A (en) * | 2005-11-18 | 2007-10-01 | Synta Pharmaceuticals Corp | Compounds for the treatment of proliferative disorders |
| WO2008024303A2 (en) | 2006-08-21 | 2008-02-28 | Synta Pharmaceuticals Corp. | Compounds for treating proliferative disorders |
| JP2010502616A (ja) | 2006-08-31 | 2010-01-28 | シンタ ファーマシューティカルズ コーポレーション | 癌を治療するためのビス(チオヒドラジドアミド)の組み合わせ |
| BR112012026644A2 (pt) * | 2010-04-23 | 2017-12-19 | Kineta Inc | compostos antivirais |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7705027B2 (en) * | 2003-02-11 | 2010-04-27 | Vernalis (Cambridge) Limited | Isoxazole compounds as inhibitors of heat shock proteins |
| AR045595A1 (es) * | 2003-09-04 | 2005-11-02 | Vertex Pharma | Composiciones utiles como inhibidores de proteinas quinasas |
| KR100544347B1 (ko) * | 2003-12-11 | 2006-01-23 | 한국생명공학연구원 | 디아릴이소옥사졸계 화합물을 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물 |
| EP1919882A2 (en) * | 2005-02-17 | 2008-05-14 | Synta Pharmaceuticals Corporation | Isoxazole combretastatin derivatives for the treatment of proliferative disorders |
-
2007
- 2007-09-13 WO PCT/US2007/019905 patent/WO2008033449A2/en not_active Ceased
- 2007-09-13 AU AU2007294752A patent/AU2007294752A1/en not_active Abandoned
- 2007-09-13 US US12/310,950 patent/US20100093670A1/en not_active Abandoned
- 2007-09-13 EP EP07838160A patent/EP2059250A2/en not_active Withdrawn
- 2007-09-13 CA CA002662554A patent/CA2662554A1/en not_active Abandoned
- 2007-09-13 JP JP2009528287A patent/JP2010503674A/ja not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015166860A1 (ja) * | 2014-04-30 | 2015-11-05 | 日本カーバイド工業株式会社 | オキシラン化合物及びそれを用いた含窒素複素環式化合物を製造する方法 |
| JPWO2015166860A1 (ja) * | 2014-04-30 | 2017-04-20 | 日本カーバイド工業株式会社 | オキシラン化合物及びそれを用いた含窒素複素環式化合物を製造する方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2662554A1 (en) | 2008-03-20 |
| WO2008033449A2 (en) | 2008-03-20 |
| US20100093670A1 (en) | 2010-04-15 |
| AU2007294752A1 (en) | 2008-03-20 |
| WO2008033449A3 (en) | 2008-08-07 |
| EP2059250A2 (en) | 2009-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5123671B2 (ja) | 増殖性疾患の治療のための化合物 | |
| JP5480623B2 (ja) | Hsp90活性を調節するトリアゾール化合物 | |
| US8501790B2 (en) | Compounds for the treatment of proliferative disorders | |
| JP2010503674A (ja) | 血管形成治療用化合物 | |
| US8399435B2 (en) | Compounds for the treatment of proliferative disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100902 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100902 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20111109 |